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ABSTRACT
4,4-Difluoro-3a,4a-diaza-s-indacene, better known as BODIPY® dyes, have attracted
considerable attention due to their intriguing physicochemical and spectral properties, including
high absorption coefficient, fluorescence quantum yield and good photochemical stability.
Despite the recent progress achieved in this field, the synthesis of BODIPY derivatives that
absorb and emit in the red- and NIR-region of the electromagnetic spectrum and their application
to biomolecular targets, represents a long-standing challenge in BODIPY chemistry. This
research work is therefore focused on the synthesis and characterization of red and NIR-emissive
BODIPY-based fluorophores for various bioanalytical and biomedical applications.
Chapter 1 of this dissertation represents a concise introduction to the fundamental
concepts, synthetic routes, post-synthetic modification strategies and various biological
applications of BODIPY dyes, that are further elaborated upon in the following Chapters.
Chapter 2 describes the synthesis, characterization, computational modeling and cellular
investigations of a series of new functionalized mono- and dibenzo-appended BODIPYs that are
promising fluorophores for biolabeling applications. These ring expanded and constrained
BODIPYs were synthesized via two different routes from a common tetrahydroisoindole
precursor. This work was done in collaboration with Dr. Petia Bobadova-Parvanova of
Rockhurst University.
Chapter 3 reports on the synthesis and characterization of several styryl- and lysylBODIPY conjugates, prepared using Knoevenagel condensation reaction, an attractive strategy
for the expeditious synthesis of π-extended BODIPYs in moderate to high yields. The effects of
the styryl substituents on their photophysical properties and in vitro photodynamic activities are
also described.

xii

Chapter 4 discusses an efficient method towards the preparation of a series of BODIPYPEG and BODIPY-Carbohydrate conjugates via Cu(I)-mediated azide/alkyne cycloaddition, i.e.
“click” chemistry. Several NIR-emissive BODIPY conjugates that are potential in vivo imaging
agents were prepared in good to excellent overall yields. The photophysical studies of novel
BODIPY-PEG and BODIPY-Carbohydrate conjugates are described in addition to the
preliminary in vitro investigations.

xiii

CHAPTER 1: INTRODUCTION

1.1: Structure of BODIPY® Dyes
Recent developments in many different fields of modern science and medicine, such as
molecular biology, material science, analytical and environmental chemistry, drug discovery and
tissue diagnostics, have fueled the design of new fluorophores that can be excited to emit within
the red or near-infrared (NIR) region of the spectrum.1 This is in part attributed to the optical
sensitivity associated with the “biological window” (700-900 nm) of the optical spectrum
including minimal interference from the endogenous chromophores, optimal photon penetration
through tissue, reduced light scattering and lower damage to the cells/tissues under observation.2
Though numerous nonradioactive fluorescent organic dyes, such as fluorescein, rhodamines and
cyanines, are available, the difluoro-boraindacene family (4,4-difluoro-4-bora-3a,4a-diaza-sindacene, abbreviated hereafter as BODIPY, registered trademark of Invitrogen (now Life
Technologies Inc., Figure 1.1) has earned increasing interest as being one of the more versatile
heterocyclic skeleton fluorophores.3
BODIPY dye, often referred to as “Porphyrin’s little sister”,4 consists of a
dipyrromethene ligand complexed with a disubstituted boron atom, generally a BF2 moiety. The
dipyrromethene ligand is formed by joining of two pyrrole units via an interpyrrolic methine
bridge. Due to BF2 complexation, the BODIPY fluorophore can be seen as “constrained” crossconjugated cyanine-type dye with fixed planarity of the chromophoric π-electron system.5 The
rigidity introduced by the boron complexation, further prevents the cis-trans isomerization and
interpyrrolic methine chain-twisting, problems commonly associated with comparatively flexible
cyanine dyes.

1

The single crystal X-ray structure of BODIPY chromophoric core indicates a fused ring
based framework with strong π-electron delocalization within the central six-membered and two
adjacent five-membered pyrrole rings of the dipyrromethene unit (Figure 1.2).6 This π-electron
delocalization is interrupted between both B-N bonds. Deviation from planarity is found for the
unsubstituted BODIPY chromophore that exhibits “saddled geometry” due to the boron atom
deviating from the mean indacene plane by a 4.8° angle. The average bond length of N 1-C3
indicates double bond character, compared with the single-bond character of N1-C4. The
molecule displays two slightly different B-F bond distances.7 The bond angles of N1- B1-N2 and
F1- B1-F2 indicate a distorted tetrahedron BF2N2 configuration. Although BODIPY resembles a
typical monomethine cyanine dye with 6π electrons delocalized over 5 atoms, the actual
fluorophore is found to be isoelectronic with heptamethine cyanines, with 12π electrons equally
distributed over 11 atoms.8

Figure 1.1: a)-c) Generic structure of common fluorophores; d) “BODIPY core” and its IUPAC
numbering system5
2

Figure 1.2: X-ray crystal structure of unsubstituted BODIPY with atom labels and 50%
probability displacement ellipsoids9

Each unit cell of BODIPY fluorophore consists of four molecules stacked in a head-totail fashion. Such crystal packing arrangement helps to optimize the π-π interactions between the
hydrophobic BODIPY molecules and variations in the dipole moments caused by the fluorine
atoms.10 Slightly polarized heteroatoms generate various electron-rich and electron-deficient
reaction sites at different positions on the internally zwitterionic BODIPY framework. These
reaction sites favor both nucleophilic and electrophilic substitution reactions on the BODIPY
core, and provide a plethora of new routes for structural modifications on unsubstituted
BODIPYs.11
The BODIPY and its derivatives are strongly UV-absorbing small molecules with
outstanding photophysical characteristics when compared with classical fluorophores, such as
fluorescein and tetramethylrhodamines dyes, with fluorescence emissions in the visible region.
BODIPY dyes are highly colored, neutral compounds with intense absorption and emission
profiles (λmax between 500-545 nm), high molar absorption coefficients (typically in the region
of 40,000 to 80,000 M-1 cm-1), high fluorescence quantum yields (normally ΦF > 0.60),
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reasonably long fluorescence lifetimes (τ in the nanosecond range) and relatively small Stokes
shift (ca.10 nm). In addition, BODIPY dyes have excellent thermal and photostability in both
solution and solid states, good solubility in most organic solvents, resistance towards selfaggregation in solution and insensitivity to changes in pH and solvent polarity.3b, 12
The absorption spectra of a typical BODIPY fluorophore shows a narrow and intense
band due to the S0-S1 (π-π*) transition with λmax between 500-525 nm, a shoulder at high energy
centered around 480 ± 5 nm assigned to the 0-1 vibrational transition, and a weak yet broad
absorption band around 375 ± 5 nm attributed to the S0-S2 (π-π*) transition.8, 13 When excited
into either the S1 or S2 states, a narrow, slightly Stokes-shifted emission band of mirror image
shape with λmax positioned between 530-560 nm is observed from the S1 state. Phosphorescence
is a rare phenomenon in BODIPY-based dyes due to negligible triplet energy state and a slow
rate of intersystem crossing (except for one report due to heavy-atom effect of
diiodoBODIPY).14
The absorption bands of BODIPY dyes can be further shifted to the red or NIR region by
facile derivatization of the BODIPY core. The photophysical characteristics of synthetically
modified BODIPYs vary with respect to the number, nature, as well as the position of the
attached substituents.15 Additionally, the emission behavior of BODIPY fluorophores are greatly
affected by the steric interactions between their components and intramolecular rotations of their
chromophoric units.16
Ever-growing success of BODIPY dyes has inspired a large amount of research into the
design, synthetic modifications and spectroscopic/photophysical characterization of these bright
small molecule fluorophores. Many synthetic methodologies and modification techniques
discussed hereafter will be used throughout the dissertation.
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1.2: Synthetic Methodologies
The first synthesis of a green fluorescent BODIPY dye was accidently achieved in 1968
by Treibs and Kreuzer17 by reaction of 2,4-dimethylpyrrole with acetic anhydride in the presence
of BF3.OEt2. This reaction afforded a mixture of mono- and di-acetylated BODIPY fluorophores,
1 and 2 (Scheme 1.1). It was therefore realized that 2,6-positions on BODIPY chromophore are
highly electron deficient i.e. susceptible to electrophilic substitution reactions.

Scheme 1.1: Synthesis of mono- and di-acetylated BODIPY fluorophores 1 and 2

In 1985, Wories and colleagues18 reported the synthesis of the first water-soluble
BODIPY fluorophore for use in angiographic studies. During this period, another group of
scientists, Haugland and Kang19 contributed significantly to the field of fluorescent materials,
including BODIPY dyes. Different derivatives of BODIPYs were prepared for lipid and protein
systems which eventually made them inventors of nearly 80 Unites States patents and the largest
commercial supplier of BODIPY dyes and its bioconjugates (founder of Molecular Probes, now
Life Technologies Inc.). BODIPYs and their bioconjugates are now recognized as fluorescent
and photostable substitutes to their predecessors, and are employed mainly for biological
labeling applications.20 However, within the past decade, due to advent of new optoelectronic
5

and biomedical technologies, there has been a BODIPY renaissance leading to enormous
research interest, patents and review articles3b, 4, 15, 21 illustrating the design of amphiphilic and
longer-wavelength absorbing and emitting BODIPY dyes for multifarious applications such as
tunable laser dyes,22 fluorescent labels for biomolecules and cellular imaging,23,
switches,25 photosensitizers,14,

26

light-emitting devices,25d,

27

24

fluorescent

drug delivery agents,3a,

26c

chemosensors28 29 and solar cells.30 31

1.2.1: Synthesis of the parent BODIPY core
Synthetic approaches to the BODIPY framework are generally based on well-known
chemistry of pyrroles and dipyrromethanes, i.e. synthetic precursors for porphyrin and related
macrocyclic compounds.1,

4

Starting from readily available pyrroles, it is relatively easy to

produce a variety of dipyrromethene ligands, which after complexation with BF3 in the presence
of a base, generate the required parent BODIPY fluorophore, often in reasonable and
reproducible quantities.
While there are a myriad of structurally variant classes of BODIPY dyes mentioned in the
literature, the synthesis of the parent unsubstituted BODIPY chromophore remained a challenge
until recently9-11 because of the synthetic limitations related to the highly unstable
dipyrromethene precursor.3b Three independent research groups reported the synthesis and
characterization of the BODIPY core chromophore 3 (Scheme 1.2). In the first report by Bruce
and co-workers (Path 1),9 the unsubstituted BODIPY chromophoric core was synthesized by
DDQ oxidation of the dipyrromethane 4 to dipyrromethene. In order to stabilize the highly
reactive dipyrromethene core, the DDQ oxidation was carried out at -78°C, under inert
conditions, for 1 hour. On reaction completion, the formed dipyrromethene was then reacted in
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situ with DBU and BF3.OEt2 to form targeted compound 3 in 5-10% yield. The structure of the
BODIPY was further characterized by 1H-,

13

C-,

11

B- and

19

F-NMR and X-ray single crystal

analysis.
Wild and co-workers,11 synthesized the desired BODIPY via a classic one-pot
asymmetric BODIPY synthesis approach involving acid-catalyzed condensation of pyrrole-2carbaldehyde 5 and pyrrole 6, followed by BF3 complexation in the presence of a base (Path 2).
Repeated purification over silica column chromatography afforded the target compound 3 in 8%
overall yield. BODIPY 3 exhibits high photostability (τ = 7.2 ns) but low thermal stability,
decomposing at temperatures above 50°C, due to lack of stabilizing substituents. BODIPY 3, as
characterized by UV/Vis and fluorescence spectroscopy, displays a typical green fluorescence
with maximum wavelength of absorption and emission at 503 and 512 nm, respectively.

Scheme 1.2: Synthesis of the core compound of BODIPY dye 3

7

A more efficient route was developed by Pena-Cabrera and co-workers (Path 3),10
generating the target compound in excellent chemical yield by mild reaction between 8thiomethyl BODIPY 732 and triethylsilane in the presence of a catalytic amount of palladium and
a stoichiometric amount of copper(I) thienyl-2-carboxylate (CuTc) in THF at 55°C for 45 min.
BODIPY 3 displays high quantum yields (up to 93%) in nonpolar and polar solvents, including
water.

1.2.2: Synthesis of symmetric BODIPY dyes
Symmetric BODIPY dyes substituted at the meso- or 8-position (Scheme 1.3) are usually
prepared by acid-catalyzed condensation of pyrroles with acid chlorides, anhydrides or aldehydes
to generate the dipyrromethene (or dipyrromethanes from aldehydes which are subsequently
oxidized). In order to avoid further polymerization, the pyrroles have to be substituted at the C-2
position.33 The dipyrromethenes are then converted to BODIPY dyes by action of a tertiary base
and BF3.OEt2. Yields for this reaction are generally more than 50% with high purity and
reproducibility. BODIPY dyes bearing substituents at the meso-position often display enhanced
stability with respect to their meso-unsubstituted counterparts. A large range of functional groups
are compatible with these reaction conditions and these methods are the most popular routes,
often referred to as “classical one-pot two/three-step reaction”. The major advantage of the
reaction lies in the ability to use the meso-substituent as a point of elaboration to build larger
architectures, an approach richly explored by many researchers to design BODIPY-based
indicators or labels.34
Symmetric BODIPY dyes unsubstituted at the meso-position are obtained by selfcondensation of an appropriate pyrrole carbinyl cation precursor under acidic conditions (for
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instance, p-toluenesulfonic acid, Montmorillonite clay), followed by BF2 complexation
(conventional approach, Scheme 1.4).35 The same compound can be prepared via selfcondensation of pyrrole-2-carbaldehyde in the presence of phosphorus oxychloride, a modified
approach recently reported by Wu and Burgess.36 In the proposed mechanism, phosphorus
oxychloride is believed to react with pyrrole-2-carbaldehyde to generate a chlorinated
azafulvene, which is then attacked by second pyrrole moiety to form the required
dipyrromethenium cation and dichlorophosphate counterion. From this step onwards, the
BODIPY is routinely synthesized by trapping the parent dipyrromethene as its BF2 complex. The
new modified reaction conditions generated products in yields much higher, as compared with
the conventional approach.

Scheme 1.3: General outline for the synthesis of symmetric BODIPY dyes
9

1.2.3: Synthesis of asymmetric BODIPY dyes
Asymmetric BODIPY dyes, substituted or unsubstituted at the meso-position, are usually
obtained by the MacDonald coupling approach, i.e. via acid-catalyzed condensation of a pyrrole2-carbaldehyde with an α-free pyrrole.37 The desired dipyrromethene is generally isolated in its
salt form, which on complexation with BF3.OEt2 in the presence of a base, usually a tertiary
amine, affords the required BODIPY dye (Scheme 1.5). Yields for these reactions are generally
very high, but are reduced drastically when an electron-deficient α-free pyrrole is used. Under
such conditions, self-condensation of pyrrole-2-carbaldehyde is the favored reaction and yields
the undesired symmetric BODIPY as the major product. The main advantage of this method lies
in the possibility to attach different functional moieties on the BODIPY scaffold for further
derivatization or bio-conjugation.

Scheme 1.4: Syntheses of symmetric meso-unsubstituted BODIPYs
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Scheme 1.5: General outline for the synthesis of asymmetric BODIPY dyes

1.3: Derivatization of the BODIPY framework
Typical BODIPY dyes have certain drawbacks, such as relatively low wavelength
absorption and emission maxima (λmax around 500 nm),38 small Stokes shifts, poor solubility in
aqueous media and lack of functional groups for conjugation to biological materials.39 These
drawbacks further limit the full utilization of BODIPY fluorophores for various biomedical and
bioanalytical applications. Many of these obstacles can be surmounted via synthetic
modifications as the BODIPY chromophore itself is intrinsically electron-rich and can be
conveniently derivatized at various positions to analogues that span the entire visible spectrum
and beyond. Efforts are underway in various laboratories (Vicente,40 Ziessel,3a Burgess,25b
Nagano,14 Rurack and Daub,41 Akkaya,42 O’Shea,43 Carreira,44 Boens and Dehaen45) to
investigate new facets of fluorescent BODIPY dyes. A variety of strategies to fine-tune the
optoelectronic properties have been achieved by functionalization of the BODIPY scaffold at the
8- (meso-), 2,6-, 3,5- positions, the boron center or by rigidification of the BODIPY core.

1.3.1: Functionalization at the meso- or 8-position
Functionalization at the C-8 (meso) position is relatively easy compared with the
substitution at the pyrrolic positions, as it can be achieved by acid-catalyzed condensation of
pyrrole with appropriately substituted aryl aldehydes or acyl chlorides.46 This method continues
11

to be the most versatile method till date for introduction of various “handles” on the BODIPY
core such as ligands,1,

4, 47

chiral auxillaries,48 donor-acceptor groups49 and water-solubilizing

groups2d, 12b for applications as chemosensors, pH probes, light-harvesting arrays and biological
labels (Figure 1.3, structures 8 to 11). In-depth photophysical studies have been carried out by
Boens and co-workers1,

45, 50

to study the effect of various electron-rich or electron-deficient

groups at the C-8 positions. It has been noticed that the spectral characteristics of 8-substituted
BODIPYs do not show a marked change due to the orthogonal geometry of the meso substituent
and the BODIPY fluorophore, which results in poor electronic conjugation between the two
moieties. However, the introduction of ortho-substituents on the meso-phenyl ring, the
replacement of phenyl with bulkier aromatic groups or the introduction of 1,7-substituents on the
BODIPY skeleton, drastically improve the fluorescence emission efficiency due to restricted
intramolecular rotation and steric hindrance between the substituents.16
Exchange of C-meso for nitrogen atom generates a sub-class of BODIPY dye commonly
called “aza-BODIPYs (e.g. 12 and 13).”25b Due to structure similarity with phthalocyanines, this
subclass of BODIPYs could also be referred to as “Semi-phthalocyanines.” The notable feature
of this dye system is its intense absorption and emission bands in the 650-850 range, high molar
extinction coefficient, moderate fluorescence quantum yields (0.23-0.36) and insensitivity to the
solvent polarity.51 Further rigidification of the chromophoric core, in turn, improves the stability
and spectral properties of the molecule. Though the precursor azadipyrromethenes were long
known, this class of BODIPY has only lately stimulated study. A handful of aza-BODIPYs have
been synthesized from substituted-chalcone (O’Shea,51-52 Akkaya53 and Burgess25b) or from a
conformationally restricted pyrrole precursor (Carreira44) and investigated as photosensitizers,54
conformationally restricted NIR imaging probes,25b,
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52, 55

NIR-emitting chemosensors44 and

fluorescent labels for polymer characterization.56 These dyes offer a number of advantages in
comparison to their carbon analogues, including ease of synthesis and an inherent red-shift in the
absorption and emission maxima due to the better stabilization of the HOMO-LUMO energy gap
by lone pair on nitrogen at the meso position.4

Figure 1.3: Chemical structures of various meso-substituted BODIPYs from literature: 8,50 9,57
10,58 11,59 1253 and 1344
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1.3.2: Functionalization at the 2,6-positions
Simple consideration of mesomeric structures of BODIPY reveal that the 2 and/or 6positions of the BODIPY core bear the least positive charge and hence are more susceptible to
electrophilic attack (Figure 1.4). Surprisingly only limited electrophilic substitution reactions
have been reported including sulfonation,18 nitration,60 halogenation,61 and formylation46 into the
BODIPY backbone through the electron-rich 2,6-positions. While sulfonate groups impart watersolubility to the hydrophobic BODIPY core without affecting the absorption and emission
maxima significantly, the introduction of nitro or halo groups drastically decrease the
fluorescence quantum yields with respect to the parent dye (Figure 1.5, structure 14). The
decrease in the fluorescence quantum yield for bromo and iodo groups is attributed to the
internal heavy-atom effect.62 Recently, a myriad of diphenylethynyl-BODIPY oligomers have
been generated from 2,6-diiodo BODIPYs to serve as potential building blocks in the
construction of several light-emitting conjugated polymers and functional supramolecular
assemblies (e.g. 15).63

Figure 1.4: Susceptible positions for the electrophilic attack on 1,3,5,7-tetramethyl BODIPY dye

Another direct approach for π-conjugation extension at the 2,6-positions of BODIPY
molecules involve palladium-mediated C-H functionalization (e.g. 16). As reported by Thivierge
and co-workers,12b the halogenated or metalated intermediates, generate both mono- and di14

substitution products with fluorescence emissions in the range of 525-570 nm. This methodology
can be employed for the syntheses of hydrophilic BODIPY systems with functional groups to act
as “tags” for bioconjugation.

Figure 1.5: Chemical structures of various 2- and/or 6-substituted BODIPYs from literature:
14,64 1563d and 1665

1.3.3: Functionalization at the 1,3-positions
The 3,5-Dimethyl substituents on electron-deficient BODIPYs are acidic enough to
undergo base-catalyzed Knoevenagel-type condensations.3b A variety of electron-donating and
recently electron-withdrawing aromatic aldehydes have been used to introduce different styryl
moieties at the 3- and/or 5-positions, in order to bring significant red-shifts in the optical spectra
with respect to the parent chromophore (Figure 1.6, structure 17). Styryl-derivatization of
BODIPYs is often a more convenient and less time consuming approach over the analogous
lengthy synthetic routes,2d and highly functionalized BODIPY derivatives can be generated in a
single step by controlling the reaction conditions.
The presence of good leaving groups (such as iodine or chlorine atoms) at the 3- and/or
5- positions allow electron-deficient BODIPYs to undergo nucleophilic aromatic substitution
(SNAr)66 and transition metal-catalyzed coupling reactions (Heck, Sonogashira, Stille and
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Suzuki, e.g. 18 and 19).67 As reported by Dehaen and Boens, 3,5-dichloroBODIPYs can be
easily modified by substitution with carbon, nitrogen, oxygen and sulfur nucleophiles to induce
large bathochromic shits of the absorption and emission maxima. Various aryl, ethenylaryl and
ethynylaryl substituents can be grafted on the BODIPY fluorophore using palladium-catalyzed
Stille, Suzuki, Heck and Sonogashira coupling reactions. These strategies have been richly
explored in the synthesis of novel BODIPY-based fluorescent materials for biosensing and
labeling applications.48a, 68

Figure 1.6: Chemical structures of various 3,5-substituted BODIPYs from literature: 17,69 1866
and 1940b
1.3.4: Modification at the boron center
Replacement of the two fluorine atoms in BODIPYs by aryl, ethynyl (or ethynylaryl) and
alkoxide groups, generates a new family of highly luminescent, redox-active and photostable
dyes called C-BODIPYs, E-BODIPYs and O-BODIPYs, respectively (Figure 1.7, structures 2022).3a This strategy provides a platform to overcome the problems commonly associated with
BODIPYs, i.e. small Stokes sifts and fluorescence quenching. Enhancement of the virtual Stokes
shift (>10 000 cm-1) can be realized by attaching one or more aromatic polycycles to the
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BODIPY fluorophore. The main strategy here is to attach many light absorbing units in one
molecule, so that there are many energy-donors but a single energy-acceptor, i.e. the BODIPY
nucleus. In such “energy-cassettes”, illumination into the appended polycycle leads to rapid
through-space energy-transfer from donor to the acceptor due to the significant overlap of the
donor emission and acceptor absorption spectra. Furthermore, the substituents on E-BODIPYs
do not affect the photophysical properties, unlike the case of BODIPYs, in which the spectral
properties can be tuned over a wide range. The attached donors merely function as near UVphoton collectors. This method of π-conjugation extension of BODIPY dyes is currently being
explored by Ziessel, Ulrich and Harriman, and many BODIPY scaffold-based molecular dyads,
photovoltaics, electroluminescent devices, energy transfer cassettes and supramolecular
assemblies have been realized so far.70

Figure 1.7: Chemical structures of various boron atom substituted BODIPYs from literature:
20,3a 2125a and 2271

1.3.5: Rigidification by the ring fusion
Aromatic ring fusion is a promising strategy towards the generation of long emission
BODIPY-based dyes with many possibilities for further functionalization.72 The pioneer work in
this field was carried out by Burgess et al. as they reported the synthesis of five conformationally
17

rigid BODIPY derivatives with heteroatom or ethylene bridge linkages (Figure 1.8, structure
23).73 As the emission behavior of luminogens is greatly enhanced by the restricted
intramolecular rotations and steric hindrance, these structurally constrained molecules were
found to be more emissive than their unconstrained analogues.16 Highly annelated-BODIPY dyes
could also be generated by aromatic ring annulation at the β,β’-positions of the BODIPY core.
This strategy has been exploited to generate BODIPYs fused with benzene,6 substituted
benzene,74 phenanthrene72, dihydronapthalene5, and spiro-fluorene moieties75 starting from either
aryl-fused pyrroles or 2-acetyl-phenols (e.g. 24 and 25).74

Figure 1.8: Chemical structures of rigidified BODIPYs from literature: 23,73 24,76 and 2572

1.4: Biological applications of the BODIPY dyes
A fluorescent dye (fluorophore) can act as an important reporting molecule when tagged
to various analytes (proton or metal ions) or biomolecules (proteins, peptides, lipid membranes
or nucleic acids). Fluorescent organic dyes are widely used as nonradioactive ligands in
biological analysis or as biomarkers in in vivo imaging.77 Dyes that fluorescence in the red or
NIR region have attracted much attention over the past few decades because of rapid
advancements in various bioanalytical and optical imaging techniques, such as DNA sequencing,
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gel electrophoresis, nucleic acid detection, in vivo imaging, vascular mapping and tissue
perfusion.19e
There are several advantages of working in the red/NIR region of the spectrum.
Endogenous chromophores present in living tissues, such as water, lipids, oxy- and
deoxyhemoglobin and other chemical compounds, absorb and scatter visible light, limiting its
penetration to only a few millimeters. Due to this phenomenon of “tissue auto-fluorescence” a
high background noise appears in the detection of biological samples, which obscures the signal
collection and quantification, as demonstrated in Figure 1.9. Fortunately, the absorption
coefficient of tissue is much lower for the NIR light, which permits its deeper penetration to
depths of several centimeters.2c

Figure 1.9: Tissue auto-fluorescence in the mouse using different excitation/emission filters;
(GB: gall bladder, SI: small intestines, BI: bladder).78 Reprinted with permission from [78]
Copyright (2002) Elsevier
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Additionally, the scattered light from the excitation source is greatly reduced in the NIR
region since the scattering intensity is proportional to the inverse fourth power of the
wavelength. Low background noise and low scattering of the NIR radiations result in a high
signal to noise ratio, thereby allowing highly sensitive detection. Further advantages of red/NIR
radiations include low interferences from Raman scattering and reduced possibility of sample
degradation. Due to these combined attributes, this region of the electromagnetic spectrum (ca.
700-900 nm) is often referred to as the “Biological window.” These advantages along with the
availability and low cost of long-wavelength diode lasers and detectors for the red/NIR light, has
led to increasing research interest in the design, development, spectroscopic characterization and
application of novel red/NIR-fluorescent labels, probes or indicators.
Besides the absorption and emission in the red or NIR region, an ideal NIR dye should
possess high molar absorption coefficients, high fluorescence quantum yields, robustness against
light and chemicals, good solubility, resistance towards self-aggregation, straightforward
synthetic routes and possibility for further and facile functionalization for construction of
fluorescent probes or indicators.1
Significant progress has been made towards the development of NIR fluorescent dyes
based on cyanines, squaraine, phthalocyanine, porphyrin and BODIPY scaffolds, with improved
photostability and fluorescence maxima ranging from 600-800 nm (Table 1.1). The principle
limitations of most of these dyes are low quantum yields, poor photo- and/or chemical- stability
and limited solubility in the aqueous media. So far, cyanine dyes form the main group of longwavelength fluorophores pursued for use in biological systems and to date, indocyanine green
[ICG: cardiogreen] is the only FDA and EMA-approved NIR imaging dye for medical use. It has
been used for decades as an angiographic contrast agent with low toxicity and negligible side
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Table 1.1: Some commercially available NIR dyes for conjugation to biomolecular targets
Dye name

Chemical Structure

Absorption
max (nm)
800

Emission
max (nm)
810

IRDye800CW
NHS ester
(LI-COR
Biosciences)

778

794

IRDye800CW
maleimide
(LI-COR
Biosciences)

778

794

DY-783 NHS
ester
(Dyomics
GmbH.)

783

800

ICG
(SigmaAldrich)
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Table 1.1: (continued)
La Jolla Blue
(Hyperion
Inc.)

680

700

BODIPY
630/650
(Life
Technologies
Inc.)

625

640

BODIPY
650/665
(Life
Technologies
Inc.)

646

660

effects. Unfortunately, like other cyanine-based dyes, ICG also has a low quantum yield (0.3% in
water and 1.2% in blood) and lacks additional functional group for conjugation to
biomolecules.79 IRDye®800CW is another promising next-generation NIR-fluorescent imaging
dye. It is a reactive dye which is functionalized with either an NHS or a maleimide reactive
group, allowing it to be attached to numerous targeting biomolecules.80 This dye has been
evaluated in several preclinical studies however, it lacks any clinical investigations.
As an emerging new class of fluorophores, BODIPY dyes have gained strong popularity
as small molecule fluorescent stains, labels and indicators. Highly fluorescent BODIPY dyes
combine many advantageous properties of NIR dyes such as high molar absorption coefficients
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(typically log εmax < 8.8), narrow and structured emission bandwidths (important in multicolor
applications), negligible dependence on solvent polarity and small Stokes shifts. BODIPY dyes
offer improved spectral characteristics compared with other conventional dyes. For instance,
when compared with the positively charged cyanines and rhodamines, BODIPY dyes are
electrically neutral and have relatively nonpolar structures.81 The lack of a net ionic charge
enhances the affinity of the BODIPY-labeled probes towards the targeted analyte or receptors.
Fluorophores based on BODIPY scaffold have been developed for various biological
applications, such as labels for biomolecules, indicators for proton and metal ions, stains for
organelles and substrates for enzymes (Figure 1.10).

Figure 1.10: Various biological applications of small molecule fluorescent probes.82 Reprinted
with permission from [82] Copyright (2008) American Chemical Society
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1.4.1: Biological Labels
There is a growing need for visualization and investigations of interactions between the
proteins, enzymes and other biomolecules in living cells. As an organism lacks selective
detectable signals, fluorescent labeling of biomolecules is often a powerful tool for this purpose.
For example, labels can be attached to proteins for imaging events in cells and whole-organisms.
BODIPY dyes, due to their excellent physicochemical properties and low dark
toxicities,40b are among the most promising candidates for fluorescent labels and probes. Also,
these organic dyes do not significantly influence the biological functions, on account of their
small molecular size. Numerous BODIPY-based fluorescent labels have been widely used to
target biological compounds such as DNAs, RNAs, nucleotides, amino acids, lipids, polystyrene
microspheres, dextran, and proteins.83 19c, 84 In general, BODIPY-based probes are functionalized
with reactive ligand/anchor groups at the end (such as carboxylic acids, sulphonic acids,
polyethylene glycol, polysaccharides, oligonucleotides), for effective bio-conjugation.2d Ligand
targeted BODIPYs have been developed for detection and visualization of various proteins
including β-amyloid plaques,85 unordered or ordered Aβ1-42 soluble oligomers86 and
neurofibrillary tangles (NFTs) tau proteins (Figure 1.11, structures 26 and 27).87
Due to their high peak intensity, fluorescent BODIPY probes are among the most readily
detectable fluorophores available for various analytical techniques such as gel electrophoresis
and DNA sequencing. Oligonucleotide conjugates of BODIPY fluorophores have been used in
DNA sequencing as the small molecule fluorescent dye exhibits a minimal effect on the fragment
mobility during electrophoresis.81
More recently, BODIPY derivatives have been evaluated as a totally new class of potent
photodynamic therapy agents,14,

88

an application more commonly associated with porphyrins
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and phthalocyanines. These photosensitizers are based on the BF2-chelated azadipyrromethene
core structure with bromo and polyethylene glycol moieties to promote singlet oxygen
generation (e.g. 28).
Additionally, many fluorescent probes based on BODIPY platform are being employed in
live cell labeling of biomolecules. A handful of potential BODIPY-based probes have been
reported for both single and two photon microscopic imaging for much deeper analysis of the
living tissue.89 Wolfbeis et al.90 reported the in vivo cellular labeling of biomolecules such as
sugars, amino acids and nucleotides using a combination of copper free and copper-mediated
click chemistry. In this approach, BODIPY-based clickable fluorophores were designed as nonnative, non-perturbing “Bioorthogonal reporters” and used for labeling the azide modified
surface glycans of CHO cells. In another report by Meijler and colleagues,91 live cell fluorescent
labeling of proteins (QS receptors) was carried out in a two-step bio-orthogonal labeling strategy
using aniline-catalyzed oxime formation between the receptor and the BODIPY fluorophore (e.g.
29).

Figure 1.11: Some known examples of fluorescent BODIPY probes as biological labels, from
the literature

25

Figure 1.11: (continued)

1.4.2: Enzyme Substrates
Enzyme activity is often analyzed using fluorometric assays, which use the difference
between the fluorescence of the substrate from the product to measure the enzymatic activities.
Enzyme-substrates that contain BODIPY fluorophore have been employed in several
fluorometric assays for measuring enzymatic activities of proteases, phospholipases,
chloramphenicol acetyltransferases, amylase and other enzymes (Figure 1.12).92 In 2009, Saba
and co-workers93 reported a new Sphingosine-1-phosphate lyase (SPL) assay to replace the
standard radioactive SPL assay. In this fluorescent assay, ω-labeled BODIPY-sphingosine-1phosphate substrate was used to effectively measure the activity of the sphingosine-1-phosphate
lyase in biological samples. BODIPY fluorophore has also been employed in designing of
fluorometric assays for proteases based on Fluorescence Resonance Energy Transfer (FRET).
The protease substrate in such assays is non-fluorescent due to phenomenon of “self-quenching”.
Hydrolysis of the protein to smaller fragments is accompanied by a dramatic increase in the
fluorescence due to disruption of intramolecular FRET quenching.94 This forms the basis of a
simple and continuum assay for a variety of proteases.
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Figure 1.12: BODIPY dyes as enzyme substrate for the detection of Fhit, a nucleotide-binding
protein92

1.4.3: Environmental Indicators
Intracellular pH and metal ions play a diverse and crucial role in several biological
processes and disorders. As a result, design and construction of selective and sensitive
fluorescent chemosensors have gained considerable research interest over the past decade.
Many fluorescent sensors are either constructed as fluorophore-spacer-receptor or as
intrinsic fluorescent probes (where the receptor is part of the π-electron system of the
fluorophore). Fluorophore-spacer-receptor systems operate on the basis of photoinduced electron
transfer (PET) and internal charge transfer (ICT) processes, respectively. Binding of the analyte
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(a metal or a proton) to the sensor is monitored by recording the alterations in either the
fluorescence intensity or wavelength. In both sensors, the absence of the analyte quenches the
luminescence due to PET or ICT in the excited state.83c In PET sensors, binding of the analyte
inhibits the PET while increasing the fluorescence intensity, without much change in the spectral
shift. In contrast, ICT sensor molecules show a moderate increase in their emission intensity
accompanied with significant shifts in their optical spectra. Hence, in most cases, for sensitivity
reasons, the interaction with the analyte is associated with the fluorescence “OFF/ON”
switching. Though many PET sensor molecules have been developed based on fluorescence
“ON/OFF” switching upon interaction with an analyte.48a
Organoboron compounds such as BODIPY dyes, have often displayed high potential as
building blocks in synthesis of novel chemosensors for various colorimetric and fluorimetric
assays.68b, 95 A series of small molecule fluorescent BODIPY-based sensors have been reported
for detection of protons, metal cations, anions and reactive-oxygen species.15 These sensors are
crucial for sensing and imaging pH,96 K+,97 Ni2+,98 Cu2+,40c Zn2+,99 Hg2+,28a etc metal ions in
living cells (Figure 1.13). There are many examples of crown,97, 100 cryptand,101 podand,102 2,2’dipyridyl,103 calixarene,104 p-(N,N-dialkyl)aniline41-based PET sensors for detection of protons,
sodium, calcium, potassium and transition metal ions, respectively.

1.4.4: Cellular Stains
Many biological samples, particularly cells are quite transparent when seen under the
microscope. The internal parts of the cells, such as the organelles are so transparent that they are
often difficult to see. Thus, visualization of the cell and its organelles with organelle specific
antibodies or organelle specific stains, provide a better understanding of cellular morphology and
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Figure 1.13: BODIPY based chemosensors1 for H+, K+, Ni2+, Cu2+, Zn2+ and Hg2+

functioning. Among the organelle specific stains, especially appealing are the small neutral dyes
such as BODIPY derivatives that can pass through a viable cell membrane more efficiently than
large molecules, and remain inside the cell depending on their reactivity and hydrophilicity.
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A range of cell-permeant BODIPY dyes either as “conjugate” or as “reactive
fluorophore”, have been employed for in vitro and in vivo visualization of intracellular
organelles. For instance, the red fluorescent BODIPY TR-glibenclamide and BODIPY TRceramide (Life Technologies Inc., Figure 1.14, structures 36 and 37), are the best known
commercially available structural markers for endoplasmic reticulum and Golgi apparatus,
respectively. Additionally, numerous yellow or green fluorescent BODIPY-conjugates such as
BODIPY FL-ceramide (e.g. 38), BODIPY FL C5-sphingomyelin (e.g. 39) and BODIPYbrefeldin A conjugates (e.g. 40), for live cell or fixed cell imaging and for flow cytometry, are
covered by several patents issued to Life Technologies Inc. In general, these dyes absorb and
emit at different wavelength ranges and the fluorescence emission of the dye does not change
with its intracellular environment.105 Low molecular weight BODIPY conjugates are often found
to be more permanent in living cells than the conjugates of charged fluorophores and the staining
at low concentrations, in general, does not appear to be toxic to the cells.92

1.5: Research Outlook
Despite the innumerable advancements in the BODIPY-field, these fluorophores are far
from being mature. The synthesis of BODIPY derivatives that absorb and emit in the red or NIR
region of the electromagnetic spectrum and their conjugation to various target biomolecules,
represent a long-standing challenge in the BODIPY biomarker community. For instance, most of
the available BODIPY dyes and bioconjugates emit in the visible region (< 600 nm) and very
few water-soluble BODIPY fluorophores have been reported in the literature. With these facts in
mind, the synthesis, characterization and in vitro evaluations of novel red and NIR emissive
BODIPY dyes and their bioconjugates will be discussed in the next Chapters.
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Figure 1.14: Commercially available red fluorescent BODIPY probes for ER and Golgi
apparatus labeling
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CHAPTER 2: SYNTHESIS, COMPUTATIONAL STUDIES AND BIOLOGICAL
EVALUATION OF NOVEL SYMMETRICAL AND UNSYMMETRICAL BENZOAPPENDED BODIPYS[a]

2.1: Introduction
Over the past decade, interest in the BODIPY dyes fused with external aromatic rings at
the β-carbon atoms has attracted considerable research interest.1 Often, referred to as “πextended BODIPYs” these dye systems possess many interesting properties, inviting applications
in many branches of material research and biomedical technology.2 Due to their high planarity,
extended π-conjugation and rigidified molecular framework, the spectral features of this class of
annelated BODIPY dyes are much sharper and well-defined, with their absorption and emission
wavelengths shifted considerably farthest to the infrared.3
Structurally constrained BODIPY dyes exhibit more favorable fluorescence emission
characteristics when compared with their unconstrained analogues.4 In general, the fluorescence
quantum yield of a fluorescent dye drops rapidly with an increase in the number of flexible
bonds in the molecule. This is attributed to the twisting of the single and/or double bonds that act
as an effective channel for dissipation of excitation energy by nonradiative decay of excited
states. Therefore, a complete fixation of the chromophoric system seems to guarantee an
intrinsically high conversion of the absorbed photons into emitted light, leading to an increased
fluorescence emission or brightness of the dye.1a
Among the rigid ring extended BODIPY systems, molecules such as dibenzo-fused
BODIPYs (hereafter abbreviated as db-BODIPYs) have become one of the most widely used
[a] This Chapter originally appeared as Uppal, T.; Hu, X.; Fronczek, F. R.; Maschek, S.;
Bobadova-Parvanova, P.; Vicente, M. G. H., Synthesis, Computational Modeling, and Properties
of Benzo-Appended BODIPYs. Chemistry – A European Journal 2012, 18 (13), 3893-3905.
Reprinted with permission from [2] Copyright (2012) John Wiley and Sons.
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building blocks for the construction of molecular switches and light-emitting polymers,5
biolabeling reagents,1b pH sensors,1c and photovoltaic cells.6 Benzo-fused BODIPY dyes often
possess high rigidity in their structure which leads to a high fluorescence quantum yield in
solution as well as strong intermolecular π-π interactions in the solid state, the factors beneficial
for their applications as π-functional materials.7 In structural terms, these ring expanded and
annelated BODIPY dyes are closely related to the tetrabenzoporphyrins (TBPs) and can be
conveniently referred to as “half-TBP’s” (Figure 2.1)

Figure 2.1: The general structure of db-BODIPYs, TBP and Ar4TBP

Currently, the main synthetic approaches to the meso-substituted db-BODIPYs B
(Scheme 2.1) includes the Ono et al. method,1a which is based on the strategy of TBPs synthesis
and centers around the “masked” isoindoles i.e. bicyclo octadiene-fused pyrroles A. Such
pyrroles fused with non-aromatic rings are readily available from “Barton-Zard isocyanoacetate
chemistry” and appear to be useful synthons for other π-extended pyrrole-based macrocycles.3 In
this approach, the precursor pyrrole A, is condensed with aromatic aldehyde under typical
Lindsey conditions, followed by the treatment with N-ethyl-N, N-diisopropyl amine and
BF3.OEt2 to generate the bicycle [2.2.2] octadiene-fused BODIPY system (bc-BDP).
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Subsequently, the meso-substituted db-BODIPY B is generated by the retro Diels-Alder reaction
upon heating the “masked” BODIPY system to 220 °C under reduced pressure (30 mmHg) for
30 minutes. Though this approach enables the fast expansion of the scope and preparative value
of the benzo-fused BODIPYs, the major drawback of this methodology includes the severe
reaction conditions required for the final aromatization step to effect the ethylene extrusion,
which often leads to considerable loss of the product at final stage of the long synthesis. As a
result, the full potential of this approach has been so far largely unexplored, resulting in only a
handful of annelated BODIPY dyes that have been reported using this method.4

Scheme 2.1: Synthetic route to db-BODIPY B from bicyclooctadiene-fused pyrrole A

In direct connection with the present work, another approach to meso-unsubstituted dbBODIPYs D, initially developed by Kang and Haugland,8 utilizes the substituted 2acylacetophenones C (Scheme 2.2) as the building units to db-BODIPY derivatives.6,

9

Compound C is first condensed with ammonia to generate the dibenzo-fused dipyrrin, which
after treatment with unig’s base and BF2-chelation, affords the constrained db-BODIPY dyes in
good overall yields. This synthetic methodology is unique as it allows the introduction of various
functional groups at the 5-position on the isoindole ring for further derivatization of the BODIPY
dyes. Though considerable efforts for the development of new methodologies for the synthesis of
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constrained benzo-fused BODIPYs have been investigated, however, there still remains a scope
for shorter and more efficacious approaches to contribute towards achieving the synthesis of
these systems in a synthetically useful manner.

Scheme 2.2: Synthetic route to db-BODIPYs D from 2-acylacetophenone C

Given an overwhelming array of applications, it appears interesting and relevant to search
for more reliable and practical approaches to π-extended BODIPYs. Starting from the closely
related pyrrolic precursors to isoindole, some plausible synthetic routes to db-BODIPYs are
depicted in Scheme 2.3.10 For db-BODIPY synthesis, the most straightforward method of acidcatalyzed condensation of aromatic aldehyde with 2H-isoindole (Scheme 2.3, Route 1) is not
possible due to the high reactivity and instability associated with the precursor pyrrole. Another
approach utilizing bicyclooctadiene-fused pyrrole (Scheme 2.3, Route 2) represents the classical
“Ono et al.” method and suffers from certain drawbacks, as discussed before. Alternatively, the
db-BODIPY system can be assembled by the use of stable pyrrolic compounds such as 4,7dihydroisoindole and 4,5,6,7-tetrahydroisoindole (Scheme 2.3, Route 3 and 4, respectively), as
explored for the synthesis of TBPs, where the final aromatization step can be performed by
oxidative dehydrogenation with DDQ. These approaches, so far, have not been developed into a
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general method of db-BODIPY synthesis, despite the preparation of π-extended dipyrrins from
4,7-dihydroisoindole, as recently reported by Filatov and co-workers.11

Scheme 2.3: Synthetic routes to symmetrical db-fused BODIPYs

Therefore, in search of a facile and reliable method for the synthesis of π-extended
benzo-fused BODIPYs, two synthetic pathways starting from thermodynamically stable 4,5,6,7tetrahydroisoindole ester were investigated. While we were hopeful that these new systems
would exhibit red-shifted spectral features, the principle motivation for this work was to study
the structural variations on the BODIPY chromophoric core, including the effect of; (1)
benzannulation of pyrroles, (2) number of fused-benzene rings, and (3) the nature of mesosubstituent (R) on the physicochemical and in vitro biological properties of the db-BODIPY
dyes.

2.2: Results and Discussion
2.2.1: Syntheses
The C-8 or meso-position of the BODIPY chromophore has often been used to attach
several aryl substituents with various functionalities for increased solubility and/or conjugation
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to target-specific molecules. Although meso-arylation on the BODIPY chromophoric core
doesn’t lead to pronounced effect on the linear absorption and fluorescence emission
wavelengths, the steric hindrance between the meso-aryl group and the 1,7-substituents on
BODIPY core is known to significantly enhance the fluorescence quantum yields due to the
restricted rotational motion of the aryl group at the meso-position, and reduced rate of
fluorescence quenching in such ring constrained, rigidified molecules.12

Scheme 2.4: Retrosynthetic route to db-BODIPYs 4a-e

Bearing this apparent analogy in mind, the structure of target db-BODIPY dyes 4a-e,
along with the retrosynthetic analysis is depicted in Scheme 2.4. The key starting material of the
entire reaction sequence is 4,5,6,7-tetrahydroisoindole ester 1. Such cyclohexenyl-fused pyrroles
can be conveniently prepared in bulk quantities from commercially available 1-nitroarenes and
ethyl isocyanoacetate, in the presence of a base (such as DBU) via Barton-Zard synthesis.13
Another useful precursor, meso-unsubstituted dipyrromethane 2a, was prepared in excellent
yields (92%) in one step by acid-mediated condensation of pyrrole 1 and dimethoxymethane,
dissolved in acetic acid at room temperature, using a published literature procedure (Scheme
2.5).14
Meso-substituted dipyrromethanes, which in principle are key synthons in this dbBODIPY synthesis, are usually prepared via a one-flask method based on the acid-catalyzed
condensation (trifluoroacetic acid or trifuoroacetic acid/K-10 clay) of an appropriate aldehyde
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with two equiv. of pyrrole-2-carboxylates, under well-established Lindsey chemistry.15 However,
in our hands, this classical approach when applied to the synthesis of dipyrromethane 2b,
afforded the target compound in moderate yields of 68% and 70% respectively, (Scheme 2.6)
due to side reactions promoted by the action of strong acid in the presence of liberated water.

Scheme 2.5: Synthetic route to 4,5,6,7-tetrahydroisoindole ester 1 and dipyrromethane 2a

Scheme 2.6: Synthetic route to dipyrromethane 2b

Recently, according to the modified protocol described by Vinogradov et al., the yields of
dipyrromethane synthesis from the pyrroles with aromatic aldehydes can be significantly
improved in the presence of mild acids, such as p-toluene sulfonic acid and anhydrous
tetrabutylammonium halide, a highly hygroscopic salt that facilitates the salt-effected water
scavenging.14 Hence, the synthesis of dipyrromethane 2b was repeated using this modified
approach to ensure an optimal yield (~ 95%) of the desired compound 2b. This strategy was later
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extended to the synthesis of a series of meso-substituted dipyrromethanes 2c-e, by condensation
of pyrrole 1 with pentafluorobenzaldehyde, p-anisaldehyde and methyl 4-formyl benzoate
respectively, followed by flash column chromatography, affording the target compounds in
moderate to excellent yields, as shown in scheme 2.7.

Scheme 2.7: Synthetic routes to dipyrromethanes 2c-e

All the synthesized dipyrromethanes were analyzed by NMR (1H,

13

C) and mass

spectrometry. Well-resolved 1H-NMR spectra of 2a-e showed a peak due to NH protons at ~ 8.7
ppm, the meso-proton as a sharp singlet at ~ 5.5 ppm, ortho and meta-protons as doublets in the
aromatic region (for 2b, 2d and 2e). The 16 protons of the two cyclohexenyl rings appeared as
three sets of triplet due to 4, 4 and 8 protons at ~ 2.7, 2.2 and 1.6 ppm, respectively. The large
difference in the chemical shifts between the α-protons on the cyclohexenyl rings is attributed to
the ring current of the meso-aryl group which is roughly perpendicular to the effective indacene
plane, leading to shielding of the α-protons in the meso-substituted area. A typical 1H-NMR
spectrum for dipyrromethane 2d is shown in Figure 2.2. MS-ESI analysis gave a molecular ion
peak at m/z 2a: 398.49; 2b: 474.25; 2c: 587.19; 2d: 504.26 and 2e: 533.26. X-ray crystal
structures were obtained for dipyrromethanes 2a-d by slow evaporation of the solvent from
dichloromethane solution of these compounds (discussed in Section 2.2.3).
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Figure 2.2: 1H-NMR spectrum of dipyrromethane 2d in CDCl3 at 400 MHz

Two pathways for the conversion of dipyrromethanes 2a-e to fully aromatized dbBODIPYs 4a-e were investigated; namely bicyclo-BODIPYs pathway (Route A) and dibenzodipyrrins pathway (Route B), as depicted in Scheme 2.8 and Scheme 2.11. In Route A, the
BODIPY chromophore was assembled first from the dipyrromethanes 2a-e, followed by
oxidative aromatization similar to TBPs synthetic methodology. In alternative Route B, the
aromatization step was performed prior to the construction of the BODIPY core.
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Scheme 2.8: Synthetic route to db-BODIPYs 4a-e following Route A

In Route A, the bicyclo-BODIPYs 3a-e (abbreviated hereafter as bc-BODIPYs) was
synthesized from corresponding dipyrromethanes 2a-e via two-step one-flask procedure. In the
first step, dipyrromethenes 2a-e was oxidized with 1.2 equiv. of DDQ in THF (for 2a) or
dichloromethane (for 2b-e) at 0 °C. The progress of the reaction was monitored by TLC analysis,
which clearly indicated the formation of corresponding dipyrromethenes 2’a-e as the sole
products within 15-20 minutes. Without isolation, compounds 2’a-e were treated with
triethylamine (6 equiv.) and BF3.OEt2 (10 equiv.), first at 0 °C for 30 min. followed by stirring
overnight at room temperature. TLC and absorption spectral analysis of the crude reaction
mixture indicated the formation of bc-BODIPYs 3a-e. The crude product was then subjected to
silica gel column chromatographic purification and afforded bc-BODIPYs 3a-e as shiny green
solids in 60-80% overall yields (3a: 67 %; 3b: 80 %; 3c: 75 %; 3d: 73 % and 3e: 60 %
respectively). Single crystal of BODIPYs 3b-e was obtained by slow evaporation of n-hexane
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into a solution of compounds in dichloromethane over a period of 2 days (see Section 2.2.3 for
details). Trace amounts of intermediate dipyrromethenes 2’b-e were also isolated in all these
reactions in< 5% yield. The formation of BODIPYs 3a-e was confirmed by molecular ion peaks
in ESI-MS at m/z 3a: 444.20; 3b: 520.23; 3c: 610.19; 3d: 550.25 and 3e: 577.22 respectively.
The absorption spectrum of bc-BODIPYs 3a-e showed one strong S0-S1 absorption band at λmax
= 553, 540, 563, 539 and 542 nm due to 3a, 3b, 3c, 3d and 3e respectively. 1H-NMR spectra for
3a-e (as shown in Figure 2.3 for 3d) when compared to their precursor dipyrromethanes 2-e, in
general, indicated the absence of signals corresponding to NH protons because of their
complexation with boron of the BF3 molecule.

Figure 2.3: 1H-NMR spectrum of BODIPY 3d in CDCl3 at 400 MHz
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Though the use of dipyrromethenes as effective chelating ligands is well-known, little
attention has been paid so far, to the studies of reaction mechanism or intermediates formed in
the synthesis of BODIPY dyes. This is partly attributed to the high rates involved in establishing
of equilibrium in such complexes, which makes the kinetics studies much difficult to monitor.
Recently, Rumyantsev et al.16 had defined BODIPY dyes as the boron fluoride complex of
dipyrromethene, formed by interaction of dipyrromethene (Hdpm, donor) and BF3 (acceptor) in a
1:1 ratio according to the following two-step mechanism:

The first step of the BODIPY synthesis is the formation of a stable donor-acceptor
complex (DAC) due to strong donor-acceptor interactions between the lone pair of electrons on
pyrrolenine nitrogen atom of the donor with the vacant p-orbital of the boron atom in the BF3
molecule (Scheme 2.9). This step is accompanied by the change in the geometry of the BF3
molecule from planar to tetrahedral, which places one of the fluorine atoms on BF3 molecule in
close proximity to the NH group of the donor. The second step then involves the hydrogen bond
formation between the hydrogen atom of the NH group of the dipyrromethene and the nearest
fluorine atom in the BF3 molecule. The hydrogen bonding [N- …..F-B] stabilizes the donoracceptor complex and further promotes the elimination of HF in the final step of the BODIPY
core formation. In general, the BF2-complexation reactions are carried out in moderately polar
solvents such as toluene and dichloromethane as the BF3 molecule is only slightly solvated under
these conditions. The use of more polar solvents such as DMF and DMSO is generally avoided
as BF3 is known to form quite stable complexes with these polar electron donor molecules.
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Scheme 2.9: Mechanism of BODIPY 4b synthesis from dipyrromethene 2’b and BF3.OEt2

The next step of this route is the aromatization of bc-BODIPYs 3a-e to db-BODIPYs 4ae, which required the removal of 8 hydrogens by the ways of oxidative dehydrogenation. Fully
aromatized db-BODIPYs 4a, 4b, 4d and 4e (with an exception of 4c) were synthesized by
heating the solution of corresponding bc-BODIPYs 3a, 3b, 3d and 3e in toluene with 9 equiv. of
DDQ at 110 °C. TLC analysis initially showed more number of spots corresponding to partially
oxidized BODIPYs, but with the progress of the reaction, these spots disappeared and one major
highly fluorescent spot corresponding to fully oxidized db-BODIPYs was observed. The
progress of the reaction was also judged by the color change of the reaction mixture from
fluorescent orange-red to a deep blue fluorescent solution and also by spectrometric monitoring
of the reaction (i.e. intensive maximum at λmax = 642, 643, 643 and 644 nm due to 4a, 4b, 4d and
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4e respectively). The crude mixture was purified by silica gel column chromatography to afford
4a, 4b, 4d and 4e as shiny deep blue crystals in 67-92% yields (Table 2.1).
Table 2.1: Synthesis of db-BODIPYs 4a, 4b, 4d and 4e from corresponding bc-BODIPYs 3a,
3b, 3d and 3e via Route A
db-BODIPYs

Time (h)

Yield (%)

4a

3-4

69

4b

6

67

4c

-

-

4d

2

92

4e

8

68

The reaction appears to be quite general. From Table 2.1, it can be seen that for
BODIPYs with electron withdrawing meso-aryl groups (BODIPY 4e), longer reaction time (~
8h) are required for complete aromatization, while for BODIPY 4d, a much shorter reaction time
of ~ 2 h was required. In the case of BODIPY 4c bearing a meso-pentafluorophenyl group, no
progress could be observed even after several hours/days of refluxing. Analysis of the reaction
mixture revealed that the aromatization of BODIPY 3c to BODIPY 4c occurred very slowly and
never came to completion, making it clear that the bc-BODIPY 3c is totally inactive in
aromatization. Well-resolved 1H-NMR spectra of 4a, 4b, 4d and 4e showed additional peaks in
the aromatic region, corresponding to the newly annelated benzo rings, as shown in Figure 2.4
for db-BODIPY 4d. The 8 protons of the two benzo rings appeared in between 7.2-8.4 ppm, as
four triplets due to two protons each. Once again, the large difference in chemical shifts between
the α-protons of the benzo rings is attributed to the superposition of the ring currents of BODIPY
core plus the benzo rings and the ring current of the meso-aryl group (shielding of the α-protons
in the meso-substituted bay with respect to those in the meso-unsubstituted bay). MS-ESI
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analysis gave a molecular ion peak at m/z 4a: 436.20; 4b: 512.17; 4d: 542.18 and 4e: 570.18
respectively.

Figure 2.4: 1H-NMR spectrum of BODIPY 4d in CDCl3 at 400 MHz

Since the oxidative aromatization is an important step to db-BODIPYs synthesis, it is
interesting to consider the possible mechanism for this transformation. Oxidations by DDQ are
usually regarded within the framework of the SET/hydride abstraction mechanistic dualism.3 The
most plausible mechanism involves the single-electron transfer (SET) from the bc-BODIPYs to
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DDQ with the formation of an ion-radical pair [bc-BODIPYs+•/DDQ‾•] at the first stage. The
semiquinone anion-radical DDQ‾• further facilitates the stepwise abstraction of a hydrogen atom
and a proton, with the net result of dehydrogenation. Alternatively, this sequence can be
presented as an abstraction of a hydride from bc-BODIPY followed by the proton transfer.
Further, when applied to the case of BODIPY 3c, it is possible that electron-withdrawing
pentafluorophenyl group has a much slower rate of oxidation due to its lower tendency to form
benzylic cation intermediate, either by SET/hydride abstraction by DDQ.2
We further attempted to carry out the synthesis of BODIPY 4c by carrying out oxidation
using “pre-metalation” - a strategy developed for the synthesis of meso-substituted Ar4TBPs
from their precursor tetracyclohexenoporphyrins (Ar4TCHPs). Ar4TBPs are often synthesized by
oxidizing metalated Ar4TCHPs (MAr4TCHPs, where M = Zn, Cu, Ni etc) upon treatment with
DDQ in refluxing solvents. After aromatization, the MAr4TBPs are demetalated to give the
corresponding Ar4TBPs as free bases. As dipyrromethenes are known to form stable and isolable
complexes with Zn and other bivalent metal cations, we anticipated that a similar methodology
when applied to dipyrromethene 2’c, could generate the desired db-BODIPY 4c as depicted in
Scheme 2.10. A mixture containing 2’c and an excess of Zn(OAc)2 [in 3:2 ratio] was stirred
overnight at room temperature in CHCl3/MeOH, under standard dipyrromethene-Zn
complexation conditions.17 The reaction mixture was filtered off using celite and the solvent was
evaporated in vacuo to afford the deep-red neutral homoleptic dipyrromethene-Zn complex (2’cZn) in 52.7% yield. 2’c-Zn complex was then treated with DDQ (16 equiv.) in boiling organic
solvents such as toluene, acetonitrile, dichloromethane and DMF. However, all our attempts to
oxidize the cyclohexyl rings in the metalated dipyrromethene complex, turned out unsuccessful
as the more labile complex rapidly lost its metal under the employed aromatization conditions,
yielding the dipyrromethene 2’c which was recovered by column chromatography.
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Scheme 2.10: Alternate synthetic route to db-BODIPY 4c

In another attempt to generate db-BODIPY 4c, the aromatization of BODIPY 3c was
studied using various inorganic oxidizing agents. In a typical procedure, a solution of BODIPY
3c in dichloromethane was treated with a methanolic solution of the oxidizing agent. The
resulting reaction mixture was first stirred at room temperature for 6 h and then heated at reflux
for additional 3 h. The progress of the reaction was monitored by MALDI MS and UV-vis
spectroscopy (Table 2.2). All attempts to oxidize BODIPY 3c using inorganic oxidizing agents
failed to generate/isolate the desired product in decent or lower yields.
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Table 2.2: Aromatization of BODIPY 3c using inorganic oxidation approach
Oxidizing agent

MALDI-MS (m/z = 531 )

UV-Vis data (nm)

AgNO3

-

533

KMnO4

+

537

Cu(NO3)2

-

536

MnO2

+

546

CuCl3

-

534

RuCl3

-

533

I2-MeOH

+

537

Pd-C

-

537

CAN

-

-

FeCl3

-

537

Scheme 2.11: Synthetic route to db-BODIPYs 4a-e following Route B

We next focused on to the synthesis of db-BODIPYs 4a-e via Route B, which
commenced with the synthesis of dibenzo-dipyrins (db-dipyrrins) 5a-e from dipyrromethanes 2ae. Aromatization of 2a-e into db-dipyrrins 5a-e was realized by oxidation with 10 equiv. of
DDQ in refluxing toluene. Progress of the reaction was monitored from clear color change of the
reaction mixture (i.e. orange-red to deep purple solution) and by absorption spectroscopy (λmax at
568, 569, 583, 569 and 572 nm for 5a, 5b, 5c, 5d and 5e respectively). Interestingly, in spite of
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the overall facile reaction, once again the effect of meso-aryls was much more pronounced as
electron-withdrawing groups in meso-aryls considerably decreased the rate of the aromatization
and the product yield (Table 2.3). For e.g. aromatization of 2c and 2e required a longer reaction
time (~ 10 and 8 h respectively), while 2b was oxidized completely in 3 h upon bringing their
solution with DDQ to reflux. 2a and 2d (with meso-H and meso-p-methoxyphenyl group) had to
be refluxed for 2 h only. Nevertheless, in all these cases, aromatization could be drive to
completion and gave the target db-dipyrrins 5a-e in moderate yields, after careful column
chromatography and recrystallization using dichloromethane/hexane solvent mixture. All the dbfused dipyrrins 5a-e were analyzed by NMR and high resolution MS. 1H-NMR spectrum for 5d
(and related compounds), as displayed in Figure 2.5, showed the absence of the cyclohexenyl
peaks (in between 2-3 ppm) and presence of additional peaks in the aromatic region.
Table 2.3: Synthesis of db-dipyrrins 5a-e from dipyrromethanes 2a-e via Route B
db-dipyrrins

Time (h)

Yield (%)

5a

2

56

5b

3

66

5c

10

62

5d

2

69

5e

8
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Reactions of db-dipyyrins 5a-e with BF3.OEt2 in the presence of Et3N, in refluxing
toluene, gave rise to the formation of the corresponding db-BODIPYs 4a-e in 55-90% yields
(Table

2.4),

after

flash

column

chromatography

by

using

dichloromethane

or

dichloromethane/ethyl acetate as the eluent and silica gel as the absorbent, in analogy to standard
procedure reported in the literature,18 In general, DDQ oxidation of 2a-e to the corresponding
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fully aromatized db-dipyrrins 5a-e gave lower yields of 56-69%, when compared to oxidativedehydrogenation of BODIPYs 3a, 3b, 3d and 3e to BODIPYs 4a, 4b, 4d and 4e (67-92%). This
could be attributed to the higher stability of BODIPYs when compared to the corresponding
dipyrromethanes under oxidative reaction conditions. However, the BF2-complexation of 2a-e
(to 3a-e) and 5a-e (to 4a-e) gave nearly similar reaction yields. Overall, Route A is far by the
method of choice for the synthesis of db-BODIPYs affording the target products in higher yields
due to the ease of aromatization of BODIPYs over corresponding dipyrromethanes. However,
Route B could be followed to synthesize π-extended BODIPYs with highly electron-deficient
meso-aryl groups (such as 4c) due to slow oxidation of their corresponding BODIPY precursors.

Figure 2.5: 1H-NMR spectrum of BODIPY 5d in CDCl3 at 400 MHz
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Table 2.4: Synthesis of db-BODIPYs 4a-e from db-dipyrrins 5a-e via Route B
db-BODIPYs

Time (h)

Yield (%)

4a

3

55

4b

4-5

80

4c

overnight

56

4d

2

90

4e

overnight

75

In order to investigate the synthesis of bc-BODIPYs 3b-e and db-dipyrrins 5b-e from
dipyrromethenes 2’b-e, a dichloromethane solution of dipyrromethanes 2b-e was treated with 1.2
equiv. of DDQ at 0 °C, causing a color change of the solution to deep orange. Further column
chromatographic separation on a silica gel eluting with petroleum ether/ethyl acetate (7/3, v/v)
solvent mixture and recrystallization from pure dichloromethane afforded dipyrromethenes 2’b-e
in overall moderate yields (2’b: 75 %; 2’c: 70 %; 2’d: 82 %; 2’e: 68 %). Further BF2complexation and DDQ oxidation reactions were performed using the same protocol as
developed above for dipyrromethanes 2a-e. The results obtained from these reactions are listed
in Table 2.5.
Table 2.5: Synthesis of bc-BODIPYs 3b-e and db-dipyrrins 5b-e from dipyrromethenes 2’b-e
Dipyrromethene
2’b

bc-BODIPYs 3
Yield (%)
66

db-dipyrrins 5
Yield (%)
53

2’c

62

48

2’d

60

65

2’e

52

45
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As can be seen, the yields of bc-BODIPYs 3b-e obtained from 2’b-e decreased
significantly, when compared to their synthesis from dipyrromethanes 2a-e. On the other hand,
the yields for the db-dipyyrins 5a-e, were nearly similar to those obtained from 2a-e. Hence, it
can be concluded, that the generation of 2’b-e in situ, during the formation of db-BODIPYs is
much more beneficial as it increases the product yield by reducing an additional purification step
in the synthesis.
A second goal of this study was to prepare monobenzo-fused BODIPYs, in order to study
the effect of the number of fused rings on the optical properties of the ring-fused BODIPYs.
Scheme 2.12 and 2.13, depicts the synthesis of monobenzo-fused BODIPY 8 from monocyclohexenyl BODIPY 7, which in turn is prepared from pyrrole 6, following BF2-complexation
and oxidation procedure similar to Route A in Scheme 2.8. Compound 6 was synthesized from
its tert-butyl protected pyrrole precursor (A) in two steps involving deprotection of ester with
trifluoroacetic acid, followed by formylation with triethyl orthoformate.

Scheme 2.12: Synthetic route to mono-cyclohexenyl BODIPY 7
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Pyrrole 6 was dissolved in a solvent mixture of dry dichloromethane and trifluoroacetic
acid at 0 °C under argon. This mixture was stirred for 20 min. while cooling with an ice bath.
Next, 5 equiv. of triethyl orthoformate were added at 4 °C and stirring was continued until TLC
indicated reaction completion. The reaction mixture was then quenched by pouring it into icecold water and was subsequently neutralized with 10N NaOH solution. The product separated
out as green droplets and was extracted into dichloromethane. Combined organic extracts were
washed with 5% NaHCO3, brine and dried over anhydrous Na2SO4. The solvent was removed
under reduced pressure and crude brown product was purified on a silica gel column eluting with
dichloromethane/ethyl acetate (10/1, v/v) to give pale green crystals of the desired product 6 in
84% yield. The product was characterized by 1H-NMR (aldehyde peak at 10.2 ppm and a broad
NH singlet peak at 9.43 ppm) and MS-ESI (a peak at m/z 209.11). The structure of the
compound 6 was also confirmed by X-ray analysis as shown in Figure 2.6.

Figure 2.6: X-ray crystal structure of pyrrole-2-carbaldehyde 6

To an equimolar solution of pyrroles 1 and 6 in dry dichloromethane at 0 °C under argon,
phosphorus oxychloride (POCl3) was added dropwise over a period of 5 min. The reaction
mixture was stirred at room temperature overnight and then treated with Et3N base and BF3.OEt2.
After the addition was over, the reaction was stirred at room temperature (16 h) and followed-up
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by silica gel TLC. Two well-separated fluorescent yellow spots due to their different Rf values
were observed on the TLC. The solvent was removed under reduced pressure and residue was
taken up in pure dichloromethane and washed with 10% aq. NaHCO3, brine and dried over
Na2SO4. The solvent was evaporated to dryness and residue was purified by column
chromatography (hexane/ethyl acetate, 3/2, v/v). Two fluorescent fractions were collected, dried
in vacuo and recrystallized from CH2Cl2/hexane to obtain the pure compounds, (later identified
as BODIPY 7 and BODIPY 7)’ as lustrous green solids in 40% and 15% yield respectively. The
structure of both the BODIPYs was unambiguously determined by NMR and mass spectrometry.
Formation of BODIPY 7’, under these reaction conditions can be attributed to the selfcondensation of pyrrole 6 as triggered by phosphorus oxychloride.

Scheme 2.13: Synthetic route to BODIPYs 8 and 8’
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The final aromatization step was performed by treating a solution of BODIPY 7 in
refluxing toluene with a solution of DDQ (5 equiv.) in toluene for a few minutes. The
aromatization took place instantaneously (within 5-10 min). Two fluorescent magenta spots with
marked difference in their Rf values were observed on silica gel TLC, ore polar spot became
prominent after 2 h. After 2 h, the reaction mixture was cooled down to room temperature and
the solvent was removed under the reduced pressure. The residue was taken in dichloromethane
and washed with saturated NaHCO3, brine and dried over Na2SO4. The solution was evaporated
to dryness and the residue was purified by column chromatography eluting with hexane/EtOAc,
3/2, v/v. The magenta fluorescent fractions were collected separately, dried in vacuo and
recrystallized from CH2Cl2/hexane to obtain the pure BODIPY 8 and BODIPY 8’ as lustrous
green solid in 4% and 71.3% yield. The percent yield of BODIPY 8 improved drastically (from
4% to 60%), on stopping the reaction after 10 min. The DDQ oxidation of the side chain methyl
group (in the substitution position 3) of BODIPY 8 can be explained by the initial abstraction of
hydride anion from the benzylic position, leading to a carbenium ion intermediate. Subsequent
trapping with water, followed by oxidation then generates the 3-formyl BODIPY 8’.19 Full
confirmation of the nature of BODIPYs 8 and 8’ was obtained using 1H-NMR, MS-MALDI and
X-ray crystal structure analysis (Figure 2.7).

Figure 2.7: X-ray crystal structure of BODIPY 8 and 8’
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Peripheral substituents on the BODIPY core can be used to impart desired
physicochemical and biological properties to the BODIPY dye. For example, these substituents
can be used to target the chromophore to various biological materials, modulate the electronic
properties such as absorption and emission or serve as scaffold for further synthetic
modifications. In addition, it is noteworthy that the aromatic ring fusion to the β-pyrrolic
positions on BODIPY chromophore is often considered to be a promising strategy, as it leaves
other positions such as meso-, 3,5-positions or boron center) for further synthetic modifications.
Hence, with the aim to further functionalize the designed db-BODIPYs, two different ways of
derivatization were investigated.
In our first attempt towards post-functionalization of db-BODIPYs, we targeted the
derivatization of the BODIPY at the boron center. Recently, Tahtaoui et al. 20 had described the
synthesis of a series of BODIPY derivatives obtained by nucleophilic displacement of the
fluorine atom at the boron center with various alcohols, in the presence of aluminium chloride. A
similar strategy was followed to obtain PEGylated-BODIPY 4f by replacing the fluorine atoms
on BODIPY 4b using 2-[2-(2-methoxyethoxy)ethoxy]ethanol, as depicted in Scheme 2.14.
A deep-blue solution of BODIPY 4b (1 equiv.) in dry dichloromethane was refluxed in
the presence of aluminium chloride (3 equiv.) under argon for 5 min, followed by addition of 2[2-(2-methoxyethoxy)ethoxy]ethanol and stirring at room temperature. TLC monitoring of the
reaction revealed the disappearance of the starting material and the formation of a more polar
green product, which was subsequently converted into a blue spot corresponding to BODIPY 4f.
Spectroscopic analysis of the reaction mixture indicated an absorption band similar to that of
parent BODIPY 4b. MALDI-analysis of the reaction mixture gave a molecular ion peak at m/z
888.42, indicating a total substitution of the two fluorine atoms on BODIPY 4b. However, all the
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attempts to isolate the highly polar BODIPY 4f on a deactivated basic alumina failed and as a
result, the product could not be isolated and/or characterized.

Scheme 2.14: Synthetic route to PEGylated-BODIPY 4f

Nucleophilic substitution reactions of the perfluorinated ring are well-documented, and
offer an effective way to generate C-S, C-N and C-O bonds to graft a variety of biological
molecules or water-solubilizing groups on a chromophore. The p-fluoro group on the
pentafluorophenyl moiety is known to react with a variety of primary nucleophiles such as HSCH2R, H2N-CH2R and HO-CH2R.21 Thus, selective nucleophilic substitution on a
pentafluorophenyl moiety of BODIPY 4c using a primary alcohol was studied with a goal to
tether an “alkyne tag” on BODIPY 4c for alkyne/azide cycloaddition via click chemistry,
following the synthetic route shown in Scheme 2.15.
A solution of BODIPY 4c in DMF was treated with 1.4 equiv of propyne-2-ol in the
presence of K2CO3 at room temperature. MALDI analysis of the reaction mixture indicated two
strong peaks at M+-19 and M+-BF2, corresponding to the loss of a fluorine atom (borenium
cation), and decomposition of the boron complex respectively, indicating that the lewis acid
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boron center is susceptible to an attack from a strong base. Though trace amounts of BODIPY 4g
could be detected as traces on TLC analysis as bright red-spot but could not be recovered after
several tedious silica gel purifications.

Scheme 2.15: Synthetic route to BODIPY 4h

2.2.2: Computational Analysis
As can be seen, experimentally the yields of the oxidation reaction depend significantly
on the meso-aryl substituent (R). The reaction yields are higher with R = 4-OMe-C6H4 and 4CO2Me-C6H4, when compared to R = C6H5 and C6F5. In order to theoretically explain the effect
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of different meso-substituents on the synthesis of db-BODIPYs, computational studies were
performed using Density Functional Theory (DFT) B3LYP potential and the 6-31G (d,p) basis
set. Four different aryl substituents, i.e. C6H5, C6F5, 4-OMe-C6H4, and 4-CO2Me-C6H4
corresponding to structures 2b-e, 2'b-e, 3b-e, 4b-e, and 5b-e respectively, were used for the
calculation of the reaction energetics (expressed in kcal mol-1). The results obtained are shown in
Scheme 2.16 and summarized in Table 2.6. As can be seen, thermodynamically, there is no
substantial difference observed on introducing different meso-aryl substituents on the BODIPY
chromophore. The calculated relative activation energies are between 2-4 kcal mol-1, which is
close to the calculation error (1-2 kcal mol-1). These results thus indicate that the significant
differences in the experimental yields obtained for the db-BODIPYs 4b-e could be tentatively
attributed to their different potential energy barriers.

Table 2.6: Relative activation energies (kcal mol-1) of BODIPY reaction species following two
different routes (Routes A and B) when different meso-aryl substituents are used.
BODIPY

C6H5

C6F5

4-OMeC6H4

4-CO2MeC6H4

reactant

2

0

0

0

0

intermediate

2'

14

13

15

14

intermediate

3

8

6

9

7

product

4

127

124

124

126

reactant
intermediate

2
5

0
138

0
136

0
135

0
137

product

4

127

124

124

126

ROUTE A

ROUTE B
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Scheme 2.16: Potential energy surface (kcal mol-1) as calculated at B3LYP/6-31G(d,p) level

As can be seen, the BF2-complexation reactions 2 → 2' and 2' → 3 were carried out in
dichloromethane, while reactions 2 → 5, 3 → 4, and 5 → 4 were performed in toluene.
Therefore, to examine the effect of different solvents on the reaction energetics, structures 2b,
2'b, 3b, 4b, and 5b were re-optimized in dichloromethane and toluene, respectively. The
presence of the solvent was found to stabilize all the structures and the results obtained are listed
in Table 2.7. As a result of different solvents, the energies for Route A shifted by 4-6 kcal mol-1,
however the relative energies remain approximately same and the potential energy is similar. On
the other hand, for Route B the solvent-effect is much more pronounced, especially in the case of
step 2. The presence of toluene shifts the energetics of step 2 by only 2 kcal mol-1, but that of
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step 1 by 7 kcal mol-1. Therefore, Route B leads to a more exothermic reaction in toluene solvent
than in gas phase mainly due to the increased exothermicity of step 1. These results suggest that
calculations in gas phase would give a more realistic description of the mechanism. However,
care must be taken when step 1 (Route B) is studied as solvent effects are more pronounced for
this step, which often results in higher exothermicity of the overall reaction than in gas phase.

Table 2.7: Relative activation energies (kcal mol-1) of BODIPY reaction species following two
different routes (Routes A and B) in gas and solvent phase.
BODIPY

In solvent

In gas-phase

ROUTE A
reactant
intermediate

2b
2'b

0
16

0
14

intermediate

3b

8

8

product
ROUTE B
reactant
intermediate

4b

131

127

2b
5b

0
145

0
138

product

4b

136

145

The molecular electrostatic potential (MEP) at a given point p(x,y,z) in the vicinity of a molecule
is defined as the force acting on a positive test charge (for instance, a proton) located at p
through the electrical charge cloud generated through the molecules electrons and nuclei. Despite
the fact that the molecular charge distribution remains unperturbed through the external test
charge (no polarization occurs) the electrostatic potential of a molecule is still a good guide in
assessing the molecules reactivity towards positively or negatively charged reactants. Thus, to
account for the different reactivity observed between 2b-e (or 2'b-e) and 3b-e, the feasibility of
the cyclohexenyl hydrogens towards oxidation reaction was investigated by calculating the
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average molecular electrostatic potentials at their nuclei (MEPN). The results obtained are
summarized in Table 2.8. The calculated MEPN showed significant differences when different
meso-aryl substituents were used. In general, dipyrromethenes 2' were found to have more
negative MEPNs when compared with the corresponding BODIPYs 3, making them less
electron-deficient and thus more prone to oxidation. As a result, the higher yields obtained from
oxidation of 3b,d,e compared with 2b,d,e and 2’b,d,e are presumably due to the higher stability
and lower tendency of BODIPYs to undergo side reactions. Interestingly, BODIPY 3c had the
highest value of MEPN among all the other BODIPYs, suggesting that this compound is too
electron-deficient to undergo oxidation, which is in line with the experimental observations.
Table 2.8: Average molecular electrostatic potential at nuclei (MEPN) at the cyclohexenyl
hydrogens of 2'b-e, 3b-e, and 2b-e.
Dipyrromethan
e

MEPNH

Dipyrromethene

MEPNH

BODIPY

MEPNH

2b

1.137

2'b

1.136

3b

1.128

2c

1.132

2'c

1.128

3c

1.120

2d

1.138

2'd

1.138

3d

1.130

2e

1.135

2'e

1.134

3e

1.126

2.2.3: X-ray Structure Determinations
Full confirmation of the nature of all compounds was obtained from the X-ray crystal
structures. Single crystals suitable for X-ray structural analysis could be obtained for compounds
2a-d, 2b’-d’, 3b-e, 4b-d, 8 and 5b-d by recrystallization from either pure dichloromethane or
mixed solvents of dichloromethane/hexane or dichloromethane/ethyl acetate (Figures 2.8 to
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2.11). The cell parameters and refinement details are reported in the Section 2.4.3 in the
experimental details.
X-ray analysis of these compounds confirmed the identity expected on the basis of their
synthesis and defined the effect of benz-annulation and boron substituent on the planarity of the
ring system. In the case of dipyrromethanes 2a-d, the two pyrrole rings showed significant
distortion from planarity , which is probably caused by the central Csp3-atom and two pyrrole
rings (average dihedral angle = 68.5°). Interestingly, the intramolecular hydrogen-bonding as
seen in the case of dipyrromethenes 2’b-d and db-dipyrrins 5b-d, caused the two pyrrole rings to
be more conjugated and coplanar as indicated by the decrease in their average dihedral angle
values of 8.6° and 7.0° respectively. Additionally, coordination of free-pyrroles to boron moiety
(for instance BODIPYs 3b-e, 4b-d and 8) indicated a tetra-coordination state on the central
boron atom and high planarity of the boron-coordinated ligand moiety.
There is a strong π-electron delocalization between the central six-membered ring and the
two adjacent pyrrole rings. However, no π-electron delocalization is observed between the mesoaryl group and the BODIPY core, due to planar indacene framework and orthogonal mesophenyl rings, as reported earlier for alkyl pyrroles and isoindole-BODIPYs.1b, c The bond angles
and bond lengths of the indacene ring system are very close to the values of previously reported
BODIPYs.1a,

12

Thus from the observed trends, it can be concluded, benzannulation and BF2-

complexation indeed induces increased conjugation and enhanced planarity in the molecule than
the corresponding saturated and free-pyrrole analogues.2 The extended conjugation and higher
ring-coplanarity are two important features of the BODIPY chromophore, with respect to its
spectroscopic properties and biological efficacy.
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Figure 2.8: ORTEP plots of dipyrromethanes 2a-d

Figure 2.9: ORTEP plots of BODIPYs 3b-e
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Figure 2.9: (continued)

Figure 2.10: ORTEP plots of BODIPYs 8, 4, 4d and 4e
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Figure 2.11: ORTEP plots of saturated dipyrromethenes 2b’-d’ and db-dipyrrins 5b-d
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2.2.4: Photophysical Studies
Comparative studies were performed for several cyclohexenyl-fused BODIPYs (7, 3a-e)
and benzo-fused BODIPYs (8, 4a-e) in solvents of different polarities (toluene, dichloromethane,
and methanol), in order to study the effect of molecular configurations including number of
benzo-rings, benzannulation and effect of meso-substituent on the spectroscopic properties of
BODIPY dyes. The results are compiled in Table 2.9 to 2.12, and the normalized absorbance and
emission spectra in three different solvents are shown in Figures 2.12 to 2.14.
Table 2.9: Spectral properties of BODIPYs 7 and 3a-e in dichloromethane and methanol at room
temperature
Absorbance log ε(M-1.cm-1)
λmax/nm

Emission
λmax/nm

Φf[a]

Stokes
Shift (nm)

4.3165

541

0.53

11

523

4.4553

536

0.32

13

DCM

553

4.0289

567

0.35

14

MeOH

545

4.0523

562

0.23

17

DCM

540

4.3079

561

0.34

21

MeOH

535

4.3358

555

0.29

20

DCM

563

4.0297

586

0.18

23

MeOH

557

4.0965

579

0.06

22

DCM

539

4.2467

559

0.34

20

MeOH

535

4.3582

556

0.20

21

DCM

542

4.2373

562

0.30

20

MeOH

538

4.3182

560

0.22

22

BODIPY

Solvent

7

DCM

530

MeOH
3a

3b

3c

3d

3e

[a] Fluorescence quantum yields for BODIPY 7 (λexc = 481 nm) and BODIPYs 3a-e (λexc = 500
nm) were calculated using Rhodamine 6G (0.80 in methanol) as the reference,[28] respectively.
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All these compounds possess characteristic features of BODIPYs including narrow
spectral bands with two absorption maxima-an intense S0-S1 transition and a weak shoulder at
high energy side due to 0-1 vibrational transition.22 The fluorescence emission spectra were
almost mirror-images of the corresponding absorption spectra. Absorption maxima for the
BODIPY core, monobenzo- and db-BODIPYs were centered at 540, 590 and 640 nm, and the
emission maxima at about 560, 595 and 665 nm, respectively. Benzannulation caused a
pronounced red-shift in the absorption and emission profiles of BODIPYs (~ 50-60 nm per
appended aromatics). Aromatization of monocyclo-BODIPY 7 to produce monobenzo-BODIPY
8 caused a bathochromic shift of ~ 60 nm in absorption and emission bands, whereas
benzannulation of bc-BODIPYs 3a-e to db-BODIPYs 4a-e resulted in nearly 90-104 nm redshift in the optical spectra.2

Figure 2.12: Normalized fluorescence spectra of BODIPYs 8 (black), 4a (red), 4b (blue), 4c
(orange), 4d (green), 4e (brown) in dichloromethane at 25 °C.
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Table 2.10: Spectral properties of BODIPYs 8 and 4a-e in dichloromethane at room temperature
BODIPY

Absorbance
λmax/nm

log ε(M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes shift
(nm)

4a

642

4.2971

664

0.38

22

4b

643

4.3881

665

0.38

22

4c

658

4.2826

680

0.31

22

4d

643

4.1858

664

0.43

21

4e

644

4.4196

666

0.43

22

8

589

4.1723

596

0.99

7

[a] Fluorescence quantum yields for BODIPY 8 (λexc = 530 nm) and BODIPYs 4a-e (λexc = 600
nm) were calculated using cresyl violet perchlorate (0.54 in ethanol) and methylene blue (0.03 in
methanol) as the reference,[28] respectively using Fluorolog®-3 Modular spectrofluorometer.

Figure 2.13: Normalized fluorescence spectra of BODIPYs 8 (black), 4a (red), 4b (blue), 4c
(orange), 4d (green), 4e (brown) in methanol at 25 °C.

It is noteworthy, that the spectral properties of BODIPYs 3c and 4c bearing electronwithdrawing pentafluorophenyl group differ significantly than those bearing the meso-aryl
groups. The absorption and emission bands for 3c and 4c showed a marked red-shift by 20 nm,
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indicating a better stabilization of HOMO/LUMO energy gap, as described recently by Galangau
and co-workers.23
Table 2.11: Spectral properties of BODIPYs 8 and 4a-e in methanol at room temperature
BODIPY

Absorbance
λmax/nm

log ε(M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes shift
(nm)

4a

635

3.5182

651

0.11

16

4b

635

4.2363

654

0.45

19

4c

652

nd

nd

nd

nd

4d

635

4.2697

655

0.38

20

4e

636

3.9434

654

0.36

18

8

582

4.2219

591

0.77

9

[a] Fluorescence quantum yields for BODIPY 8 (λexc = 530 nm) and BODIPYs 4a-e (λexc = 600
nm) were calculated using cresyl violet perchlorate (0.54 in ethanol) and methylene blue (0.03 in
methanol) as the reference,[28] respectively using Fluorolog®-3 Modular spectrofluorometer

Figure 2.14: Normalized fluorescence spectra of BODIPYs 8 (black), 4a (red), 4b (blue), 4c
(orange), 4d (green), 4e (brown) in toluene at 25 °C.
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Table 2.12: Spectral properties of BODIPYs 8 and 4a-e in toluene at room temperature
BODIPY

Absorbance
λmax/nm

log ε (M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes shift
(nm)

4a

644

4.1100

665

0.91

21

4b

643

4.000

663

0.83

20

4c

658

3.8560

679

0.60

21

4d

643

3.9150

662

0.81

19

4e

643

4.3999

663

0.82

20

8

587

4.1030

600

0.96

13

[a] Fluorescence quantum yields for BODIPY 8 (λexc = 530 nm) and BODIPYs 4a-e (λexc = 600
nm) were calculated using cresyl violet perchlorate (0.54 in ethanol) and methylene blue (0.03 in
methanol) as the reference,[28] respectively using Fluorolog®-3 Modular spectrofluorometer.
However, the electron-donating/withdrawing nature of the para-substituent on the
benzene ring of BODIPYs 4b, 4d and 4e was shown to have negligible influence on the
absorption and fluorescence emission properties of the BODIPYs.24 The absorption and emission
solvatochromism of all BODIPYs (except 4c) indicated only a weak dependence on the polarity
of the solvents, nearly 4-7 nm blue-shifts on changing solvent polarity from dichloromethane to
methanol, due to the increase in the non-radiative deactivation process in the more polar
solvents. In comparison, the fluorescence properties of BODIPY 4c were highly dependent on
the polarity of the solvent. In apolar solvents such as dichloromethane and toluene, intense
fluorescence was observed for 4c, however, in polar protic solvent such as methanol, hydrogen
bonding interactions due to pentafluorophenyl group induced the photoinduced electron transfer
between the excited BODIPY and the pentafluorophenyl moiety, resulting in significant
fluorescence quenching which lead to difficulty in recording its fluorescence spectrum and
quantum yield.22 Additionally, lower quantum yields were obtained for BODIPYs 3c and 4c,
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when compared to their analogues, presumably due to the additional aryl group rotation25 and/or
the heavy atom effect.26

Figure 2.15: Time-dependent fluorescence spectra of 0.32 mM DMSO solutions of BODIPYs 8
(a), 4a (b), 4b (c), 4c (d), 4d (e) and 4e (f), respectively, at 0 min (red), 15 min (blue), 30 min
(green), 45 min (brown), 60 min (purple), 120 min (orange) and 24 h (black) after solution
preparation, at room temperature. The excitation wavelengths for BODIPY 8 and BODIPYs 4(ae) were 530 nm and 610 nm, respectively.
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The fluorescence quantum yields for benzo-fused BODIPYs 4a-e were found to be higher
than those for cyclohexyl-BODIPYs 3a-e, as measured in dichloromethane. It is worth noting
that the presence of 3,5-methyl groups in BODIPYs 7 and 8 increased their fluorescence
quantum yields appreciably (0.53 and 0.99),

as compared to the 3,5-ethoxycarbonyls in

BODIPYs 3a-e and 4a-e, due to the “push-pull” electronic effect caused by the methyl groups at
the 3,5-positions.4,

27

All these results are is in line with the behaviour of the other methyl-

BODIPYs reported previously.
As high photostability is an important characteristic for various practical applications of
BODIPYs dyes, hence in order to study the effect of meso-substituents on BODIPY dye,
photofading process was studied for benzo-fused BODIPYs 8 and 4a-e in DMSO, over a period
of 24 h.27a As seen in Figure 2.15, significant decrease in the fluorescence emission maxima was
observed in the case of meso-free BODIPYs 8 and 4a. However, no fluorescence quenching was
observed for meso-substituted BODIPYs 4b-e, indicating that these dyes are much more stable
than dyes 8 and 4a.
2.2.5: In Vitro Cellular Studies
2.2.5.1: Cytotoxicity. The in vitro photocytotoxic activity of mono-(8) and db- BODIPYs (4a-e)
was evaluated against HEp2 cells exposed to increasing concentration of each compound up to
400 µM for 24 h, using Cell Titer Blue assay and irradiation with 1.5 J/cm2 of broad spectrum
light. Parallel assays without light irradiation were also carried out to determine the cytotoxicity
in the absence of light. Compounds stock solution was prepared in DMSO and Cremophor (<
0.9% DMSO/0.1% Cremophor). The dose-dependent survival curves for these BODIPYs are
shown in Figure 2.16 and 2.17 and the results are summarized in Table 2.13. Results were
expressed as IC50, defined as the concentration of dye (in µM) required to kill 50% of the cells.
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All BODIPYs were found to have very low dark cytotoxicities with IC 50 > 200 µM. All the
cellular studies were performed by Dr. Xiaoke Hu, from Vicente research group.
Table 2.13: Cytotoxicity (Hep2 cells) using Cell Titer Blue assay for benzo-appendedBODIPYs 8 and 4a-e.
Compound

Dark toxicity (IC50, µM)

Phototoxicity (IC50, µM)

8

400

> 100

4a

> 400

> 100

4b

236

> 100

4c

> 400

> 100

4d

> 400

> 100

4e

373.5

> 100

Figure 2.16: Dark toxicity of BODIPYs 4a-e and 8 toward HEp2 cells using Cell Titer Blue
assay
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Figure 2.17: Photo cytotoxicity of BODIPYs 4a-e and 8 toward HEp2 cells using using 1 J/cm2
light dose and the Cell Titer Blue assay

except for BODIPY 4b, which showed the highest dark toxicity presumably due to its lower
solubility in the biological media. Upon exposure to a low light dose (1.5 J/cm2), all BODIPY
derivatives were essentially non-phototoxic to HEp2 cells. The observed results are in good
agreement with previously reported in vitro photocytotoxicity investigations for various mesosubstituted BODIPYs.28, 29
2.2.5.2: Time-Dependent Cellular Uptake. The results obtained for the time-dependent uptake of
BODIPYs 8 and 4a-e at a concentration of 10 µM in human HEp2 cells, over a period of 24 h,
are shown in Figure 2.18. Significant differences were observed in the cellular uptake of these
BODIPYs and can be categorized on the basis of meso-free, meso-phenyl and mesopentafluorophenyl (C6H5)-BODIPY derivatives. BODIPY 4c with meso-C6H5 functional group,
accumulated the most within the cells than the meso-free and meso-phenyl BODIPYs, at all time
points studied. The higher cellular uptake for BODIPY 4c can be attributed to its polar
hydrophilicity which introduces charge and hydrogen bonding interactions that influence its
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ability to interact with cellular membrane and leads to increased uptake by the cells. It is
interesting to note that similar uptake results were obtained for all meso-aryl BODIPYs 4b, 4d
and 4e. On the other hand, the meso-free monobenzo- and db-BODIPYs 8 and 4a were least
taken up by the cells, presumably due to their lower photostability and significant fluorescence
self-quenching. These findings are in agreement with previous reports, indicating that the
presence of meso-aryl group increases the photostability of BODIPYs over meso-unsubstituted
BODIPYs.27b
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Figure 2.18: Time-dependent uptake of BODIPYs 8 (black), 4a (red), 4b (blue), 4c (purple), 4d
(green) and 4e (brown) at 10 M by HEp2 cells
2.2.5.3: Intracellular Localization. The preferential sites of intracellular localization of BODIPY
8 were evaluated using Leica DMRXA fluorescence microscope. First the HEp2 cells were
observed using 40X NA 0.8dip objective lens in the phase-contrast mode, followed by exposure
to UV-visible light using a Texas-red filter, DAPI and GFP filter (to check the background autofluorescence, Figure 2.19a). Next, the cells were exposed to 10 M compound concentration for
6 h. and observed under microscope using the Texas-red filter (Figure 2.19b). Later on, the cell
cultures with BODIPY 8 were incubated with ER Tracker Blue/White, Mitotracker Green,
BODIPY FL C5 ceramide and LysoSensor Green, i.e ER, Mitochondria, Golgi apparatus and
Lysosome specific tracker dye respectively. The signals obtained were first imaged using the
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DAPI/GFP filter set (to record emission by organelle-specific dye, Figures 2.19c, e, g and i) and
then using Texas-red filter (to record the emission by BODIPY 8). Finally the two images
obtained in each case were overlapped to obtain images shown in Figure 2.19d, f, h and j in
order to explore the sites of preferential localization of BODIPY 8 in HEp2 cells. The results
obtained from these studies are shown in Figure 2.19 and are summarized in Table 2.14.
The intracellular localization studies were extended to BODIPYs 4a-e using the same
method and instrumention. The fluorescence patterns obtained from these studies are shown in
Figure 2.20 to 2.24 and summarized in Table 2.14. As can be seen, all BODIPYs investigated
were found to localize preferentially in the endoplasmic reticulum of the cell. Furthermore, all
the BODIPYs were found in other cell organelles, for instance BODIPY 4a-d and 8 were found
in mitochondria, 4a and 4c-e in the lysosomes and 4a, 4d and 4e in the Golgi. Our results are in
accordance with many commercially available and previously reported alkyl and aryl-substituted
BODIPYs that show low cytotoxicity, high photo-stability, effective plasma membrane
penetration and intracellular distribution in multiple organelles.30
Table 2.14: Major Subcellular Sites of Localization for BODIPYs in Hep2 cells.
Compound

Major sites of localization

8

ER, Mito

4a

ER, Lyso, Golgi, Mito

4b

ER, Mito

4c

ER, Lyso, Mito

4d

ER, Lyso, Golgi, Mito

4e

ER, Lyso, Golgi
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2.3: Conclusion
In this work, the synthesis, spectroscopic and computational investigations of a new
series of conformationally restricted BODIPY dyes have been investigated by introducing
benzene units fused to the β,β’-pyrrolic positions of the BODIPY core. Two different synthetic
routes (i.e. Route A and Route B) were investigated to provide a practical and straightforward
approach to benzo-appended BODIPYs 4a-e. Route A involved the formation of boron complex
followed by benzannulation performed using DDQ, whereas in Route B, the aromatization step
was performed prior to BF2-complexation. Higher reaction yields for db-BODIPYs 4a-e (except
4c) were obtained via Route A, which is attributed to the better stability of BODIPYs 3a-e over
dipyrromethenes 2’a-e under oxidation conditions. However, due to slow reactivity of BODIPY
3c (bearing a meso-pentafluorophenyl group) towards oxidative conditions, the corresponding
db-BODIPY 4c could only be obtained from Route B in 35% yield. X-ray crystallographic
analysis and additional computational modeling of these compounds employing DFT, provided
further insight into the electronic features of such sterically-crowded BODIPY fluorophores. Xray-structural analysis displays the progressively extended planarity of the chromophore which is
in line with the increased conformational restriction in the series 3a-e, 4a-e and 5a-e, leading to
larger red-shifts of the absorption and emission wavelengths. The π-extended db-BODIPYs
displayed strong bathochromic shifts in their absorption and emission profiles in the order of
589-658 nm and 598-680 nm respectively, with ~ 50-60 nm shifts per attached benzene subunit.
In the series, BODIPY 4c bearing meso-pentafluorophenyl group, displayed the highest redshifted spectra (~ 20 nm more red-shift) and lowest fluorescence quantum yields, when
compared to those, that had a meso-phenyl group. In general, the BODIPYs in the series 3a-e
and 4a-e, tend to have small Stokes’ shifts due to their rigid ring-fused framework which
prevents the non-radiative deactivation of the excited state of the molecule. Moreover, the
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absorption and emission wavelengths of such rigidified BODIPYs can be easily tuned to obtain
BODIPY dyes absorbing at > 700 nm by further modification at the 3,5-positions of the
BODIPY core. In vitro biological investigations using HEp2 cells revealed low cytotoxicities,
high plasma-membrane permeability and intracellular localization mainly in the cell endoplasmic
reticulum along with other cell organelles. This work indicates that the red-emissive and
photostable benzo-appended BODIPYs (e.g. db-BODIPYs 4b-e) can supplement the existing
dyes, for instance, rhodamines in more lipophilic applications such as doping of polymer
particles/beads and study of less polar environments.

2.4: Experimental
2.4.1: General Information
All air and moisture sensitive reactions were performed under argon atmosphere in oven-dried
glassware. Common reagents were obtained from commercial source and used without further
purification, unless otherwise stated. Dry solvents were collected from PS-400 Solvent
Purification System from PS-400 Solvent Purification System from Innovative Technology, Inc.
Melting points were determined in open capillary and are uncorrected. Column Chromatography
was performed on silica gel (Sorbent Technologies, 60 Å, 40-63 µm) slurry packed into glass
columns. Analytical thin-layer-chromatography (TLC) was carried out using polyester backed
TLC plates 254 (precoated, 200 µm, Sorbent Technologies). 1H NMR and

13

C NMR spectra

were recorded on Bruker DPX-400 (operating at 400MHz for 1H NMR and 100 MHz for

13

C

NMR) in CDCl3 (7.26 ppm, 1H and 77.0 ppm,13C) with tetramethylsilane as internal standard. All
spectra were recorded at 25°C and coupling constants (J values) are given in Hz. Chemical shifts
are given in parts per millions (ppm). High resolution mass spectra were obtained at the LSU
Department of Chemistry Mass Spectrometry Facility using an ESI or MALDI-TOF method, and
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Figure 2.19: Subcellular localization of BODIPY 8 in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 8 fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 8 fluorescence. Scale bar: 10 m.
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Figure 2.20: Subcellular localization of BODIPY 4a in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 4a fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 4a fluorescence. Scale bar: 10 m.
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Figure 2.21: Subcellular localization of BODIPY 4b in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 4b fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 4b fluorescence. Scale bar: 10 m.
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Figure 2.22: Subcellular localization of BODIPY 4c in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 4c fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 4c fluorescence. Scale bar: 10 m.
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Figure 2.23: Subcellular localization of BODIPY 4d in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 4d fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 4d fluorescence. Scale bar: 10 m.
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Figure 2.24: Subcellular localization of BODIPY 4e in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 4e fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 4e fluorescence. Scale bar: 10 m.
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a peak matching protocol to determine the mass error range of the molecular ion. Bis(3ethoxycarbonyl-4,5,6,7-tetrahydro-2H-isoindolyl) methane (2a)14 was synthesized as described
previously.
2.4.2: Syntheses
General procedure for synthesis of 8-aryl-bis(3-ethoxycarbonyl-4,5,6,7-tetrahydro-2Hisoindolyl)methanes (2b-e)
Pyrrole 1 (0.1007 g, 0.5 mmoles) was treated with p-toluenesulfonic acid (0.0047 g, 0.025
mmoles), n-tetrabutylammonium chloride (0.0036 g, 0.01 mmoles) and corresponding aldehyde
(0.3 mmoles) in CH2Cl2 (50mL). The mixture was stirred overnight at room temperature under
inert atmosphere, washed with saturated NaHCO3 (2 x 30mL), brine (1 x 30mL) and dried over
Na2SO4. The solvent was evaporated in vacuum and the residue was chromatographed on a silica
column (hexane/ethyl acetate 5/1 for 2b, 2d, 2e and hexane/ethyl acetate 7/3 for 2c). The product
was finally re-crystallized from CH2Cl2-hexane mixture.
2b: Yield 117 mg (95%), beige solid , mp (110-112°C) 1H-NMR (CDCl3): δ 8.74 (br s, 2 ),
7.32-7.08 (m, 5H), 5.42 (s, 1H), 4.22-4.15 (m, 4H), 2.78 (m, 4H), 2.21 (m, 4H), 1.68 (m, 8H),
1.28 (t, J = 7.12 Hz, 6H); 13C NMR (CDCl3): δ 161.8, 139.1, 130.8, 129.2, 128.9, 128.2, 127.3,
119.7, 116.7, 59.7, 40.6, 23.3, 23.1, 21.2, 14.5; ESI-HRMS m/z 474.25; Calcd. for C29H34N2O4
[M+H+] 475.2575
2c: Yield 123 mg (87%), beige solid, mp (106-108°C) 1H-NMR (CDCl3): δ 8.71 (br s, 2 ), 5.79
(s, 1H), 4.27 (q, J = 7.12 Hz, 4H), 2.27 (m, 4H), 2.26 (m, 2H), 2.12 (m, 2H), 1.70 (m, 8H), 1.33
(t, J = 7.12 Hz, 6H); 13C NMR (CDCl3): δ 161.4, 146.0, 143.6, 141.9, 139.2, 139.1, 136.5, 128.9,
126.3, 120.2, 117.6, 113.4, 113.3, 113.1, 60.0, 29.8, 23.1,23.0, 22.8, 21.0, 20.1, 14.4; ESI-HRMS
m/z 564.20; Calcd. for C29H29F5N2O4 [M+Na+] 587.1946.
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2d: Yield 112 mg (89%), pale pink solid, mp (113-116°C) ;1H-NMR (CDCl3): δ 9.39 (br s, 2 ),
7.91 (m, 2H), 7.15 (m, 2H), 5.50 (s, 1H), 4.18-4.06 (m, 4H), 3.91 (s, 3H), 2.74 (m, 4H), 2.26 (m,
4H), 1.69 (m, 8H), 1.24 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ 166.6, 161.9, 144.9, 130.2,

129.9, 129.2, 128.9, 128.1, 120.0, 117.2, 59.8, 52.1, 40.1, 23.3, 23.1, 23.1, 21.4, 14.4; ESIHRMS m/z 504.26; Calcd. for C30H36N2O5 [M+H+] 504.2576
2e: Yield 93 mg (70%), pale pink solid, mp (104-106°C) 1H-NMR (CDCl3): δ 8.92 (br s, 2 ),
7.94 (m, 2H), 7.16 (m, 2H), 5.47 (s, 1H), 4.17 (m, 4H), 3.91 (s, 3H), 2.76 (m, 4H), 2.21 (m, 4H),
1.68 (m, 8H), 1.27 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ, 166.3, 161.1, 146.2, 143.4, 142.0,

138.6, 132.3, 131.1, 129.8, 129.5, 127.6, 61.2, 52.5, 24.5, 23.2, 22.5, 21.7, 14.0; ESI-HRMS m/z
532.26; Calcd. for C31H36N2O6 [M+H+] 533.2649.
General procedure for synthesis of 8-aryl-bis(3-ethoxycarbonyl-4,5,6,7-tetrahydro-2Hisoindolyl)methenes (2’b-e)
A solution of DDQ (0.36 mmoles, 1.2 equiv.) in dry dichloromethane (10mL) was added to a
solution of 2’b-e (0.3 mmoles, 1.0 equiv.) in dry dichloromethane (20 mL) at 0 °C. The solution
was stirred under argon for 15-20 min until TLC indicated reaction completion. Further the
reaction mixture was washed with saturated NaHCO3 (2 x 30mL), brine (1 x 30mL) and dried
over Na2SO4. The solvent was evaporated in vacuum and the residue was chromatographed on a
silica column using dichloromethane/petroleum ether 5/1 as eluent. The product was finally recrystallized from CH2Cl2-hexane mixture to yield shiny deep green crystals.
2‘b: Yield 106 mg (75%), mp (164-166°C) 1H-NMR (CDCl3): δ 7.45 (m, 3 ), 7.27 (m, 2 ),
4.37 (q, J = 7.12 Hz, 4H), 2.69 (m, 4H), 1.57 (m, 4H), 1.51 (m, 4H), 1.42 (t, J = 7.12 Hz, 6H),
1.36 (m, 4H); 13C NMR (CDCl3): δ162.3, 143.8, 141.7, 139.7, 139.0, 137.0, 133.0, 129.1, 128.8,
128.7, 60.6, 24.2, 23.2, 23.1, 22.3, 14.4; ESI-HRMS m/z 472.2362; Calcd. for C29H32N2O4
[M+H+] 473.2447.
99

2‘c: Yield 118 mg (70%), mp (158-160°C) 1H-NMR (CDCl3): δ 4.37 (q, J = 7.12

z, 4 ), 2.67

(m, 4H), 1.67 (m, 4H), 1.60 (m, 4H), 1.52 (m, 8H), 1.41 (t, J = 7.12 Hz, 6H); 13C NMR (CDCl3):
δ 161.8, 145.8, 143.2, 138.6, 137.8, 134.0, 132.4, 127.4, 60.9, 29.4, 23.3, 23.2, 23.0, 22.8, 22.4,
22.2, 22.0, 14.1 ; ESI-HRMS m/z 562.1891; Calcd. for C29H27F5N2O4 [M+H+] 563.1978.
2‘d: Yield 123 mg (82%), mp (172-174°C) ;1H-NMR (CDCl3): δ 7.28 (m, 2 ), 7.11 (m, 2 ),
4.49 (q, J = 7.12 Hz, 4H), 4.07 (s, 3H), 3.05 (m, 4H), 1.96 (m, 4H), 1.53 (m, 8H), 1.22 (t, J =
7.12 Hz, 6H); 13C NMR (CDCl3): δ 161.6, 160.3, 147.2, 142.7, 139.6, 133.0, 132.1, 129.2, 126.2,
114.2, 60.6, 55.3, 24.5, 23.2, 23.1, 22.4, 14.4; ESI-HRMS m/z 502.2467; Calcd. for C30H34N2O5
[M+H+] 503.2560.
2’e: Yield 108 mg (68%), , mp (155-157°C) 1H-NMR (CDCl3): δ 8.18 (m, 2 ), 8.01 (m, 2 ),
4.49 (m, 4H), 3.95 (s, 3H), 2.67 (m, 4H), 1.65 (m, 4H), 1.53 (m, 4H), 1.42 (t, J = 7.12 Hz, 6H),
1.31 (m, 4H);

13

C NMR (CDCl3): δ, 166.3, 162.1, 146.2, 143.6, 142.2, 138.6, 133.0, 130.1,

129.8, 129.5, 128.0, 61.2, 52.5, 24.5, 23.2, 23.1, 22.4, 14.0; ESI-HRMS m/z 530.2417 Calcd. for
C31H34N2O6 [M+H+] 531.2480.
General procedure to BODIPYs 3a-e
A solution of DDQ (0.6 mmoles, 1.2 equiv.) in dry THF (10mL) was added to a solution of 2a
(0.5 mmoles, 1.0 equiv.) in dry THF (10 mL) for 2a or CH2Cl2 for 2b-e, at 0 °C. The solution
was stirred under argon for 20 min. Et3N (3 mmol, 6 equiv.) and BF3.OEt2 (5 mmol, 10 equiv.)
were added dropwise and the solution was stirred for 20 min at 0 °C and then overnight at room
temperature. Once TLC indicated reaction completion, the solvent was removed under reduced
pressure and the residue was taken up in ethyl acetate and extracted with 0.1 M HCl (2 x 30mL)
to remove excess DDQ, brine (1 x 30mL) and dried over anhydrous Na2SO4. The solvent was
evaporated to dryness and residue purified by column chromatography (hexane/ethyl acetate,
3:2). The product was re-crystallized from CH2Cl2/hexane mixtures to yield the BODIPY.
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3a: Yield 149 mg (67%), mp (169-171°C) 1H-NMR (CDCl3): δ 5.30 (s, 1 ), 4.42 (q, J=7.11 Hz,
4H), 2.65 (m, 8H), 1.76 (m, 8H), 1.42 (t, J = 7.11 Hz, 6H);

13

C NMR (CDCl3): δ 161.7, 144.1,

142.6, 134.4, 132.8, 129.6, 128.7, 128.6, 126.1, 121.2, 61.6, 60.7, 29.7, 23.1, 22.9, 22.8, 22.7,
22.4, 22.0, 21.5, 14.3, 14.1, 14.0; ESI-HRMS m/z 444.20; Calcd. for C23H27BF2N2O4 [M+Na+]
467.1917.
3b: Yield 208 mg (80%), mp (209-211°C) 1H-NMR (CDCl3): δ 7.52 (m, 3 ), 7.23 (m, 2 ), 4.44
(q, J = 7.12 Hz, 4H), 2.57 (m, 4H), 1.57 (m, 8H), 1.42 (t, J = 7.12 Hz, 6H), 1.39 (m, 4H);

13

C

NMR (CDCl3): δ 161.6, 147.6, 143.8, 143.6, 134.6, 132.9, 132.5, 129.6, 129.5, 127.2, 61.7, 24.4,
22.6, 22.3, 22.0, 14.0; MALDI-TOF m/z 520.23; Calcd. for C29H31BF2N2O4 [M+Na+] 543.237.
3c: Yield 229 mg (75%), mp (202-204°C) 1H-NMR (CDCl3): δ 4.45 (q, J = 7.12

z, 4 ), 2.60

(m, 4H), 1.81 (m, 4H), 1.65 (m, 4H), 1.59 (m, 4H), 1.45 (t, J = 7.12 Hz, 6H); 13C NMR (CDCl3):
δ 161.0, 145.6, 142.3, 137.8, 133.9, 133.5, 132.6, 128.3, 62.0, 29.6, 23.3, 23.2, 23.0, 22.8, 22.4,
22.1, 22.0, 14.0; MALDI-TOF m/z 610.19; Calcd. for C29H26BF7N2O4 [M +] 610.1876.
3d: Yield 200 mg (73%), mp (181-183°C) 1H-NMR (CDCl3): δ 7.12 (m, 2 ), 7.03 (m, 2 ),
4.43 (q, J = 7.1 Hz, 4H), 3.89 (s, 3H), 2.76 (m, 4H), 2.57 (m, 4H), 1.64 (m, 4H), 1.58 (m, 4H),
1.41 (t, J = 7.1 Hz, 6H), 1.40 (m, 4H);

13

C NMR (CDCl3): δ 161.5, 160.6, 147.9, 143.7, 143.4,

133.3, 132.4, 128.6, 126.5, 114.8, 61.6, 55.3, 24.7, 22.6, 22.3, 22.0, 14.0; ESI-HRMS m/z
550.25; Calcd. for C30H33BF2N2O5 [M+Na+] 573.2361.
3e: Yield 174 mg (60%), mp (173-175°C) 1H-NMR (CDCl3): δ 8.21 (m, 2 ), 7.36 (m, 2 ), 4.43
(q, J = 7.12 Hz, 4H), 3.99 (s, 3H), 2.57 (m, 4H), 1.56 (m, 8H), 1.44 (t, J = 7.12 Hz, 6H), 1.39 (m,
4H);

13

C NMR (CDCl3): δ 166.6, 161.4, 146.0, 144.1, 143.5, 139.2, 132.8, 132.4, 131.4, 130.7,

127.6, 61.8, 52.5, 24.6, 22.5, 22.3, 21.9, 14.0; ESI-HRMS m/z 578.24; Calcd. for
C31H33BF2N2O6 [M+H+] 577.2299.
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General procedure for the synthesis of BODIPYs 4 via Route A
BODIPYs 3a-e (112 mg, 0.2665 mmol) were dissolved in toluene (30mL) and heated to about
110°C. A solution of DDQ (9 equiv.) in toluene (20mL) was then added and the mixture was
refluxed under Ar. The reaction was monitored by UV-Vis. Upon the completion, the reaction
mixture was cooled to room temperature and the solvent was removed under reduced pressure.
The residue was taken up in CH2Cl2 (30 mL0 and extracted with 10% aq. NaHCO3 (3 x 30 mL),
brine (1 x 30 mL) and dried over Na2SO4. The solvent was removed under reduced pressure and
the residue was purified by column chromatography (CH2Cl2 to 0.1% MeOH in CH2Cl2). The
product was re-crystallized from CH2Cl2/hexane mixtures to yield shiny copper-colored crystals.
4a: Yield 81 mg (69%), mp > 250°C 1H-NMR (CDCl3): δ 8.45 (m, 2 ), 8.15 (m, 2 ), 7.55 (m,
2H), 7.41 (m, 2H), 4.60 (q, J=7.11 Hz, 4H), 1.55 (t, J = 7.3 Hz, 6H); 13C NMR (CDCl3): δ 160.2,
140.2, 133.8, 130.9, 127.2, 124.5, 122.9, 62.4, 14.1; MALDI-TOF m/z 444.20; Calcd. for
C23H27BF2N2O4 [M+H+] 444.20
4b: Yield 91 mg (67%), mp > 250°C 1H-NMR (CDCl3): δ 8.11 (m, 2 ), 7.72 (m, 3 ), 7.52 (m,
2H), 7.26 (m, 2H), 7.08 (m, 2H), 6.16 (m, 2H), 4.62 (q, J = 7.12 Hz, 4H), 1.55 (t, J = 7.12 Hz,
6H);

13

C NMR (CDCl3): δ 160.6, 141.2, 140.2, 134.7, 134.2, 131.2, 130.1, 129.8, 129.7, 129.1,

128.5, 126.5, 124.1, 121.7, 62.2, 14.1; ESI-HRMS m/z 512.17; Calcd. for C29H23BF2N2O4
[M+Na+] 535.1633.
4d: Yield 132 mg (92%), mp > 250°C 1H-NMR (CDCl3): δ 8.11 (m, 2 ), 7.26 (m, 8 ), 6.30 (m,
2H), 4.61 (q, J = 7.12 Hz, 4H), 4.02 (s, 3H), 1.55 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ

160.8, 160.6, 141.4, 139.9, 134.7, 131.1, 129.8, 129.6, 129.5, 126.4, 126.2, 124.0, 121.8, 115.1,
62.2, 55.5, 14.1; MALDI-TOF m/z 542.18; Calcd. for C30H25 BF2N2O5 [M +] 542.260.

102

4e: Yield 103 mg (68%), mp > 250°C 1H-NMR (CDCl3): δ 8.39 (m, 2 ), 8.12 (m, 2 ), 7.65 (m,
2H), 7.27 (m, 2H), 7.09 (m, 2H), 6.12 (m, 2H), 4.62 (q, J = 7.12 Hz, 4H), 4.07 (s, 3H), 1.55 (t, J
= 7.12 Hz, 6H);

13

C NMR (CDCl3): δ 166.3, 160.5, 140.6, 139.7, 138.8, 134.4, 131.8, 131.2,

131.0, 130.0, 128.9, 128.5, 126.7, 124.3, 121.4, 62.3, 52.6, 14.1; MALDI-TOF m/z 570.18;
Calcd. for C31H25 BF2N2O6 [M+H+] 570.213
General procedure for the synthesis of dibenzo-fused dipyrrins (5a-e)
Dipyrromethanes (2a-e) (112 mg, 0.2665 mmol) were dissolved in dry toluene (30mL) and
heated to about 110°C. A solution of DDQ (9 equiv.) in dry toluene (20mL) was added and the
mixture was refluxed under Ar. The reaction was monitored by UV-Vis and on completion the
solvent was removed under reduced pressure. The purple residue was taken up in ethyl acetate
and extracted with 0.1M HCl to remove any traces of DDQ (3 x 50 mL), brine (1 x 50 mL) and
dried over Na2SO4. The solvent was removed under reduced pressure and the residue was
purified by column chromatography (CH2Cl2 for 5a, 5b and hexane/ethyl acetate, 2/1 for 5c, 5d,
5e). The product was re-crystallized from CH2Cl2/MeOH mixtures to yield deep green crystals.
5a: Yield 57 mg (56%), mp 168-169°C, UV/vis (CH2Cl2) λmax (log ε) 568 (4.24), 1H-NMR
(CDCl3): δ 8.48 (m, 2 ), 8.23 (m, 2 ), 7.40 (m, 4 ), 4.55 (q, J = 7.07
Hz, 6H);

13

z, 4 ), 1.55 (t, J = 7.3

C NMR (CDCl3): δ 161.6, 137.1, 134.5, 133.3, 133.0, 131.3, 130.8, 128.7, 127.7,

127.0, 126.5, 126.4, 123.1, 123.0, 122.8, 118.9, 61.5, 61.2, 61.1, 29.6, 14.3, 14.5 ESI-HRMS m/z
388.14; Calcd. for C23H20N2O4 [M+H+] 388.14.
5b: Yield 81 mg (66%), mp 146-147°C, UV/vis (CH2Cl2) λmax (log ε) 569 (4.48),

1

H-NMR

(CDCl3): δ 8.19 (m, 2 ), 7.66 (m, 5 ), 7.24 (m, 2 ), 6.97 (m, 2 ), 6.12 (m, 2 ), 5.30 (s, 1 ),
4.58 (q, J = 7.12 Hz, 4H), 1.56 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ 161.8, 137.7, 136.4,

135.5, 135.0, 131.6, 129.5, 129.4, 129.1, 126.9, 126.0, 122.8, 122.0, 61.2, 14.4; ESI-HRMS m/z
464.17; Calcd. for C29H24N2O4 [M+H+] 465.1788.
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5c: Yield 91 mg (62%), mp 224-225°C UV/vis (CH2Cl2) λmax (log ε) 583 (4.63),

1

H-NMR

(CDCl3): δ 8.25 (m, 2 ), 7.33 (m, 2 ), 7.18 (m, 2 ), 6.34 (m, 2 ), 4.56 (q, J = 7.12

z, 4 ),

1.56 (t, J = 7.12 Hz, 6H); 13C NMR (CDCl3): δ 161.4, 139.3, 134.6, 134.3, 131.8, 128.2, 126.8,
123.7, 119.8, 61.5, 14.4; ESI-HRMS m/z 554.13; Calcd. for C29H19F5N2O4 [M+Na+] 555.1328.
5d: Yield 90 mg (69%), mp 197-199°C UV/vis (CH2Cl2) λmax (log ε) 569 (4.59), 1H-NMR
(CDCl3): δ 8.20 (m, 2 ), 7.43 (m, 2 ), 7.24 (m, 2 ), 7.18 (m, 2 ), 7.02 (m, 2 ), 6.28 (m, 2 ),
4.57 (q, J = 7.12 Hz, 4H), 4.01 (s, 3H), 1.56 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ 161.8,

135.7, 131.7, 130.6, 126.9, 126.0, 122.7, 122.1, 114.8, 61.2, 55.5,14.4; MALDI-TOF m/z
494.18; Calcd. for C30H26N2O5 [M+H+] 495.258.
5e: Yield 81 mg (58%), mp 208-209°C UV/vis (CH2Cl2) λmax (log ε) 572 (4.59), 1H-NMR
(CDCl3): δ 8.35 (m, 2 ), 8.18 (m, 2 ), 7.65 (m, 2 ), 7.23 (m, 2 ), 6.96 (m, 2 ), 6.06 (m, 2 ),
4.57 (q, J = 7.12 Hz, 4H), 4.06 (s, 3H), 1.56 (t, J = 7.12 Hz, 6H);

13

C NMR (CDCl3): δ 166.6,

161.7, 141.1, 138.1, 137.8, 135.3, 134.4, 131.7, 131.2, 130.7, 129.5, 128.8, 127.1, 126.2, 123.0,
121.7, 61.3, 52.5, 14.4; ESI-HRMS m/z 522.18; Calcd. for C31H26N2O6 [M+H+] 522.1831
General procedure for synthesis of BODIPYs 4 via Route B
A solution of db-dipyrrins (5a-e) (0.1mmol) in toluene (20mL) was stirred at 0°C for 15 min
under Argon atmosphere. Further, Et3N (0.089 mL, 0.64 mmol) and BF3.OEt2 (0.13 mL, 1.024
mmol) were added and the mixture was stirred at room temperature for 30 min. The reaction was
then refluxed at the boiling temperature of the solvent until the UV-Vis indicated reaction
completion. The obtained fluorescent blue solution was washed with 10% aq. NaHCO3 (3 x 20
mL), brine (1 x 20 mL) and dried over Na2SO4. The solvent was evaporated to dryness and the
product was obtained as copper-colored crystals after re-crystallization from CH2Cl2/hexane
mixtures. Yields obtained: 4a, 24 mg (55%): 4b, 40 mg (80%); 4c, 34 mg (56%); 4d, 49 mg
(90%); 4e, 43 mg (75%).
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4c: mp > 250°C 1H-NMR (CDCl3): δ 8.16 (m, 2 ), 7.38-7.25 (m, 4H), 6.39 (m, 2H), 4.62 (q, J =
7.12 Hz, 4H), 1.54 (t, J = 7.12 Hz, 6H); 13C NMR (CDCl3): δ 160.1, 142.0, 133.8, 131.3, 131.2,
128.5, 127.3, 125.1, 122.5, 119.5, 62.6, 14.1; MALDI-TOF m/z 602.12; Calcd. for C29H18
BF7N2O4 [M +] 602.179.
BODIPY 7
Pyrrole 1 (150 mg, 0.7762 mmol) and 6 (162 mg, 0.7762 mmol) were dissolved in dry
dichloromethane (20 mL) at 0°C and POCl3 (0.14 mL, 0.9314 mmol) was added dropwise over 5
min. The reaction mixture was stirred at 0°C for 10 min and then left for overnight stirring at
room temperature. After TLC indicated reaction completion, Et3N (0.5 mL, 3.9 mmol) was
added dropwise at 0°C followed by BF3.OEt2 (0.8 mL, 6.2 mmol) at 0°C. After the addition was
over, the reaction was stirred for 16 h at room temperature. The solvent was removed under
reduced pressure and residue was taken up in dichloromethane (20 mL) and washed with 10%
aq. NaHCO3 (2 x 20 mL), brine (2 x 20 mL) and dried over Na2SO4. The solvent was evaporated
to dryness and residue was purified by column chromatography (hexane/ethyl acetate, 3/2).
Fraction containing the product was collected, dried to vacuum and recrystallized from
CH2Cl2/Hexane to obtain the pure BODIPY 7 (134 mg, 40%) as lustrous green solid. mp = 135137°C; 1H-NMR (CDCl3, 400 M z): δ 7.04 (s, 1 ), 4.37 (q, J = 7.12 z, 4 ), 3.67 (s, 1 ), 2.72
(m, 4H), 2.65 (overlapped m, 2H), 2.61 (s, 3H), 2.46 (m, 2H), 2.21 (s, 3H), 1.75 (m, 1H), 1.38 (t,
J -= 7.12 Hz, 3H);

13

C NMR (CDCl3, 100 M z): δ 172.6, 165.5, 161.1, 141.7, 136.7, 136.5,

132.2, 131.9, 131.7, 120.8, 60.6, 51.8, 33.4, 23.3, 23.1, 22.4, 21.5, 19.4, 14.2, 13.7, 9.6; MALDITOF m/z 432.27; Calcd. for C22H27BF2N2O6 [M+Na+] 455.251
BODIPY 8
BODIPY 7 (100 mg, 0.2313 mmol) was dissolved in toluene (15 mL) and heated to about 110°C.
A solution of DDQ (262 mg, 1.1566 mmol, 5 equiv.) in toluene (15 mL) was added and the
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mixture was refluxed under Ar. Monitored the reaction using UV/Vis. Once the reaction was
complete, cooled it to room temperature and the solvent was removed under the reduced
pressure. The residue was taken in dichloromethane (20 mL) and extracted with saturated
NaHCO3 (20 mL), brine (20 mL) and dried over Na2SO4. The solution was evaporated to dryness
and the residue was purified by column chromatography (Eluent: Hexane/EtOAc, 3/2). Fractions
containing the compound were collected, dried to vacuum and recrystallized from
CH2Cl2/Hexane to obtain the pure BODIPY 8 (59.4 mg, 60%) as lustrous green solid. mp = 162164°C; 1H-NMR (CDCl3, 400 M z): δ 8.22 (m, 1 ), 7.79 (m, 1 ), 7.46 (s, 1 ), 7.41 (m, 1 ),
7.34 (m, 1H), 4.55 (q, J = 7.12 Hz, 2H), 3.69 (s, 1H), 2.75 (m, 2H), 2.64 (s, 3H), 2.49 (m, 2H),
2.28 (s, 3H), 1.51 (t, J = 7.12 Hz, 3H);

13

C NMR (CDCl3, 100 M z): δ 172.6, 163.0, 160.4,

140.7, 135.8, 133.3, 131.3, 130.5, 128.5, 127.9, 126.3, 123.9, 118.7, 118.3, 61.4, 51.8, 33.6, 19.4,
14.3, 13.5, 9.6; MALDI-TOF m/z 428.24; Calcd. for C22H23BF2N2O4 [M +] 428.224.
2.4.3: Crystal Data
Diffraction data were collected at low temperature on either a Nonius KappaCCD diffractometer
equipped with MoK radiation (=0.71073 Å) or a Bruker Kappa Apex-II diffractometer
equipped with CuK radiation (=1.54178 Å). Refinement was by full-matrix least squares
using SHELXL, with H atoms in idealized positions, except for NH hydrogen atoms, which were
located by difference maps and in most cases their positions refined. Disorder is present in
several of the structures.
Crystal data: For 2a: C23H30N2O4, monoclinic space group P21/c, a=8.3020(6), b=18.1194(14),
c=13.5258(10) Å, =98.449(5)˚, V=2012.6(3) Å3, T=90.0(5) K , Z=4, calcd=1.315 g cm-3,
(CuK)=0.73 mm-1. A total of 13,289 data was collected at to =69.0˚. R=0.062 for 2895 data
with I>2σ(I) of 3597 unique data and 270 refined parameters.

106

For 2b EtOAc solvate: C29H34N2O4. 1/2 C4H8O2, triclinic space group P-1, a=8.698(3),
b=14.961(5), c=21.472(9) Å, =86.86(3), =88.15(2), =89.83(2)˚, V=2788.5(18)Å3, T=90.0(5)
K , Z=4, calcd=1.235 g cm-3, (CuK)=0.67 mm-1. 24,515 total data, max=58.8˚. R=0.087 for
3895 data with I>2σ(I) of 7545 unique data and 692 refined parameters.
For 2c pentafluorobenzaldehyde cocrystal: C29H29F5N2O4. 1/2 C7HF5O, tetragonal space group
I41/a, a=24.931(2), c=40.838(4) Å, V=25,383(4)Å3, T=90.0(5) K, Z=32, calcd=1.387 g cm-3,
(CuK)=1.06 mm-1. 95,523 total data, max=68.9˚. R=0.068 for 8230 data with I>2σ(I) of
11630 unique data and 838 refined parameters.
For 2d: C30H36N2O5, triclinic space group P-1, a=10.7765(10), b=11.1382(12), c=14.2929(13) Å,
=100.304(5), =103.378(4), =102.828(4)˚, V=1578.7(3)Å3, T=90.0(5) K , Z=2, calcd=1.189 g
cm-3, (CuK)=0.58 mm-1. 17,121 total data, max=68.4˚. R=0.060 for 4767 data with I>2σ(I) of
5533 unique data and 354 refined parameters.
For 3b: C29H31BF2N2O4, monoclinic space group P21/c, a=11.3252(15), b=24.088(5), c=9.778(2)
Å, =108.409(10)˚, V=2530.9(8) Å3, T=150.0(5) K , Z=4, calcd=1.366 g cm-3, (MoK)=0.10
mm-1. 8398 total data, max=27.9˚. R=0.053 for 3731 data with I>2σ(I) of 6018 unique data and
392 refined parameters.
For 3c: C29H26BF7N2O4, triclinic space group P-1, a=8.0664(4), b=14.5015(6), c=23.4495(12) Å,
=92.042(4), =97.547(4), =91.775(3)˚, V=2715.8(2)Å3, T=90.0(5) K , Z=4, calcd=1.493 g cm3

, (CuK)=1.14 mm-1. 27,216 total data, max=60.3˚. R=0.063 for 4428 data with I>2σ(I) of

8054 unique data and 780 refined parameters.
For 3d: C30H33BF2N2O5, monoclinic space group C2/c, a=25.927(2), b=8.7936(10), c=25.782(2)
Å, =114.472(5)˚, V=5350.0(8) Å3, T=90.0(5) K , Z=8, calcd=1.367 g cm-3, (CuK)=0.84 mm-
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1

. 13,921 total data, max=68.3˚. R=0.039 for 4024 data with I>2σ(I) of 4767 unique data and 364

refined parameters.
For 3e: C31H33BF2N2O6, monoclinic space group C2/c, a=41.881(3), b=15.0780(15),
c=27.105(2) Å, =97.579(5)˚, V=16,967(2) Å3, T=150.0(5) K , Z=24, calcd=1.359 g cm-3,
(CuK)=0.85 mm-1. 64,554 total data, max=68.4˚. R=0.043 for 11,391 data with I>2σ(I) of
15,206 unique data and 1150 refined parameters.
For 4b: C29H23BF2N2O4, orthorhombic space group Pbca, a=13.0867(9), b=23.649(2),
c=15.7556(10) Å, V=4876.2(6) Å3, T=100.0(5) K , Z=8, calcd=1.396 g cm-3, (CuK)=0.86
mm-1. 43,842 total data, max=68.3˚. R=0.036 for 3670 data with I>2σ(I) of 4434 unique data and
345 refined parameters.
For 4d: C30H25BF2N2O5, orthorhombic space group Pbca, a=16.208(3), b=12.384(2),
c=24.802(4) Å, V=4978.3(15) Å3, T=90.0(5) K , Z=8, calcd=1.447 g cm-3, (CuK)=0.90 mm-1.
30,190 total data, max=58.9˚. R=0.063 for 2995 data with I>2σ(I) of 3557 unique data and 397
refined parameters.
For 4e: C31H25BF2N2O6, orthorhombic space group Pbca, a=15.792(2), b=12.530(2),
c=26.067(4) Å, V=5158.0(13) Å3, T=90.0(5) K , Z=8, calcd=1.469 g cm-3, (CuK)=0.93 mm-1.
34,135 total data, max = 60.3˚. R=0.078 for 2405 data with I>2σ(I) of 3788 unique data and 382
refined parameters.
For 8: C22H23BF2N2O4, monoclinic space group P21/n, a=11.4027(15), b=7.3503(10),
c=24.381(3) Å, =102.545(6)˚, V=1994.7(5) Å3, T=100.0(5) K , Z=4, calcd=1.426 g cm-3,
(MoK)=0.11 mm-1. 22,120 total data, max=27.8˚. R=0.039 for 3415 data with I>2σ(I) of 4679
unique data and 285 refined parameters.
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For 5b hexane solvate: C29H24N2O4. 0.2 C6H14, monoclinic space group C2/c, a=18.5304(12),
b=20.7226(14), c=6.8836(4) Å, =108.738(4)˚, V=2503.2(3) Å3, T=90.0(5) K , Z=4,
calcd=1.285 g cm-3, (MoK)=0.09 mm-1. 10,372 total data, max=26.0˚. R=0.047 for 1634 data
with I>2σ(I) of 2478 unique data and 162 refined parameters.
For 5b precursor: C29H32N2O4, triclinic space group P-1, a=8.5674(5), b=11.1537(9),
c=13.4356(10) Å, =69.244(5), =89.897(4), =81.625(4)˚, V=1186.03(15)Å3, T=90.0(5) K ,
Z=2, calcd=1.323 g cm-3, (CuK)=0.70 mm-1. 14,723 total data, max=69.3˚. R=0.038 for 3608
data with I>2σ(I) of 4248 unique data and 349 refined parameters.
For 5c: C29H19F5N2O4, monoclinic space group P21/c, a=15.3125(15), b=11.0509(10),
c=15.6714(15) Å, =115.117(5)˚, V=2401.1(4) Å3, T=90.0(5) K , Z=4, calcd=1.534 g cm-3,
(CuK)=1.11 mm-1. 17,798 total data, max=68.7˚. R=0.034 for 3953 data with I>2σ(I) of 4323
unique data and 367 refined parameters.
For 5c precursor: C29H27F5N2O4, monoclinic space group P21/n, a=8.9739(5), b=24.788(2),
c=11.3754(10) Å, =100.947(5)˚, V=22484.4(3) Å3, T=90.0(5) K , Z=4, calcd=1.504 g cm-3,
(CuK)=1.08 mm-1. 26,194 total data, max=68.6˚. R=0.034 for 3823 data with I>2σ(I) of 4508
unique data and 367 refined parameters.
For 5d: C30H26N2O5, monoclinic space group P21/n, a=9.456(2), b=13.896(3), c=18.304(4) Å,
=93.890(15)˚, V=93.890(15) Å3, T=90.0(5) K , Z=4, calcd=1.369 g cm-3, (MoK)=0.09 mm-1.
14,344 total data, max=26.0˚. R=0.051 for 3109 data with I>2σ(I) of 4714 unique data and 339
refined parameters.
For 5d precursor: C30H34N2O5, orthorhombic space group Pbca, a=21.665(2), b=9.1272(10),
c=26.015(2) Å, V=5144.2(8) Å3, T=90.0(5) K , Z=8, calcd=1.298 g cm-3, (CuK)=0.71 mm-1.
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49,707 total data, max=59.0˚. R=0.034 for 3043 data with I>2σ(I) of 3696 unique data and 345
refined parameters.
2.4.4: Computation Modeling
The two reaction routes A and B were studied computationally in the framework of Density
Function Theory. The hybrid density functional B3LYP was used at the 6-31G level. The
geometry of compounds 2b-e, 3b-e, 4b-e, and 5b-e were optimized and the relative energies
were evaluated. Potential energy surface minima were confirmed with frequency calculations.
The solvent effects were accounted for using the Polarizable Continuum Model (PCM) All
calculations were performed using Gaussian 09 program package.
2.4.5: Steady-state Absorption and Fluorescence Spectroscopy
The absorption measurements were carried out on a Varian Cary 50 UV/Vis spectrophotometer
and the steady-state fluorescence spectroscopic studies were performed on a PTI Quantum
Master4/2006SE spectrofluorimeter. For the fluorescence quantum yield measurements in
solvents, dilute solutions with the absorbance between 0.04-0.06 at the excitation wavelength
were used to minimize the reabsorption effects. The fluorescence quantum yields of BODIPYs 7
and 3a-e were obtained by comparing the area under the corrected emission spectrum of the test
sample with that of rhodamine 6G (0.80 in methanol). For BODIPYs 4a-e and 8, methylene blue
(0.03 in methanol) and cresyl violet perchlorate (0.54 in ethanol) were used as external standards
respectively.[28] All spectra were recorded at room temperature using non-degassed samples,
spectroscopic grade solvents and a 10 mm quartz cuvette. In all the cases, correction for the
refractive index was applied.
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2.4.6: Cell Culture
All tissue culture media and reagents were obtained from Invitrogen. Human HEp2 cells were
obtained from ATCC and maintained in a 50:50 mixture of DMEM:Advanced MEM containing
5% FBS. The Hep2 cells were sub-cultured biweekly to maintain sub-confluent stocks. The 4th to
15th passage cells were used for all the experiments.
2.4.6.1: Time-Dependent Cellular Uptake. The HEp2 cells were plated at 7500 per well in a
Costar 96 well plate and allowed to grow for 36 h. BODIPY stocks were prepared in DMSO
containing 1% Cremophor EL, at a concentration of 32 mM and then diluted into medium to
final working concentrations. The cells were exposed to 10 M of each BODIPY compound for
0, 1, 2, 4, 8, and 24 h. At the end of the incubation time the loading medium was removed and
the cells were washed with 200 L of PBS. The cells were solubilized upon addition of 100 L
of 0.25% Triton X-100 (Calbiochem) in PBS. To determine the BODIPY concentration,
fluorescence emission was read at 570/670 nm (excitation/emission) using a BMG FLUOstar
plate reader. The cell numbers were quantified by the CyQuant cell proliferation assay
(Invitrogen) as per manufactures instruction, and the uptake was expressed in terms of nM
compound per cell.
2.4.6.2: Cytotoxicity. For the dark toxicity, the HEp2 cells were plated as described above and
allowed 36-48 h to attach. The cells were exposed to increasing concentrations of BODIPY
conjugate up to 400 M and incubated overnight. The loading medium was then removed and
medium containing Cell Titer Blue (Promega) as per manufacturer’s instructions was added to
the cells. Cell viability was then measured by reading the fluorescence at 570/615nm using a
BMG FLUOstar plate reader. The signal was normalized to 100% viable (untreated) cells and
0% viable (treated with 0.2% saponin) cells. For the phototoxicity, the HEp2 cells were prepared
as described above for the dark cytotoxicity assay and treated with BODIOY conjugate
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concentrations of 0, 6.25, 12.5, 25, 50 and 100 M. After compound loading overnight, the
medium was removed and replaced with medium containing 50 mM HEPES pH 7.4. The cells
were exposed to a NewPort light system with 175 W halogen lamp for 20 min, filtered through a
water filter to provide approximated 1.5 Jcm-2 light dose. The cells were kept cool by placing the
culture on the 5 °C Echotherm chilling/heating plate (Torrey Pines Scientific, Inc.). The cells
were returned to the incubator overnight and assayed for viability as described above for the dark
cytotoxicity experiment.
2.4.6.3: Microscopy. The cells were incubated in the glass bottom 6-well plate (MatTek) and
allowed to grow for 48 h. The cells were then exposed to 10 µM of each compound for 6 h.
Organelle tracers were obtained from Invitrogen and used at the following concentrations:
LysoSensor Green 50 nM, MitoTracker Green 250 nM, ER Tracker Blue/white 100 nM, and
BODIPY FL C5 ceramide 1 µM. The organelle tracers were diluted in medium and the cells
were incubated concurrently with BODIPY and tracers for 30 minutes before washing 3 times
with PBS and microscopy. Images were acquired using a Leica DMRXA microscope with 40×
NA 0.8dip objective lens and DAPI, GFP and Texas Red filter cubes (Chroma Technologies).
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CHAPTER 3: SYNTHESIS AND CHARACTERIZATION OF NOVEL STYRYL- AND
LYSYL-BODIPY CONJUGATES FOR BIOLABELING APPLICATIONS

3.1: Introduction
The technique of cell visualization and interrogation by labeling proteins or DNA with
non-radioactive fluorescent labels is widely applicable for detection and elucidation of various
cellular mechanisms.1 In this context, BODIPY-based dyes have attracted considerable attention
as very promising candidates for fluorescent labels and have emerged as a rising star in the
fluorescent biomarker community.2 As fluorescent markers, BODIPYs have many favorable
characteristics, such as large molar absorption coefficients, high fluorescence quantum
efficiencies, high photophysical stability and sharp yet tunable fluorescence frequencies.
An array of BODIPY fluorophores, reactive dyes and conjugates are commercially
available and sold by Invitrogen. Fluorescent BODIPY conjugates of proteins, nucleotides,
peptides, lipids and polysaccharides that span the entire visible spectrum are available for various
biological labeling experiments including DNA sequencing, nucleic acid detection and protein
analysis.3 However, among the myriad of the commercially available BODIPY dyes, only few
red-emitter BODIPYs, such as BODIPY-630/650, BODIPY-650/665, BODIPY FL-Ceramide505/620 and BODIPY TR-Ceramide-592/618 are currently known, as shown in Figure 3.1. In
addition, many Invitrogen BODIPY dyes and conjugates are emissive in the visible region of the
spectrum, are exceedingly expensive and often unsuitable for typical bioconjugation protocols.
Furthermore, most of these dyes have small Stokes shifts which require excitation and detection
of these dyes at suboptimal wavelengths.
As a result, the most important challenges in current BODIPY chemistry include: (1) the
development of dyes with longer-wavelength absorption and emission profiles, and (2) the
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preparation of dyes with additional functional groups for covalent attachment to biomolecules.
Both these aims are important to further stimulate the application of BODIPY dyes in
biomolecular labeling.4

Figure 3.1: Chemical structures of long-wavelength amine-reactive BODIPYs from Invitrogen

BODIPY dyes absorb light in the green-yellow spectral region and emit fluorescence
between 470-520 nm. On the contrary, red absorbing and emitting dyes often offer much better
resolution and sensitivity in biological labeling applications. Therefore, the design and synthesis
of far-red or NIR emitting dyes is of great interest and applicability. Several approaches have
been developed for the synthesis of longer-wavelength emitting BODIPY fluorophores as all the
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seven carbon atoms on the indacene core are readily accessible to the introduction of
substituents.5 Numerous functionalized BODIPY dyes have been engineered and realized by
introducing substituents at the meso-, 2,6- and 3,5-positions, fusing aromatic rings to the
BODIPY core and replacing pyrrole by isoindole. In general, long-wavelength absorbing and
emitting BODIPY dyes are often realized by extending conjugation via post-functionalization of
the BODIPY core rather than starting from appropriately substituted pyrrole.6 In addition,
substituents at the pyrrolic positions of the BODIPY dye allow coplanar geometries that
maximize electronic coupling in comparison with the meso-positions which often lead to poor
electronic conjugation due to their near-orthogonal geometry with respect to the aromatic
BODIPY plane.7
Among these approaches, base-catalyzed Knoevenagel condensation of BODIPYs with
aryl aldehydes to produce π-extended mono- and distyryl-BODIPY derivatives provides a facile
and versatile route to fine-tune the optical properties of green emitting BODIPYs. Like other
electron-deficient systems, the 3,5-methyls on BODIPYs are relatively nucleophilic and thus
active in the Knoevenagel reaction, which allows the BODIPY fluorophore to be condensed with
a variety of electron-donating aldehydes to form trans carbon-carbon double bonds.8 The
resulting 3-monostyryl and 3,5-distyryl BODIPY derivatives absorb at a longer wavelength in
the red visible region, making them particularly useful for biomedical applications which require
deeper light penetration into tissues for better illumination of deep seated lesions.
The biological application of a fluorescent dye is further dependent on its solubility in the
aqueous media that surrounds the biomolecules and its efficient coupling to various water
soluble biomolecule targets. It is advantageous to have amphiphilic fluorescent probes
(biolabels) as hydrophobic interactions between a fluorescent dye and a target molecule often
leads to self-aggregation and a decrease in photophysical properties of the fluorophore. In
118

addition, the bioactivity of a labeled biomolecule is affected by the nature and length of the
linker unit that joins the label to its target molecule.9 It has been demonstrated that a spacer helps
to separate the fluorophore from its point of attachment, decreasing the interaction of the
fluorophore with the conjugated biomolecule while making it more accessible to secondary
target molecules.
With these considerations in mind, we describe herein, the synthesis and characterization
of a series of novel BODIPY-based labeling agents prepared via Knoevenagel condensation of
1,3,5,7-tetramethyl-BODIPYs. These potential labeling reagents are functionalized appropriately
to generate styryl-substituted far-red and NIR emitting BODIPY fluorophores. The fluorophores
are further substituted with methylpropionyl linker arms that do not only increase the
hydrophilicity of the BODIPYs, but also serve as a spacer between the fluorophore and the
biomolecules. The performance of the new fluorescent labels is studied, with particular emphasis
on the effect of various styryl substituents on the photophysical and in vitro photodynamic
properties of the BODIPY dyes.

3.2: Results and Discussion
The key step in the present study is the Knoevenagel condensation, a well-known organic
reaction which was first discovered in 1894 by Emil Knoevenagel.10 Typically, the Knoevenagel
condensation is carried out by condensing a carbonyl compound (aldehyde or ketone) with an
active methylene compound (for instance, malonates, acetoacetates, Meldrum’s acid) in the
presence of a base (Figure 3.2). The Knoevenagel condensation belongs to the general class of
base-catalysed aldol-type condensation. As the methylene compounds are more acidic than the
aldehydes or ketones used in the aldol condensation, the bases employed as catalysts are usually
weaker than those used in aldol condensations. In general, primary, secondary or tertiary amines
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or their corresponding ammonium salts are used as catalysts. The most widely used catalysts are
pyridine with or without piperidine and ammonium salts, such as ammonium or piperidinium
acetate. Various Lewis acids, such as magnesium perchlorate, TiCl4, ZnCl2, high temperature
conditions or microwave irradiations are used to promote the reaction independently from the
employed catalytic systems.11 Aromatic aldehydes treated with perchlorates of secondary amines
form the corresponding dialkyliminium perchlorates in refluxing toluene, which are much more
active electrophilic reactants than the parent aldehydes and form adducts with carbonnucleophiles. Additionally, the condensation with aldehydes is generally much faster than
ketones, hence reactions with ketones are more difficult to perform due to their decreased
reactivity.10
Several mechanisms may be possible, however in general, the first step involves the
reaction between the free aldehyde and an amine to give an imine/iminium salt, which then
reacts with the carbanion derived from the active methylene compound. The final elimination
step generates the styryl groups exclusively in a trans (E) configuration, along with water as byproduct which is either removed azeotropically or by adding molecular sieves or Na2SO4 (Figure
3.2).
The Knoevenagel condensation of BODIPYs with aryl aldehydes in general offers a great
degree of versatility, as judged by the recent research interest.12 This clearly stems from the
following facts: (1) The Knoevenagel condensation is a straightforward and convenient way of
BODIPY derivatization; (2) A wide variety of electron-donating aromatic aldehydes can be used
to tether different styryl groups; (3) Styryl-BODIPYs tend to have extended π-conjugation with
fluorescence maxima at ~ 620-660 nm; (4) the proper choice of appended styryl arms provide
impressive opportunities to shift the optical properties of engineered dyes more towards the red
and NIR absorbing window. The present work is therefore directed towards the synthesis,
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spectral characterizations and cellular investigations of a series of 3-monostyryl and 3,5-distyrylPMe BODIPY dyes (PMe = CH2CH2CO2Me) bearing “hidden” carboxylic acid tags for
conjugation to amino acids, in order to explore their potential for effective cellular labeling. In
the following section, we first describe the preparation of the PMe-BODIPY scaffolds, followed
by their peripheral functionalization using the Knoevenagel condensation reaction, and
subsequently, we discuss their conjugation to lysine, a basic amino acid.

Figure 3.2: General mechanism of the Knoevenagel reaction using piperidine as organocatalyst13

3.2.1: Syntheses
The model 1,3,5,7-tetramethyl PMe-BODIPY scaffold chosen to tether a set of different
styryl-arms is depicted in Scheme 3.1, along with its retrosynthetic analysis. It is anticipated that
the presence of electron-withdrawing 2,6-methylpropionyl moieties can further enhance the
acidity of the methyl groups and initiate the Knoevenagel condensation of the methyls at the 3and 5-positions.
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Scheme 3.1: Structure and Retrosynthesis of tetramethyl PMe-BODIPY regioisomers

The synthetic route commenced with the synthesis of PMe-BODIPY regioisomers 2 and
3. BODIPY 2 was synthesized from its dipyrromethene hydrobromide precursor 1, as outlined in
Scheme 3.2. The dipyrromethene hydrobromide derivatives were first described by Fischer et al.
in

synthesis

of

coporphyrins

and

mesoporphyrins.14

Such

symmetric/unsymmetric

dipyrromethenes are normally synthesized by either self-condensation of a monopyrrole or by
treatment of a pyrrole-2-carbaldehyde with an α-free pyrrole in the presence of HBr and formic
acid.15

Scheme 3.2: Synthetic route to PMe-BODIPY 2

The dipyrromethene hydrobromide, 1 was dissolved in freshly distilled dichloromethane
under argon. The solution was stirred at 0 °C for ten minutes and triethylamine was added
dropwise. The resultant mixture was stirred for additional 20 minutes followed by dropwise
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addition of BF3.OEt2. Formation of the boron complex was observed immediately after addition
of BF3.OEt2 from the green-yellow fluorescence of the reaction mixture. However, stirring was
continued at room temperature and the reaction was monitored by TLC, until completion (~ 2 h).
The reaction mixture was then diluted with dichloromethane, washed with basic water, dried
over sodium sulfate and concentrated in vacuo. The crude product was purified over a pad of
silica gel eluting with dichloromethane/petroleum ether (1/1, v/v) to get rid of polar oligomeric
by-products. The fluorescent fraction was collected and the solvent was removed under reduced
pressure

to

afford

an

orange-brown

powder

which

was

recrystallized

using

dichloromethane/hexane (5/1, v/v) to give shiny orange-green crystals of desired BODIPY 2 in
90% yield. The chemical structure of the BODIPY dye was confirmed by NMR spectra and
high-resolution MS. MS-ESI gave a peak due to [M++Na] at m/z 443.18. An X-ray crystal
structure of BODIPY 2 is shown in Figure 3.3. The 1H-NMR spectrum showed two singlet peaks
at 1.96 and 2.47 ppm corresponding to two sets of methyl protons at the 2,6- and 3,5-positions,
respectively, and one single peak at 7.07 ppm corresponding to the proton at the meso-position,
as depicted in Figure 3.4.

Figure 3.3: X-ray crystal structure of BODIPY 2
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Figure 3.4: 1H-NMR spectrum of BODIPY 2 in CDCl3 at 400 MHz

Recently, Wu and Burgess16 described an interesting and highly efficient synthesis of
symmetric BODIPY dyes by self-condensation of two equiv. of pyrrole-2-carbaldehyde (or 2formyl pyrrole) in the presence of phosphorus oxychloride (POCl3). According to their
serendipitious discovery, POCl3 is capable of triggering the self-condensation of formyl-pyrroles,
therefore, eliminating the use of an additional α-free pyrrole. A possible mechanism involves the
reaction of POCl3 with one molecule of formyl pyrrole to generate a vinylogous Vilsmeyer124

Haack reagent (a.k.a. chlorinated azafulvene, Scheme 3.3), which is then attacked by another
pyrrole molecule. Formation of the product relies on subsequent attack by chloride ion, followed
by decomposition of the unstable intermediate and in situ complexation with BF3.OEt2 in the
presence of a base.

Scheme 3.3: A possible mechanism for the formation of dipyrromethene from pyrrole-2carbaldehdye 4e17

BODIPY 3 with β-PMe functionality was synthesized from the corresponding pyrrole-2carbaldehyde, 4e, according to the above mentioned one-flask two-step approach, as shown in
Scheme 3.4. Compound 4e was synthesized from its tert-butyl protected pyrrole precursor (A) in
two steps involving deprotection of ester with TFA, followed by formylation with triethyl
orthoformate, as described in the previous Chapter (Compound 6) and shown in Scheme 3.4.

Scheme 3.4: Synthetic route to PMe-BODIPY 3
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Pyrrole 2-carbaldehyde 4e was dissolved in dry dichloromethane under argon and the
solution stirred as the temperature was lowered to 0 °C. To this solution, POCl3 was added
dropwise over a period of one minute while stirring and maintaining the reaction temperature at
0 °C. The solution was then warmed to room temperature and stirred overnight (~ 12 h) until
TLC indicated absence of any starting material. The mixture was cooled to 0 °C and
triethylamine (5 equiv.) was added dropwise over 5 minutes, followed by addition of BF3.OEt2
(8 equiv.). The reaction was stirred overnight and then passed through a short pad of silica gel
eluting with pure dichloromethane to remove the polar impurities and any unreacted starting
material. The solvent was then removed in vacuo and the crude product was re-dissolved in
dichloromethane and washed with water, brine and dried over Na2SO4. The solvent was
evaporated and the residue was purified by flash chromatography (dichloromethane/petroleum
ether, 1/1) to give green fluorescent BODIPY 3 as a red solid in 94% yield. Crystals suitable for
X-ray analysis were obtained by slow crystallization using dichloromethane/hexane (5/1) solvent
mixture, as shown in Figure 3.5. The compound was further characterized by 1H-NMR and MS.
In the NMR spectrum, the two sets of methyl protons at 1,7- and 3,5-positions appeared as two
distinct singlets at 2.18 and 2.45 ppm respectively. The 1,7-methyls experienced a shielding by
approximately 0.27 ppm due to the ring-current shielding effect from the meso-phenyl ring.
Another singlet was found at 6.98 ppm for the meso-proton. MS-ESI gave a peak due to
[M++Na] at m/z 443.35.
Post-modification of BODIPY 2 for the facile introduction of various functionalities to
the chromophore was carried out by means of the Knoevenagel condensation reactions. BODIPY
2 was condensed with various commercially available aldehydes, 4a-d using modified
Knoevenagel condensation approach, as developed by Daub et al.18 (Scheme 3.5, Table 3.1).
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Figure 3.5: X-ray crystal structure of BODIPY 3

1,3,5,7-tetramethyl BODIPY 2 and benzaldehyde 4a (two equiv.) were refluxed at 110 °C in a
mixture of dry toluene, piperidine, acetic acid, together with a small amount of activated
molecular sieves (4Å, to adsorb the water produced during the reaction). The progress of the
reaction was monitored by TLC, a pink-red spot corresponding to 3-monostyryl BODIPY 5a
appeared after 6 h and after overnight stir (~10 h), a slightly polar blue spot due to 3,5-distyryl
BODIPY 6a was observed. Though TLC indicated the presence of starting material, the reaction
was stopped as molecular sieves could not withstand the high temperature and disintegrated
during the reaction. After cooling to room temperature, the reaction mixture was passed through
a filtration funnel to filter off the molecular sieves. The solvent was removed under reduced
pressure and the crude mixture was loaded on top of a silica column and eluted with
dichloromethane/hexane (20/1, v/v). The orange pink fraction containing the starting material
and BODIPY 5a was eluted first, followed by blue fraction which crystallized on standing giving
shiny deep blue crystals of BODIPY 6a in 35% yield. Mono-substituted BODIPY 5a could not
be properly purified due to contamination of the tetramethyl BODIPY 2. The first distyryl
BODIPY 6a was fully characterized by NMR, MS-ESI and X-ray crystallography. 1H-NMR
spectrum of 6a (Figure 3.6), clearly exhibits all the characteristic signals of the distyrylBODIPY. The integration of fourteen protons between 7.13-7.77 ppm corresponds to the two
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phenyl subunits and four vinyl protons on the distyryl arms. The singlet peak at 2.50 ppm due to
3,5-methyls disappeared with the formation of the vinyl bond. MS-ESI gave a molecular ion
peak [M+] at m/z 595.25. The molecular structure of BODIPY 6a confirming the trans
configuration of the double bonds is shown in Figure 3.7.

Scheme 3.5: Styryl-derivatization of PMe BODIPY 2 with various aryl aldehydes 4a-d

Table 3.1: Reaction conditions and percent yield for the derivatization of BODIPY 2 with 4a-d
Entry

Aryl Aldehyde

Reaction time (h)

Yield % for 5a-d

Yield % for 6a-d

1

4a

12

28 (crude)

35

2

4b

48

<2

-

3

4c

48

No reaction

No reaction

4

4d

48

<2

-

A similar protocol was followed for condensation of BODIPY 2 with aldehydes 4b-d.
Interestingly, the reaction didn’t give satisfactory results with any of these aldehydes. Varying
the reaction conditions such as prolonged heating, excess of base, catalyst or aryl aldehyde failed
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to generate the desired styryl-BODIPYs and the unreacted starting material was conveniently
recovered during the purification process and recycled. This is not surprising, as the literature
search via Scifinder Scholar® revealed a total of two publications mentioning about 3,5thiophene or pyrene-derivatized BODIPYs and none of the publication reported the percent yield
for the reaction. A plausible reason for the failure of these reactions could be the decrease in the
electrophilicity of the carbonyl carbon due to neighbouring electron accepting thiophene or
pyrene rings.

Figure 3.6: 1H-NMR spectrum of BODIPY 6a in CDCl3 at 400 MHz
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Figure 3.7: An X-ray crystal structure of BODIPY 6a

The chemical robustness of heteroaromatic compounds for instance, indole, pyrrole and
thiophene, and the easy tunability of their properties via facile structural modifications have
added an array of functionalized materials in dye chemistry, drug design and biodiagnostics. A
variety of pyrrole, indole and thiophene based materials have been utilized as optical indicators
(fluorimetric or colorimetric) for recognition events involving proteins or DNA as well as optical
sensors for ions of biological interest.19 Especially appealing is the non-toxic and polar
hydrophobic nature of these materials which assists their partition at the hydrophilic/hydrophobic
interface in lipid bilayer via hydrogen bonding, thereby improving their cellular uptake and
biological efficacy. In addition, several classes of indole-based inhibitors with valuable
therapeutic effectiveness have been engineered due to their structural resemblance with
tryptophan (Trp).20 Also, many fluorescent pH-responsive BODIPY-based probes have been
developed with p-phenolic subunit as the pH-sensitive group for selective sensing of alkaline and
acidic pH. The presence of water-solubilising phenol group not only improves the amphiphilicity
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of the BODIPY fluorophore, it enhances their passive cellular uptake as well. Further Oalkylation of hydroxyl-benzaldehydes with propargyl bromide helps to generate the alkylated
benzaldehyde derivatives which could serve as important building blocks for functional
BODIPY dyes bearing extra conjugation handles. Incorporation of ligation handles on the
BODIPY core allows its covalent attachment to other bioactive molecules via alkyne/azide
cycloaddition.21 In order to study the relationship between the structure and optical properties in
green emitter BODIPY 3, it was condensed with aryl aldehydes 4e-j in boiling toluene as
depicted in Scheme 3.6.

Scheme 3.6: Synthetic route to mono- and distyryl-PMe BODIPYs

Initially we investigated the Knoevenagel condensation of BODIPY 3 with pyrrole 4e via
similar procedure as mentioned for BODIPY 6a. The reaction successfully generated both single
and double condensation products, however in relatively lower yields of 8 and 5.6 %
respectively. The success of this reaction was encouraging enough and prompted us to find the
optimized conditions for the condensation reaction. The reaction was then performed using
forcing conditions (140 °C, highly concentrated reaction mixture) and Dean-Stark trap to avoid
the use of molecular sieves. We were fortunate to observe that on refluxing BODIPY 3 with 4e,
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under modified conditions, both 3-monostyryl 5e, and 3,5-distyryl BODIPYs 6e could be
generated with improved yields of 62% and 18% respectively (Table 3.2). Also, the yield percent
of distyryl BODIPY 6e increased from 18% to 31% when 4 equivalents of 4e reagent is used
instead of 2 equiv.
Table 3.2: Reaction conditions and yield % for functionalization of BODIPY 3
Entry

Aldehyde

Reaction time (h)

Yield 5e-h (%)

Yield 6e-g (%)

1

4e

12

62

31

2

4f

12

55.6

41

3

4g

12

23.4

66.6

4

4h

72

3.5

-

5

4i

72

No reaction

No reaction

6

4j

72

No reaction

No reaction

Extending the reaction to aldehydes 4f and 4g smoothly generated the π-extended
BODIPY dyes 5f, 5g, 6f and 6g in 55.6%, 23.4%, 41% and 66.6% yields respectively, after
careful column chromatography. Interestingly, reaction with 4h was successful in generating
only trace amounts of monostyryl product 5h due to instability of the ethynyl aryl groups at
higher temperature.22 As expected, no product could be formed in the case of substituted
thiophene derivatives 4i and 4h due to their lower nucleophilicity. NMR and mass spectral data
were in full agreement with the assigned molecular structures for the mono- and distyrylBODIPY dyes 5e-h and 6e-g, respectively. 1H-NMR spectra of monostyryl-BODIPYs 5e-g (such
as, Figure 3.8), when compared with the 1H-NMR spectrum of BODIPY 3, gave characteristic
signals of vinylic protons in the 3-position as a pair of doublet at approximately 6.92 and 7.25
ppm. For 5e, two single peaks appeared at 3.67 and 3.69 ppm, respectively, due to methyl ester
protons along with additional peaks in between 2-3 ppm due to CH2 and methyl protons of the
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pyrrole substitutent. For 5f, 5g and 5h, signals corresponding to indolic NH (9.87 ppm) and
ortho and meta protons appeared as doublets in the aromatic region with the most shielded one at
6.95 ppm. For 5h, two equivalent protons of the propargylic methylene group showed up as a
singlet at 4.73 ppm. In the 1H-NMR spectra of distyryl-BODIPYs 6e-g, the single peak due to 3methyl protons at 2.48 ppm was replaced by additional peaks of vinylic protons in the aromatic
region (Figure 3.9).

Figure 3.8: 1H-NMR spectrum of BODIPY 5f in deuterated acetone at 400 MHz
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Figure 3.9: 1H-NMR spectrum of BODIPY 6f in deuterated acetone at 400 MHz

Single-crystal X-ray structures were obtained for compounds (5e, 6f and 6g) by slow
diffusion of hexane into a solution of dichloromethane or acetone. The results of this study are
presented in Figure 3.10 and cell parameters and refinement details are summarized in Table 3.3.
Compound 5e crystallizes in the monoclinic space group P21 whereas crystals for 6f and 6g fall
within the centrosymmetric triclinic space group. The average bond lengths for B-N and B-F
[1.559(3), 1.394(3) Å for 6a (Figure 3.7) and 1.551(3), 1.398(2) Å for 6f respectively] and the
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average bond angles for N-B-N and F-B-F [107.22(17)°, 109.02(18)° for 6a and 107.48(15)°,
108.70(15)° for 6f respectively] indicate a tetrahedral BF2N2 configuration and are in good
agreement with previously published data.23 The average bond length of N1-C1, N2-C9
[1.370(3) Å for 6a and 1.368(2) Å for 6f] indicates double bond character, compared with the
single bond character of N1-C4, N2-C6 [1.383(3) Å for 6a and 1.394(2) Å for 6f]. For all the
compounds, there is a strong π-electron delocalization between the central six-membered ring
and the two adjacent pyrrole rings.
The molecular structure of 6a and 6f confirms the presence of two vinyl arms with bond
length C10-C11, C28-C29 [for 6a] and C10-C11, C30-C31 [for 6f] being 1.346(3) Å, 1.345(3)
Å and 1.345(3) Å, 1.347(3) Å respectively, indicating the double bond is in a transconformation, giving the molecule a “V-shape”, as previously published.23b Single crystal X-ray
crystallography of the mono-styryl BODIPY 5e reveals nearly coplanar arrangement of the
pyrrolyl-ethenyl moiety with one of the groups slightly off the molecular plane by 10°. The
styryl group is also only slightly twisted by 5° out of the plane of the BODIPY core, suggesting
efficient conjugation within the entire chromophore. It is interesting to note that both C10-H and
C30-H are in optimal distances for hydrogen bonding of the fluorine atoms on the BF2-bridge.
Table 3.3: Selected crystallographic data and structure refinement for 5e, 6a, 6f and 6g[a]
Parameters

5e

6a

6f

6g

Formula

C32H40BF2N3O6

C35H35BF2N2O4

C39H37BF2N4O4

C38H41BF2N4O7

Mr

611.48

596.46

674.54

686.54

Cell system

Monoclinic

Triclinic

Triclinic

Triclinic

Space group

P21/n

Pī

Pī

Pī

T [K]

90

100

90

90
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Table 3.3: (continued)
Parameters

5e

6a

6f

6g

a [Å]

15.063(2)

13.6417(3)

10.1096(9)

7.9104(6)

b [Å]

6.6224(10)

15.1278(3)

12.4151(10)

11.7055(9)

c [Å]

31.049(5)

15.8439(3)

13.8619(14)

19.9798(15)

α [°]

nd

90.034(1)

77.952(5)

74.172(3)

β [°]

96.512(8)

94.162(1)

85.239(4)

89.368(3)

γ [°]

nd

111.875(1)

79.271(4)

76.456(3)

V [Å3]

3077.3(8)

3024.92(11)

1670.0(3)

1727.6(2)

Z

4

4

2

2

ρcalcd [Mg m-3]

1.320

1.310

1.341

1.320

F(000)

1296

1256

708

724

Crystal size [mm]

0.25 x 0.15 x 0.32 x 0.13 x 0.24 x 0.21 x 0.06
0.08
0.06

0.30 x 0.26 x
0.12

µ [mm-1]

0.82

0.76

0.78

0.81

Ɵmax [°]

67.2

68.5

68.2

67.6

Measured reflns

18925

33183

13932

17540

Independent
reflns

5416

10666

5746

5891

Observed reflns

2357

7251

4618

5482

R [F2 > 2σ(F2)]

0.152

0.044

0.043

0.044

wR(F2)

0.451

0.119

0.119

0.117

Max/min peaks

0.71/-0.40

0.26/-0.24

0.24/-0.21

0.34/-0.27

[a] Criterion for observed reflections: I>2 σ(I). Refinement on F2
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Figure 3.10: ORTEP plots of a) 5e; b) 6f and c) 6g with co-crystallized acetone solvent
molecule at the 50% probability level

Recently, Akkaya et al.24 performed a Mulliken-charge calculation on the core carbon
atoms of 1,3,5,7-tetramethyl BODIPY derivatives. The electron density of the carbon atoms was
found to vary in the order 2,6 >> 1,7 > 3,5, indicating that 1,7-methyls are nearly as acidic as
3,5-methyls. This group also reported the synthesis of tristyryl and tetrastyryl-BODIPY dyes by
activating methyls at the 1,7-positions using electron-accepting 2,6-phenylethynyl groups. Later
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iessel’s group12a successfully synthesized butterfly-shaped BODIPY dyes by introducing four
different vinyl arms on a single tetramethyl-BODIPY core. Encouraged by these observations,
we adopted a similar methodology to generate tristyryl- and tetrastyryl-BODIPY dyes with
unique chemical structures. Thus considering the possibility of further functionalization of the
BODIPY scaffold, BODIPY 6f with indolylstyryl substituent was chosen for a quadruple
Knoevenagel condensation reaction.

Scheme 3.7: Synthetic route to tristyryl and tetrastyryl-BODIPY dyes 7f and 8f

BODIPY 6f and Indole-3-carbaldehyde 4f (5 equiv.) were added to a refluxing mixture of
dry toluene, piperidine and glacial acetic acid (Scheme 3.7). However, due to poor solubility of
the starting material in refluxing toluene, no product could be generated. Variations of solvent
(DMSO, THF and DMF) to make the reaction viable were unsuccessful as we failed to identify
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any triple or quadruple Knoevenagel condensation products and only a dark reaction mixture was
obtained. We then modified our strategy and decided to prepare the desired BODIPYs 7f and 8f
from tetramethyl BODIPY 3, by using slight excess of indole-3-carbaldehyde (Scheme 3.8). It is
worth noting, the major products obtained during the condensation were mono- and diindolylstyryl-BODIPYs 5f and 6f respectively, indicating that the first methyls to react
exclusively are 3,5-methyls. However, highly substituted BODIPYs 7f and 8f could be
successfully generated (though in low yields, < 10% crude) under harsh reflux conditions by
removal of most of the solvent. Despite the successful generation of BODIPYs 7f and 8f, the
products could not be isolated from the reaction mixture as it required chromatographic
purifications which were quite difficult to perform due to close Rf values. The above reaction
was then performed with BODIPY 3 and aldehydes 4e and 4g as shown in Scheme 3.8. All the
four (mono, di, tri and tetra) condensation products could be identified by MALDI-TOF analysis.

Scheme 3.8: Synthetic route to tristyryl and tetrastyryl-BODIPY dyes 7e-g and 8e-g
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Though the attempts to isolate pure 7e and 8e from the reaction mixture failed due to purification
difficulties, the first tristyryl- and tetrastyryl-BODIPYs 7g and 8g bearing polar phenol groups
were successfully isolated in 8% and 6.2 % yield by careful silica gel column chromatography
(dichloromethane/ethyl acetate, 10/1) followed by preparative TLC (ethyl acetate/acetone 1/1).
MALDI-TOF indicated molecular ion peaks at m/z 732.2 and 836.3 corresponding to BODIPYs
7g and 8g respectively. However, due to trace amounts of the product formed, well-resolved 1HNMR spectra could not be obtained.
Mitochondria are membrane-enclosed energy producing organelles found in eukaryotic
cells, making up to 10% of the cell volume. They are pleomorphic organelles with a pivotal role
in a range of cellular processes (cell signaling, differentiation and cell death), hyper-proliferative
diseases and cancer. However, there is only a partial understanding of mitochondrial morphology
and functioning.25 Therefore, mitochondrial specific probes will undoubtedly provide a more
detailed understanding of organelle’s activity, localization and abundance. Mitochondria
possesses a net negative charge on the membrane, hence ideal biomarker for mitochondria
should potentially be lipophilic with delocalized positive charge. Keeping this in mind, we
hypothesized that the cationic lysyl-BODIPY conjugates bearing positive charge on the amine
group might display enhanced affinity towards mitochondria.26
As the designed BODIPYs are functionalized with protected propionic acids at 2,6positions, their ability for conjugation to amine group of lysine was investigated. BODIPY 3 was
chosen as a model compound to study the hydrolysis of the methyl esters. Firstly, the basic
hydrolysis of dimethyl esters on BODIPY 3 was carried out using standard conditions with LiOH
and NaOH (pH < 10)12d, 27,

28, 29

. Under these saponification conditions, BODIPY 3 didn’t give

any desired product, but resulted in destruction of the fluorophore (due to nucleophilic attack on
boron) and generation of secondary fluorescent products. MALDI-TOF analysis of the reaction
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Scheme 3.9: Synthetic route to ester hydrolysis and lysine conjugation of BODIPYs 3 and 6g
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mixture indicated a highly intense molecular ion peak at M+-19, corresponding to molecular
fragment without a fluoride ion (borenium cation). The hydrolysis of BODIPY 3 was ultimately
accomplished under acidic conditions upon treatment with 4.5M HCl in THF/H2O mixture (3/5,
v/v) at room temperature by modifying the procedure reported by Giebler and co-workers30,
affording the mono- and dicarboxylic-acid BODIPY derivatives within 1 h (Scheme 3.9). These
intermediates were used as such without further purification in the conjugation step. In situ
carbodiimide activation with DCC/DMAP (5:3 ratio) was chosen to activate the free carboxylic
acid groups. Furthermore, coupling with H-lysine(OtBu)methyl ester.HCl (3 equiv.) generated
the mono- and dilysine(OtBu) protected BODIPY-conjugates in 26.2% and 26.5% yields
respectively. MALDI-TOF analysis showed two subsequent peaks at m/z 657.43 and 899.51, due
to lysyl-BODIPY conjugates 9 and 10 respectively, and 1H-NMR spectrum demonstrated the
existence of new peaks due to the newly appended lysine residue. The optimized acid hydrolysis
and conjugation conditions were then applied to distyryl-BODIPYs 6f and 6g. Due to limited
solubility of BODIPYs in THF, an equimolar solvent mixture of THF/DMF was chosen to run
the coupling reaction. Surprisingly, the conjugation of mono- and dicarboxylic-acid derivatives
of BODIPY 6f with lysine didn’t give the desired conjugation product, presumably due to steric
and/or electronic interactions within BODIPY 6f which prevented the formation of lysylBODIPY conjugates. On the other hand, BODIPY 6g effectively generate both mono- and
dilysyl-BODIPY conjugates 11 and 12 in 11.4% and 34.8% yields respectively. 1H-NMR spectra
of 11 and 12 showed the disappearance of methyl ester protons with the formation of amidebonds. Additionally, new peaks due to appended lysyl-group appeared between 2-3 ppm.
MALDI-TOF analysis revealed the molecular ion peaks at m/z 856.44 and 1084.60 for lysylBODIPY conjugates 11 and 12 respectively. The deprotection of OtBu-group (Boc group) of
lysyl-BODIPY conjugates with TFA can further generate the positively charged-BODIPY
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derivatives that might have affinity towards mitochondria or other charged molecules such as
phosphates or carboxylates.

3.2.2: Photophysical Studies
The UV/Vis absorption and fluorescence spectra of BODIPY dyes 5f, 5g, 6a, 6e and 6g
were studied in three solvents of different polarity, i.e. dichloromethane, THF and DMSO, along
with those of unsubstituted BODIPYs 2 and 3. The results obtained from these measurements are
represented in Figures 3.11 to 3.13 and summarized in Table 3.4 to 3.6. As is evident, all these
BODIPYs exhibit the typical spectral characteristics of the BODIPY dyes with narrow
absorption band due to S0-S1 transition, a weak and broad absorption band attributed to S0-S2
transition, high molar extinction coefficients (log ε = 4.27-4.64), an intense fluorescence
emission band and small Stokes shifts in all the three solvents.31 All fluorescence emission
spectra are identical to absorption ones and are mirror image of the latter, indicating that the
emitting species are similar to the absorbing ones. In comparison to non-styrylated BODIPYs,
introduction of first styryl group induces a significant bathochromic shift in the absorption (5080 nm) and emission maxima (56-105 nm), whereas grafting of second styryl moiety causes redshifts of both absorption and emission maxima in the order of 125-176 nm and 132-200 nm
respectively, depending on the attached styryl group. Hence by varying the aromatic aldehyde
used to generate the styryl arm, one can synthetically modify the green emissive BODIPY
scaffold to provide “any color you want”,32 highlighting the usefulness of this facile
transformation. The appended styryl substituents affect the spectral characteristics of BODIPYs
by following the trend: indole > hydroxy > phenyl in all the solvents studied. BODIPY 6f
displayed the most red-shifted and much broader absorption and emission spectra at 693 nm and
711 nm respectively, along with relatively large Stokes shift in dichloromethane, which steadily
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shifted to NIR region on moving to more polar solvent (absorption and emission spectra at 708
and 738 nm, respectively in DMSO). The solvatochromic fluorescence emission indicates that
the dipole moment of the emissive state is significantly higher as compared to the ground state, a
phenomenon that has been observed in similar compounds and explained in terms of
intramolecular charge transfer (ICT) that occurs in the locally excited states, producing more
polar and conformationally relaxed emissive excited states.33
Table 3.4: Spectral properties of BODIPYs 2, 3, 5f, 5g, 6a, 6f and 6g in dichloromethane at
room temperature
BODIPY

Absorbance
λmax/nm

log ε( M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes Shift
(nm)

2

528

4.4242

531

0.81

3

3

534

4.3950

540

0.85

6

5f

605

4.6035

622

0.84

17

5g

588

4.2760

596

0.94

8

6a

649

4.5924

658

0.58

9

6f

693

4.6218

711

0.12

18

6g

659

4.6402

672

0.68

13

[a] Fluorescence quantum yields for BODIPYs 2, 3 (λexc = 510 nm), BODIPYs 5f-g (λexc = 570
nm), BODIPYs 6a and 6g (λexc = 620 nm) and BODIPY 6f (λexc = 650 nm) were calculated using
Rhodamine 6G (0.80 in methanol), cresyl violet perchlorate (0.54 in ethanol), methylene blue
(0.03 in methanol) and ZnPc (0.28 in DMF) as the reference, respectively.[28]
All the observed spectral parameters are in good agreement with those reported
previously for mono- and distyryl-BODIPYs in various organic solvents.18, 23b, 34 Changing the
solvent polarity causes only a slight red-shift in the absorption maxima of all the BODIPYs (3-15
nm) indicating a small difference between the dipole moment of the ground and the locally
excited states.18 On the other hand, the emission maxima for all BODIPYs studied, steadily
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shifted to longer-wavelengths (10-27 nm) on moving from dichloromethane to DMSO, which
once again can be attributed to the charge-transfer nature of the emitting state.35

Figure 3.11: Normalized UV/Vis (a) and fluorescence spectra (b) of BODIPYs 2 (red), 3
(black), 5f (brown), 5g (cyan), 6a (blue), 6f (green) and 6g (pink) in dichloromethane at 25 °C
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Figure 3.12: Normalized UV/Vis (a) and fluorescence spectra (b) of BODIPYs 2 (red), 3
(black), 5f (brown), 5g (cyan), 6a (blue), 6f (green) and 6g (pink) in THF at 25 °C
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Table 3.5: Spectral properties of BODIPYs 2, 3, 5f, 5g, 6a, 6f and 6g in THF at room
temperature
BODIPY

Absorbance
λmax/nm

log ε (M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes shift
(nm)

2

523

4.5125

527

0.57

4

3

529

4.4512

536

0.77

7

5f

608

4.5618

627

0.64

19

5g

591

4.1610

600

0.92

9

6a

648

4.2836

657

0.40

9

6f

699

4.5033

718

0.10

19

6g

663

4.6531

677

0.49

14

[a] Fluorescence quantum yields for BODIPYs 2, 3 (λexc = 510 nm), BODIPYs 5f-g (λexc = 570
nm), BODIPYs 6a and 6g (λexc = 620 nm) and BODIPY 6f (λexc = 650 nm) were calculated using
Rhodamine 6G (0.80 in methanol), cresyl violet perchlorate (0.54 in ethanol), methylene blue
(0.03 in methanol) and ZnPc (0.28 in DMF) as the reference,[28] respectively using PTI Quantum
Master4/2006SE spectrofluorimeter

Figure 3.13: Normalized UV/Vis (a) and fluorescence spectra (b) of BODIPYs 2 (red), 3
(black), 5f (brown), 5g (cyan), 6a (blue), 6f (green) and 6g (pink) in DMSO at 25 °C
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Figure 3.13: (continued)

Table 3.6: Spectral properties of BODIPYs 2, 3, 5f, 5g, 6a, 6f and 6g in DMSO at rt
BODIPY

Absorbance
λmax/nm

log ε (M-1.cm-1)

Emission
λmax/nm

Φf[a]

Stokes Shift
(nm)

2

524

4.5035

530

0.78

7

3

532

4.2934

538

0.81

6

5f

612

4.4602

643

0.40

31

5g

591

4.0346

606

0.90

16

6a

646

4.3836

657

0.36

11

6f

708

4.3658

738

0.10

30

6g

667

4.6269

686

0.38

19

[a] Fluorescence quantum yields for BODIPYs 2, 3 (λexc = 510 nm), BODIPYs 5f-g (λexc = 570
nm), BODIPYs 6a and 6g (λexc = 620 nm) and BODIPY 6f (λexc = 650 nm) were calculated using
Rhodamine 6G (0.80 in methanol), cresyl violet perchlorate (0.54 in ethanol), methylene blue
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(0.03 in methanol) and ZnPc (0.28 in DMF) as the reference,[28] respectively using PTI Quantum
Master4/2006SE spectrofluorimeter
3.2.3: In Vitro Cellular Studies
In order to investigate the potential biological usefulness of the developed styryl- (5e-g,
6f, 6g, 7g) and lysyl-BODIPY conjugates (9-12), the in vitro photodynamic activities, including
cytotoxicity, cellular uptake and intracellular localization were assessed against human
carcinoma HEp2 cell lines. Cremophor surfactant was added to increase the solubility of the dyes
in the aqueous media. These studies were performed by Dr. Xiaoke Hu and N. V. S. Dinesh
Bhupathiraju.
3.2.3.1: Time-Dependent Cellular Uptake. The results obtained for the time-dependent cellular
uptake of styryl- and lysyl-BODIPY conjugates at a concentration of 10 µM in HEp2 cells, over
a period of 24 h are shown in Figure 3.14 and 3.15, respectively. At this concentration, all the
compounds were non-toxic to the cells, as evaluated using the Cell Titer Blue assay. First of all,
it is interesting to note that the introduction of different aromatics at 3- and/or- 5-positions
deeply influence the uptake of these BODIPY dyes by cells. The cellular uptake followed the
order 5e > 6f > 5f > 5g > 6g at all the time points studied. BODIPY 5e bearing a mono
pyrrolylstyryl side arm accumulated the most within the cells, followed by diindolyl styrylBODIPY 6f. BODIPYs 5f, 5g and 6g showed similar uptake kinetics with a rapid accumulation
at short time points (< 4 h), followed by a slower uptake at longer time points. The observed
results are in good agreement with previous studies indicating that the neutral pyrrole and indole
rings play an important role in facilitating the cellular uptake. Pyrroles and indoles are weak
bases with pKa value of ~ 23.0 and 21.0 respectively. In other words, they are only partially
ionized at cytosolic pH and can easily equilibrate between their ionized and unionized forms.
This allows BODIPYs 5e and 6f to cross the cell membrane in their non-ionized forms via the
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passive diffusion, while the presence of the ionized form renders them water-soluble, once inside
the cell. BODIPYs 5g and 6g which contain strongly acidic phenol groups are fully ionized at
intracellular pH and hence have difficulty crossing the lipophilic cell membrane, which affects
their cellular uptake. Additionally, the movement of less polar pyrrole and indole through the
hydrophobic core of the bilayer is more energetically favored in comparison to fully ionized
phenolate group.36, 37

Figure 3.14: Time-dependent uptake of BODIPYs 5e (black), 5f (green), 5g (orange), 6f (blue)
and 6g (purple) at 10 µM by HEp2 cells

Figure 3.15: Time-dependent uptake of BODIPY conjugates 9 (orange), 10 (green), 11 (blue),
12 (black) and 7g (purple) at 10 µM by HEp2 cells
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Similarly, all lysyl-BODIPY conjugates 9-12, were readily taken up by the cells, reaching
a plateau after < 2 h exposure time to the cells (Figure 3.15). The cellular uptake of the lysylBODIPY conjugates is dependent on the structure of the conjugate and their hydrophobic
character. Lysyl-BODIPY conjugates 11 and 12 accumulated within the cells to a much higher
extent (two-fold increase) than lysyl-BODIPY conjugates 9 and 10, presumably due to the
presence of two additional benzene rings which impart enhanced hydrophobicity and improved
membrane permeability.25a, 26, 38

Figure 3.16: Dark toxicity and b) Phototoxicity of BODIPYs 5e (black), 5f (green), 5g (orange),
6f (blue) and 6g (purple) toward HEp2 cells using 1 J/cm2 light dose and CellTiter Blue assay.

151

3.2.3.2: Cytotoxicity. The dark toxicity and photo cytotoxicity of styryl- and lysyl-BODIPY
conjugates was evaluated in HEp2 cells exposed to increasing concentration of each compound
up to 400 µM, using Promega’s Cell Titer Blue viability assay. The results are shown in Figure
3.16 and 3.17, respectively. It can be seen that all the BODIPY-conjugates are essentially noncytotoxic in the absence [IC50 (dark) > 300 µM] or presence of light [IC50 (1 J/cm2) > 100 µM]
and the observed results are in consensus with the previously reported investigations.37a, b

Figure 3.17: a) Dark toxicity and b) Phototoxicity of BODIPY-conjugates 9 (red), 10 (black),
11 (blue) (orange), 12 (green) and 7g (purple) toward HEp2 cells using 1 J/cm2 light dose and
CellTiter Blue assay.
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Table 3.7: Major (++) and Minor (+) Subcellular Localization sites for BODIPYs in HEp2 cells.
BODIPY

ER

Mitochondria

Golgi

Lysosomes

2

++

-

++

-

3

++

-

++

-

5e

++

-

++

+

5f

++

-

++

+

5g

+

++

+

++

6a

++

+

++

-

6f

++

_

++

+

6g

++

+

++

-

3.2.3.3: Subcellular Localization. The preferential sites of the subcellular localization of
unsubstituted BODIPYs 2 and 3 along with styryl-BODIPY conjugates 5e-g, 6a and 6f-g were
investigated by fluorescence microscopy upon exposure of HEp2 cells to 10 µM compound
concentrations for 6 h, using the method described in Chapter 2 (Section 2.2.5.3). Colocalization
experiments were performed for all compounds using ER-Tracker Blue/White, MitoTracker
Green, BODIPY Ceramide and LysoSensor Green, which are specific fluorescent probes for
endoplasmic reticulum, mitochondria, golgi apparatus and lysosomes respectively.26, 39 Figure
3.18 to 3.25 display the fluorescence patterns observed for all compounds and Table 3.7
summarizes their main sites of subcellular distribution. All BODIPY derivatives showed
substantial intracellular fluorescence and were found to preferentially accumulate in the
endoplasmic reticulum and Golgi apparatus, and to a smaller extent in lysosomes, indicating
similar mechanism of cellular uptake for all the BODIPYs studied. This is not surprising, as the
commercially available green fluorescent BODIPY FL and red-orange fluorescent BODIPYBSA conjugates are known cell-permeant ER- and Golgi-Tracker dyes.40
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Figure 3.18: Subcellular localization of BODIPY 2 in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 2 fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 2 fluorescence. Scale bar: 10 m
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Figure 3.19: Subcellular localization of BODIPY 3 in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 3 fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 3 fluorescence. Scale bar: 10 m
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Figure 3.20: Subcellular localization of BODIPY 5e in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 5e fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 5e fluorescence. Scale bar: 10 m
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Figure 3.21: Subcellular localization of BODIPY 5f in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 5f fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 5f fluorescence. Scale bar: 10 m
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Figure 3.22: Subcellular localization of BODIPY 5g in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 5g fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 5g fluorescence. Scale bar: 10 m
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Figure 3.23: Subcellular localization of BODIPY 6a in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 6a fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 6a fluorescence. Scale bar: 10 m
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Figure 3.24: Subcellular localization of BODIPY 6f in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 6f fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 6f fluorescence. Scale bar: 10 m
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Figure 3.25: Subcellular localization of BODIPY 6g in HEp2 cells at 10 μM for 6 h. (a) Phase
contrast, (b) overlay of 6g fluorescence and phase contrast, (c) ER tracker Blue/White
fluorescence, (e) MitoTracker Green fluorescence, (g) BODIPY Ceramide, (i) LysoSensor Green
fluorescence, and (d, f, h, j) overlays of organelle tracers with 6g fluorescence. Scale bar: 10 m
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3.3: Conclusion
A series of new red and NIR emissive BODIPY dyes with different styryl substituents
were prepared in moderate yields starting from green emissive 1,3,5,7-tetramethyl BODIPYs.
All styryl-BODIPY derivatives are highly soluble in polar organic solvents and displayed
fluorescence and quantum yields in the range of 591-738 nm and 0.12-0.90, respectively, in
DMSO. BODIPY 6f bearing two indolylstyryl arms displayed the most red-shifted absorption
and fluorescence emission profiles in DMSO at 708 nm and 738 nm, respectively, reaching into
the NIR region. In vitro biological studies using human carcinoma HEp2 cells revealed that the
styryl-BODIPY conjugates (2, 3, 5e-g, 6a, 6f, 6g and 7g) and lysyl-BODIPY conjugates (9-12)
are potential non-cytotoxic, photostable and cell-permeant optical probes with preferential
localization in endoplasmic reticulum and Golgi apparatus and high cellular uptake, which
depends significantly on the number and nature of the styryl group attached to the BODIPY core.
This work presents a series of novel BODIPY derivatives that could be extensively used as nontoxic and non-photobleachable biolabels or fluorescent tracers for drug delivery or sensing
applications. Currently, we are investigating; (1) different approaches to improve upon the
synthesis and percent yield of tri- and tetrastyryl-BODIPY derivatives to obtain highly
substituted NIR-emissive BODIPY dyes, and (2) TFA-mediated deprotection of Boc-protected
lysyl-BODIPY conjugates 9-12, to obtain positively-charged lysyl-BODIPY conjugates with
increased affinity towards specific cell organelles.
3.4: Experimental
3.4.1: General Information
All reagents were purchased from commercial sources and were used as received. All air and
moisture sensitive reactions were performed under argon atmosphere in oven-dried glassware.
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Dry solvents were collected from PS-400 Solvent Purification System from Innovative
Technology Inc. Melting points were obtained without correction with a MEL-TEMP® capillary
melting point apparatus. Analytical thin-layer-chromatography (TLC) was performed on
polyester backed TLC plates 254 (pre-coated, 200 µm, Sorbent Technologies). Column
chromatography separations were performed using silica gel (Sorbent Technologies, 60 Å, 40-63
µm, 230-400 mesh) slurry packed into glass columns. NMR spectra were recorded on Bruker
DPX-400 (operating at 400MHz for 1H NMR and 100 MHz for 13C NMR) in CDCl3 (7.26 ppm,
1

H and 77.0 ppm,13C) and acetone (2.05 ppm, 1H and 206.7 and 29.9 ppm,

13

C) with

tetramethylsilane as internal standard. All spectra were recorded at 298K and coupling constants
(J values) are given in Hz. Chemical shifts are given in parts per millions (ppm). High resolution
mass spectra were obtained at the LSU Department of Chemistry Mass Spectrometry Facility
using an ESI or MALDI-TOF method, and a peak matching protocol to determine the mass error
range of the molecular ion.

3.4.2: Syntheses
BODIPY 2
To a solution of dipyrromethene hydrobromide 1 (540 mg, 1.20 mmol) in dry dichloromethane
(80 mL) at 0 °C, added Et3N (0.89 mL, 6.4 mmol) dropwise over a period of 10 min. After
stirring for 20 min, BF3.OEt2 (1.30 mL, 10.24 mmol) was added dropwise to the solution over a
period of 10 min. The reaction was then stirred at 25 °C until TLC indicated reaction completion.
The solvent was removed under reduced pressure and residue was taken in dichloromethane and
extracted with water, saturated NaHCO3, brine and dried over Na2SO4.The solvent was removed
under reduced pressure and the residue was purified over a pad of silica gel using
dichloromethane/petroleum ether 1:1 as eluent. Recrystallization using DCM/Hexane (5:1 v/v)
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gave BODIPY 2 (537 mg, 90%) as shiny orange-green crystals; m.p. (142°C); 1H-NMR (CDCl3,
400 M z): δ = 1.96 (s, 6H), 2.47(s, 6H), 2.52 (t, J = 7.6 Hz, 4H), 2.89 (t, J = 7.6 Hz, 4H), 3.67
(s,6H), 7.07 (s,1H);

13

C NMR (CDCl3, 100 M z): δ = 7.99, 8.26, 11.98, 19.11, 34.27, 46.24,

51.06, 118.73, 124.53, 131.02, 138.92, 154.66, 172.16; ESI-HRMS: m/z calcd for
C21H27BF2N2O4 [M+Na+]: 443.188; found: 443.18.
BODIPY 3
To a solution of 4e (123 mg, 0.5878 mmol) in dry dichloromethane (20 mL) at 0 °C, added
POCl3 (0.11 mL, 0.7054 mmol) dropwise over 5 min. The brown reaction mixture was kept for
overnight stirring at 25 °C. When TLC indicated reaction completion, Et3N (0.89 mL, 2.9 mmol)
was added dropwise over a period of 10 min at 0 °C. After stirring for 15 min, BF3.OEt2 (1.30
mL, 4.7 mmol) was introduced dropwise over 10 min. The reaction was then stirred at 25 °C for
16 h. The solvent was removed under reduced pressure and residue was taken in
dichloromethane and extracted with saturated NaHCO3, brine and dried over Na2SO4.The solvent
was removed under reduced pressure and the residue was purified by column chromatography
using

dichloromethane/petroleum

ether

1:1

as

eluent

and

recrystallized

using

dichloromethane/Hexane (5:1 v/v) to afford BODIPY 3 (112 mg, 94%) as orange crystals with
green lustre; m.p. (138°C); 1H-NMR (CDCl3, 400 M z): δ = 2.18 (s, 6 ), 2.44 (t, J = 7.44 Hz,
4H), 2.50 (s, 6H), 2.71 (t, J = 7.44 Hz, 4H), 3.67 (s,6H), 6.98 (s,1H);

13

C NMR (CDCl3, 100

M z): δ = 9.30, 12.39, 19.24, 33.87, 51.46, 118.98, 127.74, 132.23, 137.53, 154.81, 172.86;
ESI-HRMS: m/z calcd for C21H27BF2N2O4 [M+Na+]: 443.188; found: 443.35.
Distyryl BODIPY 5a and 6a
BODIPY 2 (112mg, 0.2665 mmol) and benzaldehyde 4a (0.055 mL, 0.533 mmol) were refluxed
in dry toluene (50 mL) along with piperidine (0.4 mL), glacial acetic acid (0.4 mL) and a small
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amount of activated molecular sieves. Once the reaction was complete, the mixture was cooled
to room temperature, filtered off to remove the molecular sieves and the solvent was removed
under the reduced pressure. The crude was purified by silica column and eluted with
dichloromethane/hexane (20/1). The blue fraction was collected and recrystallized from
dichloromethane to yield BODIPY 6a as blue shiny needles (56 mg, 35%); m.p. (172°C); 1HNMR (CDCl3, 400 M z): δ = 2.31(s, 6 ), 2.58 (t, J = 7.6 Hz, 4H), 2.97 (t, J = 7.6 Hz, 4H), 3.69
(s,6H), 7.13 (s,1H), 7.77-7.13 (m, 10H);

13

C NMR (CDCl3, 100 M z): δ = 12.22,14.21, 19.62,

22.78, 29.45, 29.78, 32.01, 35.18, 51.92, 117.73, 120.20, 126.78, 127.47, 128.87, 128.95, 131.03,
134.25, 137.18, 137.22, 140.22, 151.76, 172.93; ESI-HRMS: m/z calcd for C35H35BF2N2O4 [M
+

]: 596.2785; found: 595.25.

Mono and Distyryl BODIPY 5e and 6e
A mixture of BODIPY 3 (100 mg, 0.2379 mmol), 5-formyl pyrrole 4e (194.2 mg, 0.9516
mmol), piperidine (0.4 mL) and glacial acetic acid (0.4 mL) were refluxed overnight in dry
toluene (50 mL) using Dean-Stark apparatus to remove any water formed azeotropically. Crude
product was then concentrated under reduced pressure and purified by silica gel column
chromatography (eluent: dichloromethane/ethyl acetate 20:1). The blue fraction was collected
and the solvent removed under reduced pressure to obtain BODIPY 5e in the form of blue
needles (90.16 mg, 62%); m.p. (176°C); 1H-NMR (CDCl3, 400 M z): δ = 2.04 (s, 3 ), 2.24 (s,
6H), 2.27 (s, 3H), 2.43 (m, 4H), 2.45 (s, 3H), 2.58 (t, J = 7.8 Hz, 2H), 2.70 (m, 4H), 3.01 (t, J =
7.8 Hz, 2H), 3.67 (s, 6H), 3.69 (s, 3H), 6.86 (s, 1H), 6.94 (d, J = 16.6 Hz, 1H), 7.25 (d, J = 16.7
Hz, 1H), 8.49 (s, 1H);

13

C NMR (CDCl3, 100 M z): δ = 9.1, 9.5, 11.5, 12.5, 19.6, 19.7, 21.4,

33.3, 34.3, 34.9, 51.5, 516, 51.7, 109.6, 115.8, 120.3, 124.3, 124.4, 126.3, 127.2, 128.5, 130.6,
132.5, 134.4, 135.3, 138.4, 152.0, 152.5, 173.1, 173.2, 173.5; MALDI-TOF: m/z calcd for
C32H40BF2N3O6 [M +]: 611.30; found: 611.372.
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The green fraction was collected and the solvent was removed under reduced pressure.
Recrystallization with dichloromethane/ethyl acetate (1:1 v/v) afforded the desired BODIPY 6e
as lustrous green needles (59.2 mg, 31%); m.p. (< 250°C); 1H-NMR (Acetone-d6, 400 M z): δ =
2.04 (s, 6H), 2.14 (s, 6H), 2.43 (t, J = 7.8 Hz, 4H), 2.58 (t, J = 7.8 Hz, 4H), 2.67 (t, J = 7.8 Hz,
4H), 2.79 (s,6H), 2.97 (t, J = 7.8 Hz, 4H), 3.60 (s, 6H), 3.65 (s, 6H), 7.11 (s, 1H);

13

C NMR

(Acetone-d6, 100 M z): δ = 9.1, 9.5, 11.5, 12.5, 19.6, 19.7, 21.4, 33.3, 34.3, 34.9, 51.5, 516,
51.7, 109.6, 115.8, 120.3, 124.3, 124.4, 126.3, 127.2, 128.5, 130.6, 132.5, 134.4, 135.3, 138.4,
152.0, 152.5, 173.1, 173.2, 173.5; MALDI-TOF: m/z calcd for C43H53BF2N4O8 [M +]: 802.39;
found: 802.457.
Mono and Distyryl BODIPY 5f and 6f
BODIPY 3 (100 mg, 0.2379 mmol), indole-3-carboxaldehyde 4f (103.6 mg, 0.7137 mmol),
piperidine (0.4 mL) and glacial acetic acid (0.4 mL) were refluxed overnight in dry toluene (50
mL) using Dean-Stark apparatus. The crude was then concentrated under reduced pressure and
purified by silica gel column chromatography (eluent: ethyl acetate/hexane 2:1). The deep blue
fraction was collected and the solvent removed under reduced pressure to obtain BODIPY 5f as
blue solid (72.9 mg, 55.6%); m.p. (185°C); 1H-NMR (CDCl3, 400 M z): δ = 2.20 (s, 6 ), 2.46
(t, J = 7.8 Hz, 2H), 2.57 (m, 5H), 2.74 (t, J = 7.8 Hz, 2H), 3.04 (t, J = 7.8 Hz, 2H), 3.69 (s, 6H),
3.71 (s, 3H), 7.10-8.03 (m, 9H), 8.64 (s, 1H); 13C NMR (CDCl3, 100 M z): δ = 11.8, 12.1, 17.3,
20.7, 22.1, 35.2, 36.5, 51.9, 101.0, 110.1, 111.1, 116.1, 118.7, 119.6, 119.8, 120.7, 121.7, 127.7,
128.9, 129.5, 131.4, 133.4, 137.1, 138.4, 146.6, 173.3, 184.4; MALDI-TOF: m/z calcd for
C30H32BF2N3O4 [M +]: 547.25; found: 547.302
The green fraction was collected and the solvent was removed under reduced pressure afforded
the desired BODIPY 6f as shiny green needles (65.7 mg, 41%); m.p. (195°C); 1H-NMR
(Acetone-d6, 400 M z): δ = 2.30 (s, 6 ), 2.69 (t, J = 7.8 Hz, 4H), 3.13 (t, J = 7.8 Hz, 4H), 3.67
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(s, 6H), 7.13 (s,1H), 7.25-7.31 (m, 5H), 7.54 (m, 2H), 7.76 (m, 3H), 7.79 (s, 1H), 7.93 (s, 1H),
7.98 (s, 1H), 8.28 (m, 2H);

13

C NMR (Acetone-d6, 100 M z): δ = 8.3, 20.9, 33.1, 50.9, 112.1,

115.2, 115.7, 116.0, 121.0, 122.6, 125.3, 128.4, 128.6, 130.4, 134.4, 137.9, 150.9, 172.6;
MALDI-TOF: m/z calcd for C39H37BF2N4O4 [M +]: 674.29; found: 674.416.
Mono and Distyryl BODIPY 5g and 6g
BODIPY 3 (100 mg, 0.2379 mmol), p-hydroxy benzaldehyde 4g (87.2 mg, 0.7137 mmol),
piperidine (0.4 mL) and glacial acetic acid (0.4 mL) were refluxed overnight in dry toluene (50
mL) using Dean-Stark apparatus. The crude was then concentrated under reduced pressure and
purified by silica gel column chromatography (eluent: dichloromethane/ethyl acetate 20:1). The
red fraction was collected and the solvent removed under reduced pressure to obtain BODIPY 5g
as red solid (29 mg, 23.4%); m.p. (172°C); 1H-NMR (Acetone-d6, 400 M z): δ = 2.04 (s, 6 ),
2.21 (s, 3H), 2.09 (t, J = 7.6 Hz, 2H), 2.35 (t, J = 7.6 Hz, 2H), 2.50 (t, J = 7.6 Hz, 2H), 2.79 (t, J
= 7.6 Hz, 2H), 3.68 (s,6H), 5.35 (s, 1H), 6.95 (d, J = 16.8 Hz, 1H), 6.99 (d, J = 16.8 Hz, 1H),
6.65 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 8.3 Hz, 2H), 7.49 (s, 1H);

13

C NMR (Acetone-d6, 100

M z): δ = 11.8, 12.1, 17.3, 20.7, 22.1, 35.2, 36.5, 51.9, 101.1, 115.8, 116.1, 119.6, 120.7, 123.5,
130.1, 130.6, 131.2, 131.4, 138.4, 146.6, 157.7, 164.6; MALDI-TOF: m/z calcd for
C28H31BF2N2O5 [M +]: 524.23; found: 524.266
The blue fraction was collected and the solvent was removed under reduced pressure to afford
the desired BODIPY 6g as shiny green needles (99.5 mg, 66.6%); m.p. (183°C); 1H-NMR
(Acetone-d6, 400 M z): δ = 2.14 (s, 6 ), 2.62 (t, J = 7.8 Hz, 4H), 3.05 (t, J = 7.8 Hz, 4H), 3.65
(s, 6H), 6.94 (d, J = 8.3 Hz, 4H), 7.40 (d, J = 16.8 Hz, 2H), 7.53 (d, J = 8.3 Hz, 4H), 7.59 (d, J =
16.8 Hz, 2H); 13C NMR (Acetone-d6,, 100 M z): δ = 8.39, 20.8, 33.0, 50.9, 115.9, 116.6, 117.4,
128.8, 129.0, 129.1, 134.7, 134.1, 136.1, 138.5, 150.8, 158.7, 172.5, 184.9; MALDI-TOF: m/z
calcd for C35H35BF2N2O6 [M +]: 628.26; found: 628.295
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Monostyryl-BODIPY 5h
BODIPY 3 (100 mg, 0.2379 mmol), 4-(prop-2-ynyloxy) benzaldehyde 5h (115 mg, 0.7137
mmol), piperidine (0.4 mL) and glacial acetic acid (0.4 mL) were heated under reflux overnight
in dry toluene (50 mL) using Dean-Stark apparatus. The crude was then concentrated under
reduced

pressure

and

purified

by

silica

gel

column

chromatography

(eluent:

dichloromethane/ethyl acetate 20:1). The first red fraction was collected and the solvent removed
under reduced pressure to obtain BODIPY 5h as red solid (4.68 mg, 3.5%); 1H-NMR (CDCl3,
400 MHz): δ = 2.17 (s, 6H), 2.22 (t, J = 7.6 Hz, 2H), 2.48 (s, 3H), 2.55 (t, J = 7.6 Hz, 2H), 2.71
(t, J = 7.6 Hz, 2H), 3.02 (t, J = 7.6 Hz, 2H), 3.68 (s, 3H), 3.71 (s, 3H), 4.73 (s, 2H), 6.98 (m,
3H), 7.54 (m, 3H), 7.26 (s, 1H); MALDI-TOF: m/z calcd for C31H33BF2N2O5 [M +]: 562.28;
found: 562.289.
Tri- and Tetrastyry-BODIPY 7g and 8g
BODIPY 3 (100 mg, 0.2379 mmol) and p-hydroxy benzaldehyde 4g (203.4 mg, 1.6653 mmol)
were added to a round bottom flask containing dry toluene (50 mL) and to this solution was
added piperidine (0.4 mL) and glacial acetic acid (0.4 mL). The mixture was refluxed overnight
using Dean-Stark apparatus. The crude was then concentrated under reduced pressure and
purified by preparative thin layer chromatography (eluent: ethyl acetate). The first blue-green
fraction was collected, dissolved in acetone and filtered. The solvent was then removed under
reduced pressure to obtain BODIPY 7g as blue solid (13 mg, 8%); MALDI-TOF: m/z calcd for
C42H39BF2N2O7 [M +]: 732.28; found: 732.289.
The second blue-green fraction was collected, dissolved in acetone and filtered. The solvent was
then removed under reduced pressure to obtain BODIPY 8g as blue solid (12.3 mg, 6.2%);
MALDI-TOF: m/z calcd for C49H43BF2N2O8 [M +]: 836.31; found: 836.31.
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General procedure for synthesis of Lysyl-BODIPY conjugates 9-12
PMe-BODIPY (38 mg, 0.0904 mmole) was dissolved in a mixture of THF (4.9 mL), H2O (3.3
mL) and 4.5 M HCl (2.0 mL). After stirring at room temperature for 1 hour, dichloromethane
was added (10 mL) and the two phases were separated. The aqueous phase was extracted with
dichloromethane (2 x 10 mL) and the combined organic phase was washed with brine and
concentrated in vacuo. The crude was dried in the oven overnight and then dissolved in dry
dichloromethane (10 mL) containing N, N-Diisopropylethylamine (0.5434 mmole, 6 equiv.).
After stirring the reaction mixture for 1 hour, HOBt (0.113 mmole, 1.25 equiv.), DCC (0.113
mmole, 1.25 equiv.) and DMAP (0.0678 mmole, 0.75 equiv.) were added and reaction was
allowed to stir for an additional 1 hour. Finally, H-lysyl(Boc)OMe.HCl (0.1650 mmole) was
added and the reaction was left for overnight stirring. It was then diluted with dichloromethane
and washed with 5% aqueous citric acid, followed by a wash with brine and water. It was dried
over anhydrous Na2SO4 and then evaporated to dryness. The residue was dissolved in 12%
acetone/dichloromethane and purified via preparative thin layer chromatography with the same
mobile phase to afford mono- and dilysyl-BODIPY derivatives 9-12.
BODIPY 9: Yield (15.4 mg, 26.2%); 1H-NMR (acetone-d6, 400 M z): δ 1.0-2.0 (m, 8H), 1.36
(s, 9H), 2.39 (s, 6H), 2.41 (m, 2H), 2.48 (s, 6H), 2.70 (m, 4H), 2.95 (m, 2H), 3.60 (s, 3H), 3.63
(s, 3H), 7.34 (s, 1H), 7.44 (s, 2H); MALDI-TOF: m/z calcd for C32H47BF2N4O7 [M+Na +]:
634.35; found: 657.43 and 899.51.
BODIPY 10: Yield (20.8 mg, 26.5%); 1H-NMR (acetone-d6, 400 M z): δ 1.27 (m, 4H), 1.38 (s,
18H), 1.60 (m, 2H), 1.73 (m, 2H), 2.39 (s, 6H), 2.41 (m, 4H), 2.45 (s, 6H), 2.70 (m, 4H), 3.60 (s,
6H), 7.41 (s, 2H); MALDI-TOF: m/z calcd for C43H67BF2N6O10 [M+Na +]: 876.50; found:
899.51.
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BODIPY 11: Yield (3.5 mg, 11.4%); 1H-NMR (acetone-d6, 400 MHz): δ 1.19 (m, 3H), 1.34 (s,
8H), 2.40 (s, 6H), 2.48 (s, 6H), 2.60 (m, 4H), 2.65 (m, 2H), 2.70 (m, 4H), 2.95 (m, 2H), 3.66 (s,
3H), 6.94 (m, 4H), 7.42-7.58 (m, 5H), 8.45 (s, 1H); MALDI-TOF: m/z calcd for C32H47BF2N4O7
[M +]: 856.40; found: 856.44.
BODIPY 12: Yield (13.6 mg, 34.8 %); 1H-NMR (acetone-d6, 400 M z): δ 1.37 (m, 3H), 1.36 (s,
21H), 1.47 (m, 4H), 1.68 (m, 4H), 2.39 (s, 6H), 2.41 (m, 4H), 2.48 (s, 6H), 2.60 (s, 6H), 2.95 (m,
8H), 3.65 (s, 6H), 6.92-7.58 (m, 10H), 7.96 (s, 2H); MALDI-TOF: m/z calcd for C32H47BF2N4O7
[M +]: 1084.55; found: 1084.60.

Crystal Data
A single crystal of compound was selected under a microscope and mounted on a glass fiber.
The unit-cell parameters and diffraction data were collected at low temperature on either a
Nonius KappaCCD diffractometer equipped with MoK radiation (=0.71073 Å) or a Bruker
Kappa Apex-II diffractometer equipped with CuK radiation (=1.54178 Å). The structures
were determined by direct methods and refined by full-matrix least squares method with the
SHELXL program, with H atoms in idealized positions, except for NH hydrogen atoms, which
were located by difference maps and in most cases their positions refined. Disorder is present in
several of the structures.

3.4.3: Steady-state Absorption and Fluorescence Spectroscopy
UV/Vis absorption spectra of BODIPYs were recorded on a Varian Cary 50 UV/Vis
spectrophotometer and the steady-state fluorescence spectroscopic studies were performed on a
PTI Quantum Master4/2006SE spectrofluorimeter. All measurements were carried out at room
temperature within 2 h of solution preparation, using non-degassed samples, HPLC grade
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solvents and a 10 mm quartz cuvette. For the fluorescence experiments, only dilute solutions
with the optical density between 0.04-0.06 at the excitation wavelength were used. Fluorescence
quantum yields (Φf) were determined using a relative method by comparing the area under the
corrected emission spectrum of BODIPYs 2 and 3 relative to rhodamine 6G (0.80 in methanol),
BODIPYs 5c and 5d relative to cresyl violet perchlorate (0.54 in ethanol) and BODIPYs 5b and
6a and 6g with respect to methylene blue (0.03 in methanol) and 6f with respect to ZnPc (0.28 in
DMF) as external standards respectively. In all the cases, correction for the refractive index was
applied.
3.4.4: Cellular Studies. All tissues culture media and reagents were obtained from Invitrogen.
Human carcinoma HEp2 cells were obtained from ATCC and maintained in a 50:50 mixture of
D-MEM:Advanced MEM supplemented with 5% Fetal Bovine Serum (FBS), 1% Primocin
antibiotic and 5% CO2 at 37°C. The cells were sub-cultured twice per week to maintain subconfluent stocks. The fourth to fifteenth passage cells were used for all the experiments.
3.4.4.1: Time-Dependent Cellular Uptake. The HEp2 cells were plated at 7500 cells per well in a
Costar 96-well plate and allowed to grow for 48 h at 37°C under 5% CO2. The BODIPYs stock
solutions were prepared at 32 mM in DMSO and Cremophor (1% of Cremophor EL in DMSO).
For the update result, the compounds were diluted to 20 µM (2 x stock solution) and added to the
96-well plate to give a final working concentration of 10 M at 0, 1, 2, 4, 8, 12 and 24 h interval.
At the end of the incubation period, the loading medium was removed and the cells were rinsed
with 200 L of Phosphate buffer saline (PBS). The cells were then solubilized using 100 L of
0.25% Triton X-100 (Calbiochem) in PBS. The fluorophore concentration was measured using a
BMG FLUOstar plate reader. The cell numbers were quantified by the CyQuant cell proliferation
assay (Invitrogen) as per manufactures instructions, as previously reported.ref The uptake is
expressed in terms of nM compound per cell.
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3.4.4.2: Dark Cytotoxicity. The HEp2 cells were plated as described above for the uptake
experiment. The cells were treated with BODIPY conjugate concentrations of 25, 50, 100, 200
and 400 M and incubated overnight. After compound loading overnight, the loading medium
was replaced by medium containing CellTiter Blue (Promega) as per manufacturer’s instructions.
Cell toxicity was then measured with untreated cells considered as 100% viable and cells treated
with 0.2% saponin as 0% viable. The IC50 values were determined from dose-dependent survival
curves obtained using GraphPad Prism software.
3.4.4.3: Phototoxicity. The cells were prepared as described above for the dark cytotoxicity assay
with BODIPY conjugate concentrations of 0, 6.25, 12.5, 25, 50 and 100 M. After loading
overnight, the medium was removed and replaced with medium containing 50 mM HEPES pH
7.4. The cells were exposed to a NewPort light system with 175 W halogen lamp for 20 min,
filtered through a water filter to provide approximately 1.5 Jcm-2 light dose. The cells were kept
cool by placing the culture on a 5°C Echotherm chilling/heating plate (Torrey Pines Scientific,
Inc.). After exposure to light for 20 min, the plate was incubated overnight in a 37°C incubator.
Cells were assayed for viability using CellTitre Blue Viability Assay Kit, as described above for
the dark cytotoxicity experiment.
3.4.4.4: Microscopy. The cells were incubated in the glass bottom 6-well plate (MatTek) and
allowed to grow for 48 h. The cells were then exposed to 10 µM of each compound for 6 h and
stained with organelle tracers (Invitrogen) at the following concentrations: ER Tracker
Blue/white (100 nM), MitoTracker Green (250 nM), BODIPY FL C5 ceramide (1 µM) and
LysoSensor Green (50 nM), which are specific fluorescent dyes for Endoplasmic Reticulum,
Mitochondria, Golgi Apparatus and Lysosomes respectively. After 30 min incubation, both the
media and the organelle tracers were removed and the cells were rinsed with PBS (3 times, to
remove any unincorporated fluorophore). Images were taken using a Leica DMRXA microscope
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with 40× NA 0.8 dip objective lens and DAPI, GFP and Texas Red filter cubes (Chroma
Technologies). The subcellular localization was revealed by comparing the intracellular
fluorescence images caused by the organelle tracers and the BODIPY dyes.
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CHAPTER 4: SYNTHESIS AND APPLICATION OF NOVEL BODIPY-PEG AND
BODIPY- CARBOHYDRATE CONJUGATES AS POWERFUL TOOLS FOR
BIOIMAGING

4.1: Introduction
Molecular imaging is defined as the in vivo visualization and characterization of various
cellular and molecular pathways occurring in living animals and human patients.1 Progress in
this field is becoming more advanced due to the multi-disciplinary collaborations among various
chemists, physicists, imaging scientists, clinicians and molecular biologists. As a result,
molecular imaging is often considered as the future for medical imaging.2
A number of diagnostic imaging modalities such as magnetic resonance imaging (MRI),
positron emission tomography (PET), X-ray computed tomography (CT), nuclear imaging and
ultrasound have been successfully utilized in clinical diagnosis for the past decades. However,
most of these predominant modalities are either highly expensive or lack the specificity and
sensitivity needed for early disease detection, coupled with the deleterious radioactive risks.3
Moreover, several “contrast agents” (such as super-paramagnetic or paramagnetic metals for
MRI, radioisotopes for PET and microbubbles for ultrasound) used to improve the visibility of
internal bodily structures and to extract valuable information from these imaging modalities,
often tend to be nonspecific, unstable and toxic, which limits their repeated use. In order to attain
truly targeted imaging of specific molecules that exist in relatively low concentrations in the
tissues, the imaging dyes and techniques must be highly effective and sensitive.1
Optical bioimaging, on the other hand, is emerging as a promising non-invasive, realtime and high resolution technique that uses sophisticated fluorescent probes to visualize normal
and abnormal biological processes in vivo.4 Among the various optical imaging technologies,
NIR fluorescence imaging (within the wavelength range 700-900 nm) has attracted much
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attention due to the improved deep tissue penetration and low auto-fluorescence characteristics
associated with the NIR radiation. As a result, satisfactory cell targeting and imaging of living
organisms relies greatly on the development of stable, highly sensitive and targeted NIR imaging
probes.5
A general and simple approach to improving the target-specific accumulation of an
imaging probe is to conjugate the far-red and NIR fluorophore with targeting ligands (such as
amino acids, peptides, proteins, antibodies, aptamers, enzymes and other small molecules) which
have been applied in molecular imaging.1 Targets for the fluorescent imaging probes are usually
over-expressed cell membrane receptors (such as human epidermal growth factor receptor
(EGFR2), cell-specific membrane antigens, vascular endothelial growth factor receptor
(VEGFR2) or molecules that are abundant in the extracellular matrix (such as integrins, matrix
metalloproteinases).6
NIR dyes have rapidly emerged as fluorescent probes for the imaging of biological
processes in vitro and in vivo. Along with the stringent spectral characteristics i.e. red visible or
NIR absorption and emission, the fluorescent probes that are bright, small, amphiphilic and
contain no net charge are useful candidates for in vivo bioimaging.3 For most biological
applications, good solubility in aqueous media and resistance to the formation of non-fluorescent
aggregates is highly essential.7 Low water solubility of a fluorescent probe often leads to selfaggregation and modification or loss of its absorption and fluorescence properties. Moreover,
fluorescent probes that are electrically neutral have numerous advantages over their ionic
analogues, as they avoid potential nonspecific binding through electrostatic interactions between
the dye and the targeted molecule.8
Among the multitude of available synthetic fluorophores (such as Cyanines, Quantum
dots, fluorescent nanoparticles) exhibiting high extinction coefficients, high quantum yields,
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narrow emission bands, and good physicochemical stability, many have limited biological utility
due to poor solubility and tendency for aggregation in aqueous media that surrounds a
biomolecule. Furthermore, the lack of reactive functional groups limits modification of the
fluorophoric core, which results in significantly reduced target-selective accumulation and the
biological efficacy of the fluorophore.
Several strategies have been investigated to enhance aqueous solubility as well as tumor
specificity of fluorescent probes including introduction of ionizable hydrophilic groups (such as
carboxylic acid, phosphonic acid, sulfonic acid, and ammonium groups)9 within the
chromophoric core, or grafting the hydrophobic molecule onto hydrophilic and biodegradable
macromolecules (such as oligonucleotides, polyethylene glycol and carbohydrates).7,

10

Both

these methodologies have been widely used with cyanine, fluorescein, rhodamine and oxazine
dyes, resulting in a number of new amphipathic fluorescent labels. Surprisingly, little synthetic
effort has been devoted towards the use of these strategies with hydrophobic, yet tunable
BODIPY fluorophores, resulting in only a handful of BODIPY-based imaging probes currently
known.11,

12

Further, many of these derivatives have not been applied to imaging due to their

poor uptake by the target molecules and short excitation/emission wavelength.12b

4.2: Our Approach
Recently, interdisciplinary research at the interface of polymer chemistry, glycobiology
and bioimaging sciences has led to an increasing use of hydrophilic polymers such as
polyethylene glycol (PEG) chains and carbohydrates in the design of various targeted bioimaging
probes for the diagnosis and treatment of diseases.13 A combination of several imaging
techniques and various biocompatible and hydrophilic polymers has generated more specific
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bioimaging probes which could significantly differentiate the target areas from its background in
vivo.
PEGylation was first described in the 1970s by Davis and Abuchowsky in context to
albumin and catalase modifications.14 Since then, the process of PEGylation has been extensively
utilized in biomedical research for diagnosis and treatment of a disease. PEGylation is defined as
a process by which one or more PEG chains are grafted on a biomolecule to improve its
pharmacokinetic, pharmacodynamics and immunological properties. The PEG-based molecules
(drugs or fluorescent probes) have numerous advantages over the non-PEGylated derivatives,
such as improved serum half-lives, increased resistance to proteolysis, reduced toxicity and
increased tumor accumulation along with reduced nonspecific binding.13, 15 As a result, an array
of covalently-linked PEG-conjugates of porphyrin,16 phthalocyanines,17 benzoporphyrins,18
carbocyanines,19 quantum dots,20 nanoparticles21 and radiometal chelators22 have been developed
either as therapeutic or bioimaging agents for cancer targeting and imaging.
Another important approach, widely utilized for the modification of a protein, peptide or
a non-protein molecule to increase its pharmacokinetic profile is via glycosylation. Glycosylation
refers to the process which attaches carbohydrate chains to target proteins, lipids or other organic
molecules. Carbohydrates in the form of glycopeptides, glycolipids, proteoglycans or other
glycoconjugates regulate a myriad of biological and pathological processes including protein
folding, energy storage, signal transduction, inflammation, viral entry and as structural motifs for
cell-cell communications.23 As a result, carbohydrate conjugates have been investigated for
targeting various cells including hepatocytes, macrophages, vascular endothelial cells and
various cancer cells including lectins.24 Intense research efforts have been focused on developing
tumor-specific carbohydrate-based therapeutic and diagnostic agents by targeting cell membrane
proteins. Carbohydrate-functionalized macromolecules have shown promise in photodynamic
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therapy and in vivo optical imaging due to their enhanced interactions with tumor cell receptors
via carbohydrate-mediated cell recognition processes, and increased cellular uptake and
solubility, without significant alterations of the physicochemical and photophysical properties.25
The indispensable role of PEG- and carbohydrate-functionalized macromolecules in drug
discovery and tumor imaging has initiated the work presented herein to design, synthesize and
investigate a series of novel PEG- and carbohydrate-functionalized BODIPY conjugates as
potential candidates for in vivo imaging. The key step in this synthesis is the 1,3-dipolar
cycloaddition between a terminal alkyne and an azide, often referred to as the azide/alkyne“Click”-reaction or “CuAAC reaction”.
Since being first introduced by Nobel Laureate Dr. Barry Sharpless in 2001, Click
chemistry has become a popular concept with wide utility in diverse fields. Click chemistry
refers to a group of reactions that are fast, high-yielding, simple to use, easy to purify, versatile
and regiospecific.26 This concept covers a wide range of reactions such as cycloadditions,
nucleophilic ring opening, non-aldol carbonyl chemistry, addition to carbon-carbon multiple
bonds etc. While there are a number of reactions that fulfill the criteria, the copper-catalyzed
Huisgen 1,3-dipolar cycloaddition of azides and terminal alkynes, abbreviated as CuAAC
(Copper-catalyzed azide alkyne cycloaddition) is the best known click reaction.27

Scheme 4.1: 1,3-Dipolar cycloaddition of azides and alkynes pioneered by Rolf Huisgen
The azide/alkyne cycloaddition reaction which combines an alkyne and an azide together
by heating, to produce a mixture of 1,4- and 1,5-triazoles (Scheme 4.1), was first discovered by
Rolf Huisgen. However, the harsh reaction conditions were considerably softened by the use of a
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copper catalyst (as discovered independently by Sharpless and Meldal groups) which accelerates
the rate of the reaction by 7 orders of magnitude.28 In contrast to the uncatalyzed conditions, the
use of copper (I) salts ensures the exclusive 1,2,3-triazole regioselective formation of the 1,4regioisomer (Scheme 4.2). The reaction has several unique characteristics including simple
reaction conditions (insensitive to oxygen and water), readily available starting materials, simple
product isolation and purification. For these reasons, the reaction has been widely used in
carbohydrate chemistry as it is especially suitable for fragile compounds, and more generally for
the synthesis of biomolecules.27

Scheme 4.2: Copper catalyzed 1,3-Dipolar cycloaddition by Sharpless/Meldal

The ever-increasing success of the CuAAC reaction is rooted in its selectivity, efficiency
and versatility. The CuAAC reaction is a virtually quantitative, very robust, insensitive to the
environment, and the orthogonal ligation reaction, suitable for even biomolecular ligation and in
vivo tagging or as a polymerization reaction for synthesis of long linear polymers. The triazole
formed is stable to acid and base hydrolysis, reductive and oxidative conditions, and is relatively
resistant to metabolic degradation.29 In this work, Click chemistry was chosen as the preferred
facile synthetic methodology to conjugate BODIPYs to several azido-PEGs and azidocarbohydrates due to the: (1) great versatility of the reaction and various functional group
tolerance (2) mild reaction conditions that could be well tolerated by the BODIPY scaffold, and
(3) straightforward reaction work-up involving simple purification techniques.
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4.3: Results and Discussion
The main aim of the present work was to design and synthesize a series of new
fluorescent bioconjugates consisting of a BODIPY fluorophore bearing non-hydrolysable 1,2,3triazole ring, linked either by an ethylene glycol spacer (for attachment to biomolecules) or
carbohydrate moiety (for target-specific accumulation). Additionally, the major goal was to
move the emission wavelength into the red and NIR region while making use of the unique
BODIPY chemistry along with versatile Huisgen alkyne/azide cycloaddition methodology
(Scheme 4.3). The facile and efficient strategy for the generation of BODIPY-PEG and
BODIPY-carbohydrate conjugates discussed below, has been previously explored on porphyrins
and related macrocycles, resulting in an array of porphyrin-carbohydrate30 and pegylatedporphyrin15, 31 conjugates for use as photosensitizers in photodynamic therapy.

Scheme 4.3: The general structure of BODIPY derivatives prepared in this work

A careful investigation of porphyrin-conjugates generated via click chemistry indicated
that the click labeling of biomolecules is generally completed on the functionalized macrocycle
(except one case in which the click reaction was performed on the precursor of the porphyrin).27
Hence, a similar methodology was adopted for the work described in this Chapter. The key step
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in the synthesis is the placement of the terminal alkyne “handle” on the BODIPY fluorophore, to
generate the so-called “clickable BODIPY fluorophores”.
p-Hydroxy benzaldehyde was O-alkylated by Williamson reaction, using propargyl
bromide and potassium carbonate in acetone, according to the literature procedure,32 to generate
p-propargyloxy-benzaldehyde, 2 in quantitative yield. Meso-alkynylphenyl-BODIPY 4,
containing alkynyl functionality at the C-8 position was then synthesized according to the threestep one-pot classical approach, starting from p-propargyloxy-benzaldehyde 2 and two equiv. of
3-ethyl-2,4-dimethyl pyrrole 3, in the presence of a catalytic amount of TFA and dry
dichloromethane as solvent (Scheme 4.4). The final reaction mixture was stirred under argon and
the reaction was monitored by TLC until completion (~16 h). The resulting mixture was cooled
down to 0 °C and treated with 1.2 equiv. of DDQ oxidant. After stirring for 20 min.,
triethylamine was added dropwise over a period of 5 min. while stirring and maintaining the
temperature at 0 °C. After 30 min. stirring, the reaction mixture was treated with BF3.OEt2 and
the resulting reaction mixture was stirred at room temperature under argon. The progress of the
reaction was closely monitored by TLC and UV-Vis (for a band at 525 nm) until completion.
The reaction mixture was then filtered through a pad of silica gel to separate the oxidized
dipyrromethene derivative, higher molecular weight oligomers, unreacted DDQ and starting
materials. The solvent was reduced in vacuo to afford the crude mixture which was then
redissolved in a mixture of dichloromethane and water and stirred overnight to decompose any
unreacted BF3.OEt2. The subsequent reaction mixture was extracted with dichloromethane and
the combined organic layers were dried over sodium sulfate and the solvent removed under the
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Scheme 4.4: Synthetic route to BODIPYs 4, 6 and 7
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reduced pressure. The crude product was purified on a silica gel column eluting with a solvent
mixture of dichloromethane/petroleum ether in a 1:1 ratio. The first orange-green fluorescent
band containing the product was collected and after solvent evaporation, afforded the desired
BODIPY 4 in 94% over three steps. This compound was characterized by NMR (1H,

13

C) in

deuterated chloroform and MS (MALDI) giving a molecular ion peak [M+] at m/z 434.23. The
1

H-NMR spectrum showed the ortho and meta protons as doublets in the aromatic region, and

the resonance corresponding to the CH protons in the terminal position of the propargyl group
was identified as a singlet at δ 2.52 ppm. The two equivalent protons of the propargylic
methylene group were identified as a broad doublet centered at 4.72 ppm and the ethyl protons
appeared as a triplet at 0.98 ppm and a quartet at 2.29 ppm. The two sets of methyl protons (3,5
and 1,7) appear as singlets at 2.53 and 1.33 ppm, respectively. 1,7-methyls are in the shielding
zone of the phenyl substituent and experience a shielding by approximately 1.2 ppm. The 1HNMR spectrum for BODIPY 4 is shown in Figure 4.1.
The reactivity of the acidic 3- and 5-methyls on the BODIPY core and the syntheses of
both monostyryl- and distyryl-derivatives from symmetric tetramethyl-BODIPY is now firmly
established.11c,

33

Styryl-derivatized BODIPY compounds are known to display red-shifted

fluorescence emissions due to the extended π-conjugation, and their emission wavelengths vary
according to the styryl moieties.34 The introduction of two styryl groups on BODIPY 4 was
accomplished

with

electron-rich

indole-3-carbaldehyde

5

via

classical

Knoevenagel

condensation, using piperidine and acetic acid in refluxing toluene and a Dean-Stark apparatus.
The use of a Dean-Stark apparatus seems to be critical for removing the water formed in the
reaction and thus shifting the equilibrium to the double condensation product, which is the
distyryl BODIPY dye 7.35 The use of indole-3-carbaldehyde 5 for styryl-derivatization was based
on the results obtained in Chapter 3. Additionally, indole derivatives have been long known for
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their biological resemblance with tryptophan, a naturally occurring amino acid and an important
component of many enzymes, peptides and proteins.36 It is anticipated that the anchoring of the
indolylstyryl arms on the BODIPY platform will further increase the biological efficacy of the
fluorophore.

Figure 4.1: 1H-NMR spectrum of BODIPY 4 in CDCl3 at 400 MHz

BODIPY 4 and indole-3-carbaldehyde 5 in 1:3 ratio, were refluxed in a mixture of dry
toluene, glacial acetic acid and piperidine. Any water formed during the reaction mixture was
removed azeotropically by heating overnight in a Dean-Stark trap. The progress of the reaction
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was followed by TLC analysis, a blue spot corresponding to the monostyryl-BODIPY derivative
appeared after 2 h and after ~ 6 h, a slightly polar spot of the distyryl-BODIPY derivative
appeared. However, as the TLC indicated the presence of starting material, the reaction was left
to stir overnight. Once the reaction was complete (~14 h), the reaction mixture was cooled to
room temperature and the solvent evaporated under reduced pressure. The crude product was
purified by silica gel chromatography using dichloromethane/petroleum ether (in 2:1 ratio) as
eluent and a mixture of three compounds was obtained, which could be further separated by
column chromatography as three distinct bands due to the marked difference in their polarity.
The orange-green fraction corresponding to the unreacted starting material was eluted first,
followed by a reddish-blue fraction (monoindolyl styryl-BODIPY 6) and a deep-green fraction
(diindolyl styryl-BODIPY 7). All the bands were collected separately and after solvent removal
in vacuo, afforded BODIPY 4 (recycled), BODIPY 6 and BODIPY 7 in 2%, 36% and 55.6%
yields, respectively. Mass spectrometry of the derivatized BODIPYs was performed using
MALDI-TOF. MS analysis gave a peak at m/z 561.35 and 688.32, corresponding to BODIPY 6
and BODIPY 7 respectively. The 1H-NMR spectra of BODIPYs 6 and 7, as shown in Figures 4.3
and 4.4 respectively, showed some interesting features. For BODIPY 6, bearing monoindolyl
styryl- arm and in comparison with the 1H-NMR spectrum of BODIPY 4, characteristic signals
of protons belonging to indolic NH (10.7 ppm), fused aryl (additional ortho and meta protons)
and α-pyrrolic (7.74 ppm) units of indole moiety were observed. In particular, in the NMR
spectrum of BODIPY 6, the vinylic protons in the 3-positions appeared as a single shielded
doublet at 7.91 ppm and 7.65 ppm. In the case of symmetrically substituted distyryl-BODIPY 7,
the vinylic protons in the 3 and 5-positions appear as two pairs of trans coupled protons, the
most shielded at 8.05 ppm.
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Figure 4.2: 1H-NMR spectrum of BODIPY 6 in deuterated acetone at 400 MHz

The use of PEG as carrier or covalently attached to a macromolecule is widely known. 37
In general, low molecular weight PEG spacers have shown to be effective linkers between a
porphyrin-based fluorophore and target biological entity, as they: (1) minimize the steric
hindrance between the two moieties, (2) favor extended conformation for the bioconjugates, (3)
enhance the enthalpic interactions of the fluorophore with polar solvents including water, and (4)
minimize fluorophore aggregation in biological media.16a Hence, in order to increase the
amphiphilicity of BODIPYs and for effective conjugation with various biomolecules, the spacers
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consisting of hydrophilic triethylene glycol and hexaethylene glycol chains were chosen for click
chemistry with BODIPY 6.

Figure 4.3: 1H-NMR spectrum of BODIPY 7 in deuterated acetone at 400 MHz
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Scheme 4.5: Synthetic route to BODIPY conjugates 9a-c

The hetero-bifunctional PEG linkers 8a and 8b that possess terminal hydroxyl and azido
groups were obtained from Dinesh Bhupathiraju, a fellow colleague in the Vicente group. AzidoPEGs 8a and 8b could be prepared from commercially available triethylene glycol and
hexaethylene glycol by a two-step conversion involving selective mesylation in the presence of
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excess mesyl chloride, followed by nucleophilic substitution by sodium azide at room
temperature. Both the reactions are high-yielding and generally afford the products in moderate
to high yields.38
Finally the conjugation of the PEG 8a and 8b to the BODIPY 6 was performed using
click chemistry. The mild aqueous conditions required for azide/alkyne cycloadditions offer
distinct advantages when utilized for bioconjugations. To demonstrate the utility of “click
chemistry” on BODIPY dyes, conjugation of PEG-groups to the BODIPY scaffold was
performed by solution phase “click reaction” in the preence of CuSO4/Cu/sodium ascorbate in
THF/water (3:1), as shown in Scheme 4.5.38a
A solution of meso-alkynylphenyl-BODIPY 6, azido-PEG 8a (2.6 equiv) and Cu (0) (1.0
equiv) in a solvent mixture of THF:H20 (8 mL, 3:1) was treated with a solution of CuSO4.5H2O
(0.20 equiv) and Na-ascorbate (0.5 equiv.) in THF:H20 (8 mL, 3:1). The elemental copper serves
as a convenient reductant for Cu(II) in aqueous solution to generate Cu(I), which is a powerful
catalyst for the formation of 1,2,3-triazoles from terminal alkynes and azides.39 The reaction
mixture was heated for 6 h at 70 °C, under inert gas atmosphere. Once the reaction was
complete, the mixture was cooled to room temperature and partitioned between EtOAc and
water. The aqueous layer was re-extracted with EtOAc (to remove copper salts) and the
combined organic layers were dried over Na2SO4. The solvent was evaporated under reduced
pressure and the crude product was purified by silica gel preparative TLC eluting with 10:1
dichloromethane/ethylacetate solution, to afford the first 1,2,3-triazole cycloadduct 9a in 70%
yield. The reaction was repeated with Azido-PEG 8b, in order to study the effect of increased
PEG chain length on the synthesis and in vitro biological investigations, affording cycloadduct
9b in excellent yield (98%). MS (MALDI) analysis of cycloadducts 9a and 9b gave a molecular
ion peak at m/z 736.40 and 868.48 respectively. 1H-NMR spectral analysis of these cycloadducts
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(Figures 4.4 and 4.5) gave the most characteristic signal of the proton on the triazole ring at 8.16
ppm as a broad singlet. The signals of protons belonging to spacer group showed up between
3.50-3.94 ppm.

Figure 4.4: 1H-NMR spectrum of BODIPY-PEG cycloadduct 9a in deuterated acetone at 400
MHz
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Figure 4.5: 1H-NMR spectrum of BODIPY-PEG cycloadduct 9b in deuterated acetone at 400
MHz

To demonstrate the functional group tolerance of azides with BODIPY 6, commercially
available carbohydrate-azide (1-azido-1-deoxy-β-D-galactopyranoside tetraacetate), 8c was
tested for “click” ligation. Azido-sugars have frequently been used for click labeling of surface
glycoproteins.40 The acetyl protecting group “masks” the otherwise reactive hydroxyl group
while increasing the cell permeability of the carbohydrates and allowing the unnatural sugars to
easily pass through the cell membrane. Once the monosaccharide is in the cell, the
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carboxyesterases enzyme cleaves the acetyl groups, thereby unmasking the protected hydroxyl
moiety. The BODIPY-carbohydrate cycloadduct 9c was prepared in virtually quantitative
amount, using the optimized reaction conditions as developed for cycloadduct 9a and 9b. For
cycloadduct 9c, 1H-NMR spectrum displayed singlet peaks at 2.21, 2.05, 2.03 and 1.90 ppm due
to four acetyl groups on sugar respectively, along with the broad singlet of the proton on the
triazole ring at 8.17 ppm, as shown in Figure 4.6. MS (MALDI-TOF) further confirmed the
successful synthesis of cycloadduct 9c (molecular ion peak at m/z 934.42).

Figure 4.6: 1H-NMR spectrum of BODIPY-carbohydrate cycloadduct 9c in deuterated acetone
at 400 MHz
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Table 4.1: Isolated yields of ligation experiment performed on diindolyl styryl BODIPY 7*
Entry

Azido-derivative

Cycloadduct Yield (%)

1

8a

15

2

8b

20

3

8c

57.3

4

8d

18.2

5

8e

22.5

* In each case TLC analysis indicated complete consumption of the starting materials.

The click labeling strategy was extended to prepare another series of PEG- and
carbohydrate-functionalized cycloadducts 10a-e, as fluorescently labeled biological building
blocks, starting from diindolyl styryl-BODIPY 7, as shown in Table 4.1 and Scheme 4.6. Along
with azido-derivatives 8a-c, two commercially available azido-sugars namely, 1-azido-1-deoxyβ-D-glucopyranoside (8d) and 1-azido-1-deoxy-β-D-lactopyranoside (8e) were used to generate
glucose- and lactose-conjugated BODIPYs as potential chemical probes for galectin proteins, a
lectin that is often over-expressed in tumor cells for tumor growth and development. The
cycloadducts 10a-e were obtained in moderate yields providing further proof for the efficiency
of the CuAAc reaction in ligation process. All the BODIPY cycloadducts were fully
characterized using NMR and MALDI-TOF analysis. Well-resolved 1H-NMR spectra of PEGand carbohydrate-functionalized cycloadducts 10a-e showed typical proton on the triazole ring at
approximately 8.18 ppm. For 10a and 10b, the characteristic signals of protons belonging to the
ethylene group appeared between 3.51-4.61 ppm. For 10c, the four acetyl groups showed up as
four singlets at 2.21, 2.05, 2.03 and 1.96 ppm, respectively. Glucose and lactose units in
cycloadducts 10d and 10e were found to resonate in a very crowded region of the NMR
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spectrum, between 3.31-4.26 ppm and 3.49-4.67 ppm, respectively. MALDI analysis gave a
molecular ion peak at m/z 10a: 863.42; 10b: 995.50; 10c: 1061.40; 10d: 893.42 and 10e:
1055.45.
Carbohydrates are known as ligands of various cell surface lectins.30a Intense research
efforts have been focused to develop tumor-specific imaging probes by targeting cell membrane
glycoproteins, such as galectins. The galectins are a family of small soluble proteins that play
significant roles in numerous types of cancer.41 Galectins are defined by a highly conserved
carbohydrate recognition domain (CRD) and their affinity for glycoconjugates. Among the
galectins, Galectin-1 (Gal-1) and Galectin-3 (Gal-3) have been the most widely studied as they
are abundant in tumor cells to promote tumor growth and development, angiogenesis and
metastasis. Because the mechanisms by which galectins play a role are generally poorly
understood, novel carbohydrate-based fluorescent probes would be particularly useful for
detection of galectins in tissues, in order to generate a better understanding of this protein.42
Clickable BODIPY 4 is highly versatile chromophore and can be conveniently
derivatized with suitably substituted benzaldehyde (for instance, Compound 2) to produce
BODIPYs 11 and 12, with two or more alkyne “handles” for further click tagging (Scheme 4.7).
The envisioned synthesis makes use of a convergent click reaction build up approach with
strategically placed Huisgen alkyne click components. This approach not only allows the
synthesis of long wavelength emissive BODIPYs, but also two or more biomolecules could be
tagged to BODIPY fluorophore in a straightforward sequence of reactions.
BODIPY 4 was condensed with compound 2 (3 equiv.) using classical Knoevenagel
condensation approach as described above for the synthesis of BODIPYs 6 and 7 (Scheme 4.7).
The reaction was monitored using TLC and after 2 days, the reaction mixture still had a
substantial amount of unreacted starting material. Thus 4 equiv. of compound 2 were introduced
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Scheme 4.6: Synthetic route to BODIPY conjugates 10a-e

and the reaction was allowed to reflux for 24 h, but TLC barely indicated the formation of any
product. It was then concluded that compound 2 was not nucleophilic enough for the electrondeficient BODIPY system. This was not surprising as several electron-poor aldehydes have been
found unreactive when condensed with electron-deficient BODIPY dyes during Knoevenagel
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condensation reaction.43 An alternate route to BODIPY 11 and 12 was then developed as shown
in Scheme 4.8. It was anticipated that electron-donating p-hydroxy benzaldehyde (compound 1)
would be a better candidate for Knoevenagel condensation and that terminal alkyne units could
be generated on the functionalized BODIPY instead, by O-alkylation using propargyl bromide.
Knoevenagel condensation of BODIPY 4 was first attempted via the classical approach, similar
to the one reported for the synthesis of BODIPY 6 and 7, i.e. by treating the tetramethyl
BODIPY 4 with p-hydroxy benzaldehyde 1, piperidine and glacial acetic acid in boiling toluene.
Unfortunately, in our hands, this reaction did not give any satisfactory results.
Recently, a modified version of the Knoevenagel condensation was described, which
employs the addition of Lewis acids such as ZnCl2, TiCl4 etc to promote the Knoevenagel
condensation between poorly reactive BODIPYs and aromatic aldehydes.44 A similar modified
procedure as developed by Raymond et al.44b was followed using a catalytic amount of p-TsOH.
Compound 1 and BODIPY 4 were refluxed in a mixture of dry toluene, piperidine and a crystal
of p-TsOH. The solution was heated at reflux until the solvent evaporated to dryness. The
resulting crude was washed with water and extracted with dichloromethane. The organic phase
was dried over magnesium sulfate and the solvent evaporated under reduced pressure. The crude
residue was subjected to several silica gel columns in order to get rid of the starting material and
other side products which were difficult to separate. As a result, BODIPY 13 could only be
isolated in < 2% yield and could not be characterized by 1H-NMR. However, MALDI-TOF
analysis indicated the product formation by a molecular ion peak at m/z 538.26.

199

Scheme 4.7: Synthetic route to BODIPYs 11 and 12

Enhancing the donor-acceptor balance between the vinyl arm and the BODIPY core
further shifts its absorption and fluorescence emission towards the red. A careful investigation of
the electron density change upon the excitation of the BODIPY dyes indicates that the C-8
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experiences a marked increase in electron density in the excited state of the BODIPY. Hence,
introduction of a strong electron-withdrawing group such as p-bromophenyl on the mesoposition of BODIPY should bring a concominant increase in the acidity of the 3- and 5- methyl
groups, which should result in higher reactivity of the BODIPY dyes toward Knoevenagel
condensation reaction.45 Hence, another approach towards the synthesis of BODIPYs with two
alkyne “handles” was adopted as displayed in Scheme 4.9.
Meso-(p-bromophenyl) BODIPY 15 was synthesized using the classical approach as
mentioned for the synthesis of BODIPY 4. p-Bromo-benzaldehyde and 3-ethyl-2,4-dimethyl
pyrrole 3 were dissolved in dry dichloromethane under argon at room temperature. Three drops
of TFA was added and the reaction was stirred overnight at room temperature. The reaction was
followed via TLC and upon completion, a solution of DDQ in dichloromethane was added and
the reaction was stirred for another 15 min. Subsequently, triethylamine and BF3.OEt2 were
added and the reaction was stirred overnight. Upon completion, the reaction mixture was passed
through a short silica plug eluting with pure dichloromethane and the solvent was removed in
vacuo. The crude product was re-dissolved in a mixture of dichloromethane and water and the
product was extracted with dichloromethane. The organic layers were collected and dried over
magnesium sulfate and the solvent evaporated under reduced pressure. The resulting crude
mixture was purified by silica gel column chromatography using 1:1 dichloromethane/petroleum
ether solvent mixture. The product containing fluorescent orange-green fraction was collected
and the solvent was removed. The pure product was dissolved in minimum amount of
dichloromethane and crystallized by gradually adding hexane to obtain shiny green crystals
which were then dried in vacuo. The obtained BODIPY 15 was fully characterized using 1HNMR and MS (MALDI) giving a peak at m/z 458.13. This methodology follows the procedure
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already developed by Noll et al.,46 though minor variations of the procedure made it possible to
synthesize the BODIPY in higher yields with minimal chromatography.

Scheme 4.8: Alternative route to BODIPYs 11 and 12
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In order to introduce the alkyne “handles” on the BODIPY 15, Knoevenagel
condensation with compound 2 was performed using piperidium acetate and glacial acetic acid in
boiling toluene using a Dean-Stark apparatus. The efficiency of styryl derivatization was
evaluated using several reaction conditions as depicted in Table 4.2. The reaction was repeated
several times by varying the reaction conditions such as longer reaction time, excess
catalyst/base/solvent. Longer reaction times and excess base/reactant increased the percent yield
of the monostyryl-BODIPY 16 (from 2% to ~ 16%), along with generation of a complex mixture
of products which could not be fully characterized by 1H-NMR spectrum. Surprisingly, no
distyryl-BODIPY derivative could be obtained under these conditions.
Table 4.2: Isolated yields of Knoevenagel condensation reaction performed on BODIPY 15
Entry

Compound 2

Piperidine-HOAc

Reflux time

Yield of product
(BODIPY 16)

1

1 equiv.

0.2 mL - 0.2 mL

24 h

1.8 %

2

2 equiv.

0.4 mL- 0.4 mL

24 h

1.5 %

3

4 equiv.

1 mL-1 mL

24 h

2.2 %

4

7 equiv.

2 mL- 2 mL

24 h

2.9 %

5

10 equiv.

4 mL- 4 mL

48 h

10 %

6

20 equiv.

8 mL- 8 mL

48 h

16 %

4.3.2: Photophysical Studies
UV/vis absorbance and fluorescence emission spectra of BODIPY-conjugates 9a-c and
10a-e were recorded in DMSO at room temperature along with their unconjugated precursor
BODIPYs 4, 6 and 7 (Figure 4.7) and the key values are summarized in Table 4.3. In the
absorption spectra, a strong absorbance band centered at 525, 613 and 703 nm for BODIPY 4,

203

Scheme 4.9: Synthetic route to BODIPYs 15 and 16

monoindolyl styryl-BODIPY 6 and diindolyl styryl-BODIPY 7, respectively is assigned to the
S0-S1 transition. In the wavelength region below the absorption maximum, there exists a
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“shoulder” due to 0-1 vibrational transition and a second higher energy absorption
maximumpeak due to S0-S2 transition. These three peaks constitute the main spectral
characteristics of the absorption spectrum of the BODIPY system.47 All BODIPYs showed
absorptions with high molar extinction coefficients (log ε = 4.1-4.5) and narrow fluorescence
emission bands. Upon excitation at 480, 575 and 660 nm, BODIPYs 4, 6 and 7 showed a
fluorescence emission centered at 534, 644 and 732 nm respectively. As expected, styrylderivatization caused a large bathochromic shift in the absorption and emission spectra, of about
Table 4.3: Spectral properties of BODIPYs 4, 6, 7, 9a-c and 10a-e in DMSO at room
temperature
BODIPY

Absorbance
λmax/nm

log ε (M-1.cm-1)

Emission
λmax/nm

Stokes shift (nm)

4

525

4.4363

534

9

6

613

4.5286

643

30

9a

613

4.4938

642

29

9b

613

4.4482

644

31

9c

613

4.7723

644

31

7

702

4.3847

732

30

10a

704

4.1482

731

27

10b

702

4.1473

730

28

10c

703

4.5614

732

29

10d

703

4.5575

732

29

10e

703

4.5567

731

28
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Figure 4.7: Normalized (a) absorption spectra (1.5 x 10-5 M), and (b) fluorescence emission
spectra (1.5 x 10-6 M) of BODIPYs 6 (red), 7 (dark yellow), 9a (dark cyan), 9b (magenta), 9c
(blue), 10a (olive), 10b (royal), 10c (navy), 10d (wine) and 10e (orange) in DMSO at room
temperature
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Figure 4.8: Solutions of BODIPYs 4, 6 and 7 in dilute DMSO under (a) normal and (b) UV light

90-100 nm per each styryl arm. For instance, the single Knoevenagel condensation of BODIPY 4
to produce monoindolyl styryl-BODIPY 6 lead to nearly a 80 nm bathochromic shift in the
absorption and emission bands, whereas double Knoevenagel condensation to generate diindolyl
styryl-BODIPY 7 lead to an approximate 100 nm red-shift. The spectral properties of BODIPYconjugates 9a-c and 10a-e in DMSO showed little difference from each other (1-3 ppm) or from
the starting alkyne BODIPY derivatives 6 and 7 respectively, demonstrating that cycloaddition
reaction does not alter the spectral properties of the BODIPYs. The Stokes shifts for all the
BODIPYs (except 4) were in the range of 27-30 nm. Measurement of the fluorescence quantum
yields of the BODIPYs reported herein are underway in our laboratory. In photographs of
solutions for BODIPYs 4, 6 and 7 in DMSO (Figure 4.8), the solutions of the unsubstituted
BODIPY 4 are clearly orange, whereas those of 6 and 7 are deep blue and green, respectively.
Under UV light (λexcitation = 365 nm), these solutions exhibit strong fluorescence.

4.3.3: In Vitro Cellular Studies
Preliminary in vitro cellular investigation, including dark and photo cytotoxicity and
cellular uptake were investigated against human carcinoma HEp2 cell lines in order to
investigate the biological efficacy of the PEG- and carbohydrate-functionalized BODIPY207

conjugates. Cremophor surfactant was added to increase the solubility of the dyes in the aqueous
media. These studies were performed by N. V. S. Dinesh Bhupathiraju, a fellow colleague in
Vicente research group.
4.3.3.1: Time-Dependent Cellular Uptake. The time-dependent uptake of BODIPY-conjugates
9a-c and 10a-e, by human carcinoma HEp2 cells was investigated at a concentration of 10 µM
and the results are shown in Figure 4.9. For comparison purposes, the uptake of unconjugated
BODIPYs 6 and 7 was also determined. At this concentration, all conjugates were non-toxic to
cells as evaluated using the Cell Titer Blue assay. All conjugates displayed similar uptake
kinetics showing a rapid accumulation at short time points, within 2-4 h, after BODIPY
exposure. Significant differences in the cellular uptake were observed indicating, the nature and
structure of the conjugates along with the chain length of the PEG moiety affect the cellular
uptake of the conjugates. In general, the monoindolyl styryl-BODIPY conjugates 9a-c
accumulated within the cells nearly 5 times more than the diindolyl styryl-BODIPY conjugates
10a-e, at all the time points studied. This can be attributed to the low molecular weight,
increased polar hydrophobic nature and enhanced solubility of the conjugates 9a-c over
conjugates 10a-e. Additionally, the PEG-functionalized BODIPYs showed a much higher uptake
by the cells than the carbohydrate-functionalized BODIPYs, for both the series, except conjugate
10d with glucose functionality, which had the similar uptake as conjugate 10b. These results are
in good agreement with previous studies48

16a, 47a

indicating that the use of PEG groups enhance

the hydrophobic/ hydrophilic interactions of the conjugates with the cell membrane and improve
their cellular uptake. For the 9a-c series, the uptake trend followed the order 9b > 9a > 9c. While
the uptake of 9a and 9c was similar in the first 2 h, however after 24 h, the amount of 9a
accumulated in the cells is about 25% higher than that of 9c. For the 10a-e series of conjugates,
uptake trend followed the order, 10b ~ 10d > 10a > 10c ~ 10e. Once again, the highest uptake in
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the series was that of 10b, i.e. hexaethylene glycol-functionalized BODIPY followed by 10a,
which was rapidly taken up by the cells within the first 1 h after BODIPY exposure.
Interestingly, conjugates 10c and 10e, containing tetraacetate galactose and lactose, were the
least accumulated within cells at all the time points studied. Although there was a slight
difference in the uptake of 10e compared with the corresponding 10c, this difference was not
significant and probably reflects, better ability of 10e to bind to specific cell receptors.
4.3.3.2: Cytotoxicity. The dark toxicity and photo cytotoxicity of BODIPYs and BODIPYconjugates was evaluated in HEp2 cells exposed to increasing concentration of each compound
up to 100 µM, using Cell Titer Blue viability assay (Promega). The results are shown in Figure
4.10. It can be seen that all the compounds are essentially non-cytotoxic in the absence [IC50
(dark) > 100 µM] or presence of light [IC50 (1 J/cm2) > 100 µM] and the observed results are in
consensus with the previously reported investigations.

Figure 4.9: Time Dependent Cellular Uptake of BODIPYs 6 (Grey), 9a (Red), 9b (Orange), 9c
(Brown), 7 (Light Green), 10a (Purple), 10b (Black), 10c (Dark Green), 10d (Light Blue) and
10e (Blue) at 10 µM by HEp2 cells.
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Figure 4.10: (a) Dark Cytotoxicity and (b) Photocytotoxicity of BODIPYs 6 (Grey), 9a (Red),
9b (Orange), 9c (Brown), 7 (Light Green), 10a (Purple), 10b (Black), 10c (Dark Green), 10d
(Light Blue) and 10e (Blue) toward HEp2 cells using a Cell Titer Blue assay and 1 J/cm-2 light
dose.

4.4: Conclusion
In conclusion, a series of ten novel red and NIR-emissive BODIPY-PEG and BODIPYcarbohydrate conjugates containing either one or two diindolyl styryl- arms at 3- and/or 5positions were successfully synthesized in moderate to excellent yields using a very convenient,
rapid and efficient Cu(I)-catalyzed azide-alkyne Huisgen cycloaddition (so called “click
chemistry”). All these new conjugates were fully characterized using 1H-NMR, 13C-NMR, Mass
spectrometry (MALDI-TOF) and UV-Vis/fluorescence spectroscopy. BODIPY-PEG and
BODIPY-Carbohydrate conjugates displayed good photophysical properties, i.e. strong
absorbance and emission in the range of 525-704 and 534-732 nm, respectively and high molar
extinction coefficient (4.1-4.5). Furthermore, the attractive cycloaddition strategy had negligible
effects on the spectral characteristics of BODIPY-PEG and BODIPY-Carbohydrate conjugates.
Preliminary in vitro studies using human carcinoma HEp2 cells indicated all the BODIPYconjugates were cell permeable, non-cytotoxic with high cellular uptake. The monoindolyl
styryl-BODIPY conjugates (9a-c) were the most efficiently taken up by the HEp2 cells,
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accumulating nearly 5 times more than the di- indolyl styryl BODIPY (10a-e) conjugates. Since
a plethora of azido-PEGs and carbohydrate azides are readily available, this flexible modular
synthesis is expected to provide a versatile platform for vast arrays of functionalized BODIPYs
possessing potential utility in in vivo imaging.

4.5: Experimental
4.5.1: General Information
Commercially available reagents were purchased from Sigma-Aldrich Co. Canada, Alfa Aesar
Co. or TCI America Co. and were used without further purification. All solvents were purchased
from Fisher Scientific (HPLC grade) and either used directly or dried and distilled according to
the literature procedures. All air and moisture sensitive reactions were performed under argon
atmosphere in oven-dried glassware. Melting points were measured on an Electrothermal MELTEMP instrument. Analytical thin-layer-chromatography (TLC) was performed on polyester
backed TLC plates 254 (pre-coated, 200 µm, Sorbent Technologies). Column chromatography
was performed on silica gel (Sorbent Technologies, 60 Å, 40-63 µm) slurry packed into glass
columns. 1H NMR and 13C NMR spectra were recorded using a Bruker DPX-400 spectrometer
(operating at 400MHz for 1H NMR and 100 MHz for
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C NMR) in CDCl3 (7.26 ppm, 1H and

77.0 ppm,13C), (CD3)2CO (2.05 ppm, 1H and 29.84 ppm and 206.26 ppm,

13

C) and (CD3)2SO

(2.50 ppm, 1H and 39.52 ppm,13C). Chemical shifts are given in parts per millions (ppm) relative
to tetramethylsilane (TMS, 0 ppm); multiplicities are indicated as br (broad), s (singlet), d
(doublet), t (triplet), q (quartet) and m (multiplet). All spectra were recorded at 298 K and
coupling constants (J values) are given in Hz. High resolution mass spectra were obtained at the
LSU Department of Chemistry Mass Spectrometry Facility using Bruker Omniflex MALDI
Time-of-Flight Mass Spectrometer. The absorption measurements were carried out on a Varian
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Cary 50 UV/Vis spectrophotometer and the steady-state fluorescence spectroscopic studies were
performed on a PTI Quantum Master4/2006SE spectrofluorometer. All spectras were recorded at
298 K using non-degassed samples, spectroscopic grade solvents and a 10 mm quartz cuvette.

4.5.2: Syntheses
4-(prop-2-ynyloxy)-benzaldehyde (2)
4-hydroxybenzaldehyde, 1, (3.00 g, 24.6 mmol) and propargyl bromide (11.70 g, 98.3 mmol, 4
equiv.) were added to a solution of potassium carbonate (13.58 g, 98.3 mmol) in 150 mL
acetone. The reaction mixture was heated to reflux overnight and then cooled to room
temperature. The heterogeneous solution was filtered off to remove solid potassium carbonate
and the solvent was removed under reduced pressure. The crude product was dissolved in
dichloromethane (30 mL) and washed successively with water (2 x 30 mL), 5% NaHCO3 (1 x 30
mL) and brine (1 x 30 mL). The organic extracts were combined, dried over Na2SO4 and
concentrated under vacuum. The resulting crude product was purified by column
chromatography using pure dichloromethane as the eluent to afford 3.70 g of the compound 2 as
pale yellow solid (quantitative). m.p. 77-78°C; 1H NMR (400 MHz, CDCl3) δ 9.90 (s, 1H), 7.84
(d, J = 8.4 Hz, 2H), 7.09 (d, J = 8.4 Hz, 2H), 4.78 (d, J = 2.4 Hz, 2H), 2.57 (t, J = 2.4 Hz, 1H);
MALDI-TOF m/z 161.059; calcd. for C10H9O2: 161.16.
BODIPY 4
Kryptopyrrole, 3 (1.0 g, 8.1168 mmole, 2 equiv.) and compound 2 (0.6490 g, 4.0584 mmol, 1
equiv.) were dissolved in dry dichloromethane (80 mL) under the inert gas atmosphere. Three
drops of trifluoroacetic acid were added and the reaction mixture was stirred overnight at room
temperature. When the aldehyde was consumed (monitored by TLC), a solution of DDQ (0.9212
g, 4.0584 mmole, 1.2 equiv.) in dry dichloromethane (10 mL) was added via syringe at 0°C.
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After stirring for 20 min at room temperature, triethylamine (4 mL, 7 equiv.) was added
dropwise over a period of 5 min and reaction mixture was stirred for another 30 min at room
temperature. Further, BF3 Et2O (5.6 mL, 11 equiv.) was added dropwise at 0°C over a period of
10 min and the mixture was stirred for 10h at room temperature. Once TLC indicated reaction
completion, the reaction mixture was passed through a short pad of silica gel to get rid of the
oxidized dipyrromethene derivatives and starting materials. The solvent was removed under
reduced pressure and the residue was taken up in dichloromethane (30 mL) and kept for
overnight stirring at room temperature to decompose any unreacted BF3 Et2O. The subsequent
reaction mixture was extracted with 0.1M HCl (2 x 30mL) to remove excess DDQ, brine (1 x 30
mL) and dried over Na2SO4. The organic extracts were collected, dried over Na2SO4 and the
solvent was evaporated. The crude product was purified by column chromatography using
petroleum ether/dichloromethane (1/1, v/v) as eluent. The orange-green fluorescent fraction
containing the desired BODIPY 4 was collected and recrystallized from dichloromethane/hexane
mixtures to yield the title compound as lustrous orange-red solid. Yield: 1.656 g, 94%. 1H NMR
(400 MHz, CDCl3) δ 7.19 ( d, J = 8.8 Hz, 2H), 7.08 (d, J = 8.8 Hz, 2H), 4.76 (d, J = 2.0 Hz,
2H), 2.56 (d, J = 2.0 Hz, 1H), 2.53 (s, 6H), 2.29 (q, J = 7.6Hz, 4H), 1.33(s, 6H), 0.98 (t, J = 7.6
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 157.9, 153.6, 139.9, 138.4, 132.7, 129.5, 128.8, 115.5,
78.1, 75.8, 56.0, 17.0, 14.6, 12.4, 11.8; MALDI-TOF m/z 434.33; calcd. for C26H29BF2N2O:
434.23.
BODIPYs 6 and 7
BODIPY 4 (0.3123 g, 0.7190 mmol) and indole-3-carbaldehyde, 5 (0.3131 g, 2.157 mmol, 3
equiv.) were added to a 150 mL single necked round bottom flask containing a mixture of dry
toluene (50 ml), piperidine (0.4 ml) and glacial acetic acid (0.4 ml). The mixture was refluxed
and any water formed during the reaction was removed azeotropically by using a Dean-Stark
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trap. After completion of the reaction (monitored via thin-layer chromatography), the mixture
was cooled to room temperature and the solvent was removed under reduced pressure. The
residue was purified by silica gel column chromatography using dichloromethane/petroleum
ether (2/1, v/v) as eluent.
(BODIPY 6): The first fraction with red fluorescence was dried in vacuo, affording BODIPY 6
as a red-blue solid (145 mg, yield 36%). 1H NMR (400 MHz, (CD3)2CO): δ; 10.72 (s, NH), 8.16
(m, 1H), 7.91 (d, J = 8.1 Hz, 1H), 7.74 (d, 1H), 7.65 (d, J = 8.1 Hz, 1H), 7.49–7.51 (m, 2H),
7.20-7.32 (m, 6H), 4.89 (d, J = 2.0 Hz, 2H), 3.13 (t, J = 2.0 Hz, 1H), 2.69 (q, J = 7.6 Hz, 2H),
2.56 (s, 3H), 2.36 (q, J = 7.6 Hz, 2H), 1.41 (s, 3H), 1.38 (s, 3H), 1.19 (t, J = 7.6 Hz, 3H), 0.99 (t,
J = 7.6 Hz, 3H);
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C NMR (100MHz, (CD3)2CO): δ; 158.3, 152.1, 151.4, 129.8, 128.7, 128.2,

125.3, 122.5, 120.9, 120.7, 120.2, 115.8, 115.7, 115.6, 112.0, 78.5, 76.4 55.7, 18.0, 16.6, 14.1,
13.5, 11.8, 11.1, 10.9; MALDI-TOF m/z 561.28; calc. for C35H34BF2N3O: 561.35.
(BODIPY 7): The second fraction with green fluorescence was dried in vacuo, affording
BODIPY 7 as a green solid (0.275 g, yield 55.6%). 1H NMR (400 MHz, (CD3)2CO): δ; 10.70
(br, 2H), 8.30 (d, J = 8.1 Hz, 2H), 8.05 (d, J = 8.1 Hz, 2H), 7.69 (m, 4H), 7.51 (d, J = 2.0 Hz,
2H), 7.20–7.35 (m, 8H), 4.88 (d, J= 2.0 Hz, 2H), 3.09 (s, 1H), 2.73 (q, J=7.6 Hz, 4H), 1.42 (s,
6H), 1.22 (t, J = 7.6 Hz, 6H);
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C NMR (100 MHz, (CD3)2CO) δ 184.3, 137.7, 137.0, 132.7,

130.2, 129.9, 128.4, 125.3, 124.6, 123.5, 122.5, 122.1, 121.3, 121.0, 120.5, 116.3, 116.0, 115.5,
112.0, 76.3, 55.7, 18.1, 13.5, 10.9; MALDI-TOF m/z 688.36; calcd. for C44H39BF2N4O: 688.32.
General procedure for click chemistry
Meso-alkynylphenyl-BODIPY (40 mg), azido-compound (2.6 equiv) and Cu (0) (1.0 equiv) were
dissolved in a mixture of THF:H20 (8 mL, 3:1), under inert gas atmosphere. Next, a solution of
CuSO4.5H2O (0.20 equiv) and Na-ascorbate (0.5 equiv.) in THF:H20 (8 mL, 3:1) was added
(after sonication for 10 min) and the reaction mixture was heated for 6 h at 70°C. Once the
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reaction was complete, the mixture was cooled to room temperature and partitioned between
EtOAc (30 mL) and water (30 mL). The aqueous layer was re-extracted with EtOAc (2 x 30 mL)
and the combined organic layers were dried over Na2SO4 and the solvent was evaporated under
reduced pressure. The crude product was then purified by preparative thin layer chromatography
to obtain the desired product.
(9a): Eluent: Dichloromethane/EtOAc (10/1, v/v); Yield: 36.7 mg, 70%. 1H NMR (400 MHz,
(CD3)2CO): δ; 10.72 (s, NH), 8.16 (m, 2H), 7.92 (d, J = 8.1 Hz, 1H), 7.75 (s, 1H), 7.65 (d, J = 8.1
Hz, 1H), 7.50–7.52 (m, 2H), 7.22-7.33 (m, 6H), 4.60 (d, J = 2.0 Hz, 2H), 3.50-3.94 (m, 13H),
2.69 (q, J = 7.6 Hz, 2H), 2.55 (s, 3H), 2.36 (q, J = 7.6 Hz, 2H), 2.05 (s, 3H), 1.43 (s, 3H), 1.39 (s,
3H), 1.20 (t, J = 7.6 Hz, 3H), 1.00 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, (CD3)2CO): δ 159.3,
152.1, 151.4, 142.9, 139.0, 138.7, 137.8, 137.1, 132.7, 132.4, 132.2, 131.4, 130.3, 129.8, 128.2,
128.1, 125.3, 124.6, 122.5, 120.6, 120.2, 115.8, 115.7, 115.5, 112.0, 72.6, 70.1, 69.1, 61.7, 61.1,
49.8, 18.0, 16.6, 14.1, 13.5, 11.8, 11.1, 11.0; MALDI-TOF m/z 736.47; calcd. for
C41H47BF2N6O4: 736.40.
(9b): Eluent: 12% acetone in EtOAc; Yield: 60.5 mg, 98%. 1H NMR (400 MHz, (CD3)2CO): δ;
10.72 (s, NH), 8.16 (m, 2H), 7.88 (d, J = 8.1 Hz, 1H), 7.75 (s, 1H), 7.67 (d, J = 8.1 Hz, 1H),
7.50–7.52 (m, 2H), 7.22-7.31 (m, 6H), 4.61 (d, J = 2.0 Hz, 2H), 3.50-3.94 (m, 25H), 2.69 (q, J =
7.6 Hz, 2H), 2.55 (s, 3H), 2.35 (q, J = 7.6 Hz, 2H), 2.05 (s, 3H), 1.43 (s, 3H), 1.39 (s, 3H), 1.19
(t, J = 7.6 Hz, 3H), 1.00 (t, J = 7.6 Hz, 3H);
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C NMR (100 MHz, (CD3)2CO): δ 159.3, 152.1,

151.4, 142.8, 139.0, 138.7, 137.8, 137.1, 132.7, 132.4, 132.3, 130.4, 129.8, 128.2, 125.3, 124.6,
122.5, 120.6, 120.2, 115.8, 115.6, 115.5, 112.1, 72.5, 70.2, 70.1, 69.2, 61.8, 61.0, 49.9, 18.0,
16.6, 14.1, 13.5, 11.8, 11.1, 11.0; MALDI-TOF m/z 868.61; calcd. for C47H59BF2N6O7: 868.48.
(9c): Eluent: 12% acetone in EtOAc; Yield: 65.0 mg, quantitative. 1H NMR (400 MHz,
(CD3)2CO): δ; 10.72 (s, NH), 8.34 (s, 1H), 8.17 (m, 1H), 7.90 (d, J = 8.1 Hz, 1H), 7.75 (s, 1H),
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7.65 (d, J = 8.1 Hz, 1H), 7.50–7.52 (m, 2H), 7.22-7.33 (m, 6H), 6.25 (d, J = 9.2 Hz, 1H), 5.75 (t,
J = 9.2 Hz, 1H), 5.57 (m, 1H), 5.46 (m, 2H), 5.32 (s, 2H), 4.63 (m, 1H), 4.12-4.27 (m, 2H), 2.72
(q, J = 7.6 Hz, 2H), 2.36 (q, J = 7.6 Hz, 2H), 2.21 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 1.90 (s,
3H), 1.80 (s,3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.19 (t, J = 7.6 Hz, 3H), 1.00 (t, J = 7.6 Hz, 3H); 13C
NMR (100 MHz, (CD3)2CO): δ 169.8, 169.6, 169.2, 168.4, 159.1, 151.4, 143.9, 137.8, 137.0,
132.6, 130.3, 129.9, 128.4, 128.1, 125.3, 122.8, 122.5, 120.6, 120.2, 115.8, 115.7, 115.4, 112.0,
85.5, 73.7, 70.9, 68.1, 67.3, 61.6, 61.4, 19.6, 19.5, 19.3, 18.0, 16.6, 14.1, 13.5, 11.8, 11.1, 11.0;
MALDI-TOF m/z 934.58; calcd. for C49H53BF2N6O10: 934.42.
(10a): Eluent: Acetone/EtOAc (1/1, v/v); Yield: 8.6 mg, 15%. 1H NMR (400 MHz, (CD3)2CO):
δ 10.7 (br, 2H), 8.30 (m, 2H), 8.18 (s, 1H), 8.04 (d, J = 8.1 Hz, 2H), 7.76 (d, J = 8.1 Hz, 2H),
7.69 (m, 2H), 7.53 (m, 2H), 7.23–7.36 (m, 8H), 5.30 (s, 2H), 4.62-3.65 (m, 12H), 2.75 (q, J=7.6
Hz, 4H), 1.45 (s, 6H), 1.21 (t, J = 7.6 Hz, 6H); 13C NMR (100 MHz, (CD3)2CO): δ 138.0, 137.8,
132.7, 130.2, 129.9, 128.6, 128.4, 125.3, 124.4, 122.4, 121.0, 120.5, 116.3, 116.0, 115.4, 112.0,
72.6, 70.1, 69.2, 61.7, 61.1, 49.8, 18.1, 13.5, 10.9; MALDI-TOF m/z 863.51; calcd. for
C50H52BF2N7O4: 863.42.
(10b): Eluent: Acetone/EtOAc (1/1, v/v); Yield: 13.2 mg, 20%. 1H NMR (400 MHz, (CD3)2CO):
δ 10.7 (br, 2 ), 8.30 (m, 2 ), 8.18 (s, 1 ), 8.03 (m, 2 ), 7.23–7.54 (m, 14H), 5.30 (s, 2H), 3.514.61 (m, 24H), 2.73 (q, J=7.6 Hz, 4H), 1.38 (s, 6H), 1.15 (t, J = 7.6 Hz, 6H);

13

C NMR (100

MHz, (CD3)2CO): δ 150.3, 138.0, 137.7, 132.7, 130.2, 129.9, 128.4, 125.3, 124.4, 122.4, 121.0,
120.5, 116.3, 116.0, 115.4, 112.0, 72.5, 70.1, 69.2, 61.8, 61.0, 49.9, 18.1, 13.5, 10.9; MALDITOF m/z 995.65; calcd. for C56H64BF2N7O7: 995.50.
(10c): Eluent: Dichloromethane/EtOAc (1/1, v/v); Yield: 40.8 mg, 57.3%. 1H NMR (400 MHz,
(CD3)2CO): δ 10.70 (brs, 2H), 8.32 (m, 2H), 8.17 (m, 1H), 8.05 (d, J = 8.1 Hz, 2H), 7.67-7.77
(m, 4H), 7.54 (m, 2H), 7.23–7.36 (m, 8H), 6.25 (d, J = 9.1 Hz, 1H), 5.77 (t, J = 9.2 Hz, 1H), 5.57
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(m, 1H), 5.46 (m, 1H), 5.31 (s, 2H), 4.63 (m, 1H), 4.13-4.28 (m, 2H), 2.73 (q, J=7.6 Hz, 4H),
2.21 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 1.96 (s, 3H), 1.44 (s, 6H), 1.20 (t, J = 7.6 Hz, 6H); 13C
NMR (100 MHz, (CD3)2CO): δ 184.4, 169.8, 169.7, 169.2, 168.4, 159.1, 150.3, 143.9, 138.0,
137.8, 137.1, 136.1, 132.7, 130.3, 129.8, 128.8, 128.5, 128.3, 125.3, 123.6, 122.9, 122.5, 122.1,
121.3, 121.07, 120.5, 116.3, 116.07, 116.02, 115.4, 112.1, 85.5, 73.7, 70.9, 68.1, 67.4, 61.6, 61.4,
19.69, 19.61, 19.3, 18.1, 13.5, 10.9; MALDI-TOF m/z 1061.65; calcd. for C58H58BF2N7O10:
1061.40.
(10d): Eluent: Acetone/EtOAc (1/1, v/v); Yield: 10.8 mg, 18.2%. 1H NMR (400 MHz,
(CD3)2SO): δ 10.7 (br, 2H), 8.48 (s, 1H), 8.08 (m, 2H), 7.80 (m, 4H), 7.54 (m, 4H), 7.13-7.32
(m, 8H), 5.56 (m, 2H), 5.23 (s, 2H), 5.01 (m, 2H), 4.45 (m, 1H), 4.13-4.28 (m, 2H), 3.31 (m,
2H), 2.66 (m, 2H), 1.38 (s, 6H), 1.15 (t, J = 7.6 Hz, 6H); MALDI-TOF m/z 893.39; calcd. for
C50H50BF2N7O6: 893.42.
(10e): Eluent: Acetone/EtOAc (3/2, v/v); Yield: 15.8 mg, 22.5%. 1H NMR (400 MHz,
(CD3)2SO): 11.7 (br, 2H), 8.49 (s, 1H), 8.08 (m, 2H), 7.80 (m, 4H), 7.54 (m, 4H), 7.23 (m, 8H),
5.62 (m, 2H), 5.23 (s, 2H), 4.94 (m, 2H), 3.49-4.67 (m, 17H), 2.66 (m, 4H), 1.22 (s, 6H), 1.15 (t,
J = 7.6 Hz, 6H); MALDI-TOF m/z 1055.62; calcd. for C56H60BF2N7O11: 1055.45.
BODIPY 15
Kryptopyrrole (1.0 g, 8.1168 mmole, 2 equiv.) and p-Bromobenzaldehyde (0.7508 g, 4.0584
mmol, 1 equiv.) were dissolved in dry dichloromethane (80 mL) under the inert gas atmosphere.
Three drops of trifluoroacetic acid were added and the reaction mixture was stirred overnight at
room temperature. When the aldehyde was consumed (monitored by TLC), a solution of DDQ
(0.9212 g, 4.0584 mmole, 1 equiv.) in dry dichloromethane (10mL) was added via syringe at
0°C. After stirring for 20 min at room temperature, triethylamine (4 mL, 7 equiv.) was added
dropwise over a period of 5 min and reaction mixture was stirred for another 30 min at room
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temperature. Further, BF3 Et2O (5.6 mL, 11 equiv.) was added dropwise at 0°C over a period of
10 min and the mixture was stirred for 3h at room temperature. Once TLC indicated reaction
completion, the solvent was removed under reduced pressure and the residue was taken up in
dichloromethane (30 mL) and extracted with 0.1M HCl (2 x 30mL) to remove excess DDQ,
brine (1 x 30 mL) and dried over Na2SO4. The organic extracts were collected, dried over
Na2SO4 and the solvent was evaporated. The crude product was purified by column
chromatography using petroleum ether/dichloromethane (1/1, v/v) as eluent. The red-orange
fluorescent fraction containing the desired BODIPY 15 was collected and recrystallized from
dichloromethane/hexane mixtures to yield title compound as lustrous green solid. Yield: 1.690 g,
91%. 1H NMR (400 MHz, CDCl3): δ 7.63 (m, 2H), 7.19 (m, 2H), 2.53 (s, 6H), 2.31(q, J = 7.6Hz,
4H), 1.32 (s, 6H), 0.98 (t, J = 7.6 Hz. 6H); 13C NMR (100 MHz, CDCl3): δ 154.1, 138.4, 138.1,
134.8, 133.0, 132.3, 130.5, 130.1, 123.0, 17.0, 14.5, 12.5, 11.9; MALDI-TOF m/z 458.13; calcd.
for C23H26BBrF2N2: 458.136.
BODIPY 16
BODIPY 15 (1g, 2.48 mmol ) and compound 2 (8.0 g, 49.6 mmol, 20 equiv.) were added to a
150 mL single necked round bottom flask containing a mixture of dry toluene (50 mL),
piperidine (2 mL) and glacial acetic acid (2 mL). The mixture was refluxed and any water
formed during the reaction was removed azeotropically by using a Dean-Stark trap. After
completion of the reaction (monitored via thin-layer chromatography), the mixture was cooled to
room temperature and the solvent was removed under reduced pressure. The residue was purified
by silica gel column chromatography using petroleum ether/dichloromethane (1/2, v/v) as eluent.
The pink fluorescent fraction was collected, evaporated to dryness and recrystallized from
dichloromethane/hexane mixtures to yield BODIPY 16 as lustrous solid. Yield: 238mg, 16%. 1H
NMR (400 MHz, CDCl3): δ 7.64 (d, J = 8.0 Hz, 2H), 7.54-7.59 (m, 3H, 2H for ArH, 1H for
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vinylic), 7.19-7.21 (m, 3H, 2H for Ar H, 1H for vinylic), 6.98 (d, J = 8.0 Hz, 2H), 4.72 (d, J = 2.3
Hz, 2H), 2.57 (m, 6H), 2.32 (q, J = 7.6Hz, 2H), 1.35 (s, 3H), 1.33 (s, 3H), 1.14 (t, J = 7.6 Hz,
3H), 0.99 (t, J = 7.6 Hz, 3H); 13C NMR(100 MHz, CDCl3): δ 157.9, 155.5, 149.7, 142.2, 142.1,
138.4, 137.5, 134.9, 133.8, 132.3, 131.5, 130.2, 130.1, 128.9, 123.2, 121.3, 117.7, 117.5, 115.3,
78.2, 75.7, 55.9, 14.8, 14.6, 14.5, 12.5, 11.7, 10.9; MALDI-TOF m/z 600.18; calcd. for
C33H32BBrF2N2O: 600.20.

4.5.3: Steady-state Absorption and Fluorescence Spectroscopy
All absorption spectra were recorded on a Varian Cary 50 UV/Vis spectrophotometer. All
solvents used were HPLC grade and all studies were performed using non-degassed samples.
Steady-state emission spectra were obtained on a

PTI Quantum Master4/2006SE

spectrofluorimeter. For the fluorescence experiments, only dilute solutions with the optical
density between 0.04-0.06 at the excitation wavelength were used. All measurements were
carried out at room temperature within 2 h of solution preparation, using a 10 mm path length
spectrophotometric cell.

4.5.4: Cellular Studies. Human carcinoma HEp2 cells were maintained in a 50:50 mixture of
DMEM:Advanced MEM (Invitrogen) supplemented with 5% FBS (Invitrogen), 1% Primocin
antibiotic (Invitrogen) in a humidified, 5% CO2 incubator at 37°C. The cells were sub-cultured
biweekly to maintain sub-confluent stocks. The fourth to fifteenth passage cells were used for all
the experiments.
4.5.4.1: Time-Dependent Cellular Uptake. The HEp2 cells were plated at 7500 cells per well in a
Costar 96-well plate and allowed to grow for 48 h. Compound stock solutions were prepared at
32 mM in DMSO and Cremophor (1% of Cremophor EL in DMSO). Further dilution into the
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cells of the 96-well plate gave a final concentration of 10 M with maximum DMSO
concentration of 1% and Cremophor concentration of 0.1%. For the uptake test, the compounds
were diluted to 20 µM (2 x stock solution) and added to the 96-well plate to give a final
concentration of 10 M at 0, 1, 2, 4, 8, 12 and 24h interval. The uptake was terminated by
removing the loading medium and washing the wells with PBS (Phosphate buffer saline). The
cells were then solubilized using 100 L of 0.25% Triton X-100 (Calbiochem) in PBS. The
concentration of the compounds was measured using intrinsic fluorescence as measured with a
BMG FLUOstar plate reader equipped with a 355 nm excitation and a 650 nm emission filter.
The cells were measured using a CyQuant cell proliferation assay (Invitrogen) as per
manufactures’ instructions, and the uptake was expressed in terms of nM compound per cell.
4.5.4.2: Dark Cytotoxicity. The HEp2 cells were plated as described above for the uptake
experiment and allowed 36-48 h to attach. The cells were exposed to increasing concentrations
of BODIPYs up to 100 M and incubated overnight. After compound loading overnight, the
loading medium was removed, and the cells were fed medium containing CellTiter Blue
(Promega) as per manufacturer’s instructions. Cytotoxicity was then measured with untreated
cells considered as 100% viable and cells treated with 0.2% saponin as 0% viable. The IC50
values were determined from dose-response curves obtained using GraphPad Prism software.
4.5.4.3: Phototoxicity. The cells were prepared as described above for the dark cytotoxicity assay
with compounds concentration range from 6.25 to 100 M. After loading overnight, the medium
was removed and replaced with medium containing 50 mM HEPES pH 7.4. The cells were
exposed to a 175 W halogen lamp filters through a 610 nm long pass filter to provide
approximately 1.5 Jcm-2 light dose. The cells were kept cool by placing the culture on a 5 °C
Echotherm chilling/heating plate (Torrey Pines Scientific, Inc.). After exposure to light for 20
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min, the plate was incubated overnight in a 37°C incubator. Cells were assayed for viability using
CellTitre Blue Viability Assay Kit, as described above for the dark cytotoxicity experiment.
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APPENDIX A: CHARACTERIZATION DATA FOR COMPOUNDS IN CHAPTER 2

Figure A.1: 1H-NMR Spectrum of BODIPY 8 in CDCl3 at 400 MHz

Figure A.2: 1H-NMR Spectrum of BODIPY 4b in CDCl3 at 400 MHz
227

Figure A.3: 1H-NMR Spectrum of BODIPY 4c in CDCl3 at 400 MHz

Figure A.4: 1H-NMR Spectrum of BODIPY 4e in CDCl3 at 400 MHz
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APPENDIX B: CHARACTERIZATION DATA FOR COMPOUNDS IN CHAPTER 3

Figure B.1: 1H-NMR Spectrum of BODIPY 5e in CDCl3 at 400 MHz

Figure B.2: 1H-NMR Spectrum of BODIPY 5h in CDCl3 at 400 MHz
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Figure B.3: 1H-NMR Spectrum of BODIPY 6g in deuterated acetone at 400 MHz
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APPENDIX C: CHARACTERIZATION DATA FOR COMPOUNDS IN CHAPTER 4

Figure C.1: 13C-NMR spectrum of BODIPY 9a in deuterated acetone at 400 MHz

Figure C.2: 13C-NMR spectrum of BODIPY 9b in deuterated acetone at 400 MHz
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Figure C.3: 13C-NMR spectrum of BODIPY 9c in deuterated acetone at 400 MHz

Figure C.4: 1H-NMR spectrum of BODIPY 10a in deuterated acetone at 400 MHz
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Figure C.5: 1H-NMR spectrum of BODIPY 10b in deuterated acetone at 400 MHz

Figure C.6: 1H-NMR spectrum of BODIPY 10c in deuterated acetone at 400 MHz
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APPENDIX D: LETTERS OF PERMISSION
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